Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40406,0.108492391659967,0.00265388364824732,0.103290779709402,0.113694003610532,0
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40327,0.106710789086803,0.00263014528676512,0.101555704324743,0.111865873848862,0
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,37985,-0.182442759044273,0.0068196557973879,-0.195809284407154,-0.169076233681393,1.10645715417748e-153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37993,-0.0914766364888685,0.00363335668227872,-0.0985980155861348,-0.0843552573916022,9.77907207538691e-137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37895,-0.115748715545557,0.00469865135933133,-0.124958072209847,-0.106539358881268,4.2647219849589e-131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,40327,-0.0871229292620687,0.00364663551579404,-0.094270334873025,-0.0799755236511124,5.75841049301878e-124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,39975,-0.254548474035817,0.0107703917582568,-0.275658441882001,-0.233438506189634,2.36879724813198e-121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,40288,-0.0807995543056372,0.00349379524644759,-0.0876473929886745,-0.0739517156225999,2.10652913891804e-116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,40121,0.106918197204022,0.0046241775736189,0.0978548091597291,0.115981585248315,2.46906610063019e-116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40495,0.225337725497795,0.0101737149430204,0.205397244209475,0.245278206786115,4.27292066429624e-107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,40300,-0.174993298450829,0.00798741861866694,-0.190648638943416,-0.159337957958242,7.6938425662976e-105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,37982,0.0908919172950296,0.00421230713960968,0.0826357953013946,0.0991480392886646,1.48545349350558e-101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,40370,0.0368841725378312,0.00174844150924794,0.0334572271797052,0.0403111178959571,1.8810769811805e-97
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,37982,0.0440166274552588,0.00209145544397507,0.0399173747850676,0.0481158801254499,8.79621696815989e-97
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,37557,-0.171686728839821,0.00823168913486212,-0.18782083954415,-0.155552618135491,4.59485587401408e-95
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,40304,0.0552483153111183,0.0027065788802174,0.0499434207058922,0.0605532099163445,1.9304882578477e-91
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40466,-0.232386402193791,0.0114871487131366,-0.254901213671538,-0.209871590716043,7.04305541410556e-90
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40417,0.0477797478098436,0.00238279123429757,0.0431094769906204,0.0524500186290668,2.36727013518992e-88
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37937,0.0637913150739008,0.00318762079818696,0.0575435783094544,0.0700390518383472,8.07895780336328e-88
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,40336,-0.0915477238908529,0.00465384305826462,-0.100669256285052,-0.0824261914966543,3.8999394069302e-85
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,40484,0.057296831611946,0.00300769666857105,0.0514017461415467,0.0631919170823453,5.01802653993971e-80
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,40327,-0.064030162768693,0.0037127703465853,-0.0713071926480002,-0.0567531328893858,4.79755801004718e-66
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40398,0.0560541269195733,0.00327826436194841,0.0496287287701545,0.0624795250689922,5.75314219122013e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,40448,-0.171614305225777,0.0102152483367452,-0.191636191965798,-0.151592418485757,8.45258262921832e-63
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,40410,-0.0491842396084574,0.00298858257444979,-0.055041861454379,-0.0433266177625359,2.33259939837748e-60
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,40406,0.0589974469587685,0.00360633324469307,0.0519290337991701,0.0660658601183669,1.14057399761599e-59
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40492,0.0899991545054108,0.00554985504236693,0.0791214386223716,0.10087687038845,1.12913878610061e-58
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,40354,-0.0824340619753638,0.00519410175437921,-0.0926145014139471,-0.0722536225367806,2.73397114471169e-56
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40511,0.035566463140469,0.00226430257003386,0.0311284301032026,0.0400044961777354,3.46115586922412e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37623,-0.0707041978172347,0.00450353687017962,-0.0795311300827868,-0.0618772655516826,4.79027717692911e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,40419,0.0383929862701065,0.00246237114086212,0.0335667388340167,0.0432192337061962,2.08192001395856e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,37993,0.0819738793855025,0.00527360377892496,0.0716376159788096,0.0923101427921954,5.09972588758519e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,37982,0.0721038873508201,0.0047028395318506,0.0628863218683929,0.0813214528332473,1.29365692948348e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37785,-0.0346143662455034,0.00226060688427866,-0.0390451557386896,-0.0301835767523172,1.77695914637771e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,40327,0.0385035483109892,0.0025410673572042,0.033523056290869,0.0434840403311094,1.67147439762553e-51
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,40348,0.0694430536290075,0.0047273019659493,0.0601775417757469,0.0787085654822682,1.55918374836801e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40484,-0.0475460009983654,0.00323757630909267,-0.053891650564187,-0.0412003514325438,1.64513262643411e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,40484,-0.085169775809218,0.00582918938815866,-0.096594987010009,-0.073744564608427,4.87209821464546e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,40347,-0.0955479560323528,0.00665752438110262,-0.108596703819314,-0.0824992082453917,2.02241621127713e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),37730,0.216840024176386,0.0153939787347109,0.186667825856353,0.24701222249642,9.71446926595697e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,38008,0.0816332249213661,0.00580583686268799,0.0702537846704977,0.0930126651722346,1.3651001921756e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40223,-0.0358278309348741,0.00256504520940342,-0.0408553195453048,-0.0308003423244434,4.49122048232201e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40531,0.0293755429714579,0.00212158898106926,0.0252172285685622,0.0335338573743537,2.38471724570585e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,37896,-0.0818084197454935,0.00597301000484784,-0.0935155193549953,-0.0701013201359918,2.05585887878219e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,40352,-0.0630662583122001,0.00462778409317938,-0.0721367151348316,-0.0539958014895685,4.71881406188854e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,38008,-0.0222003113740435,0.00162966498783077,-0.0253944547501918,-0.0190061679978952,5.55092181715448e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,40332,-0.120288544499679,0.00883809940586524,-0.137611219335175,-0.102965869664184,5.98526484102647e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40367,0.0350596464823837,0.00259965158915573,0.0299643293676384,0.0401549635971289,3.17249265239921e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,37693,0.0359255448459861,0.00269553045741204,0.0306423051494585,0.0412087845425137,2.89771156307301e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,37666,-0.0331065662998725,0.00252473516515178,-0.0380550472235699,-0.028158085376175,4.86861298046922e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40327,0.030683603322724,0.00236506806994948,0.026048069905623,0.035319136739825,2.70184686952441e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,40387,-0.0365894032108072,0.00282477530265903,-0.0421259628040189,-0.0310528436175955,3.52020324191888e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,40395,-0.0385567067340369,0.00299015673206115,-0.0444174139288767,-0.032695999539197,7.46905987014807e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40354,0.0303099385640915,0.00235589530873974,0.0256923837589616,0.0349274933692214,1.08417131777491e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,40219,0.0317849038401175,0.00248658185804488,0.0269112033983495,0.0366586042818855,3.14013123510325e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40531,0.0350655148814455,0.00277094139074097,0.0296344697555932,0.0404965600072978,1.57310527717843e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,40406,-0.0371925806859648,0.00294996363911406,-0.0429745094186284,-0.0314106519533013,2.84794318483548e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40300,0.0453773672766235,0.00361072053284725,0.0383003550322429,0.0524543795210041,4.73990679796077e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,39956,-0.0552152379783906,0.00440507916758964,-0.0638491931468663,-0.0465812828099149,7.21897870973155e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40374,0.0347640022949739,0.00277937184084756,0.0293164334869126,0.0402115711030351,9.95407262585433e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,40466,0.0405521117272446,0.00326623688287998,0.0341502874367999,0.0469539360176894,3.12621193623081e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,40417,0.0476427209536956,0.00388805615617252,0.0400221308875975,0.0552633110197938,2.29278884691291e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37593,-0.129827582594993,0.0106355642807446,-0.150673288585253,-0.108981876604734,4.36579126248644e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40398,0.0474123114373065,0.00388899927203106,0.0397898728641256,0.0550347500104873,4.89673879106403e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,40406,-0.0427089768457336,0.0035109504805388,-0.0495904397875896,-0.0358275139038775,6.78659763516963e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,40223,0.0357072576707388,0.0029392616483211,0.0299463048400294,0.0414682105014482,8.28529844431434e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40448,-0.0439456798144296,0.00367771074838328,-0.0511539928812608,-0.0367373667475984,9.03873862365865e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40049,-0.0778600806685285,0.00652608057603252,-0.0906511985975522,-0.0650689627395048,1.13721402269898e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,40354,0.0470893355802682,0.0040197729218671,0.0392105806534087,0.0549680905071277,1.44934712099755e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,40497,0.055620740738601,0.00475212638630409,0.0463065730214449,0.064934908455757,1.62552843050049e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,40037,-0.0689358375841514,0.00589183265966763,-0.0804838295970999,-0.0573878455712028,1.72118811773261e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40398,0.0348703552746641,0.00298447201256546,0.0290207901300358,0.0407199204192924,2.0680769264828e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37365,-0.0327422566123334,0.00280104954206851,-0.0382323137147877,-0.0272521995098791,2.08134017281723e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,37985,-0.0921216589570586,0.00799179752201484,-0.107785582100208,-0.0764577358139095,1.33965034516163e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40398,0.0277960081332307,0.00242674307181987,0.0230395917124638,0.0325524245539976,2.94733476946263e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37968,0.0736695974618966,0.00643753473550579,0.0610520293803052,0.0862871655434879,3.47989809890231e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,39958,-0.059592432381886,0.0052125085531628,-0.0698089491460851,-0.0493759156176869,3.79579687022277e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40466,0.0218253984410359,0.00191316840075015,0.0180755883755656,0.0255752085065062,4.9820954559785e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40037,-0.0487474970430085,0.00429247409612205,-0.0571607462714077,-0.0403342478146093,9.01360209885985e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,39238,-0.039703421545006,0.00350922213577624,-0.0465814969311274,-0.0328253461588846,1.47943467075531e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,40223,-0.0512144679499678,0.0045273913295777,-0.0600881549559401,-0.0423407809439955,1.48530676837128e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,40484,0.0455647338883304,0.0040338753484786,0.0376583382053123,0.0534711295713485,1.78445770634436e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,40393,-0.0632113220739972,0.00561825977581224,-0.0742231112345892,-0.0521995329134052,2.95004793458949e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,40531,0.0272289453530921,0.00242388078047342,0.0224781390233642,0.03197975168282,3.58100011619313e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40354,-0.0332066545306043,0.00296963835899532,-0.0390271457142351,-0.0273861633469735,6.39988769927361e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,40039,-0.0750101649760909,0.00672663981119021,-0.0881943790060237,-0.0618259509461581,9.07631282291725e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40354,-0.0411186141267883,0.00369013774571168,-0.0483512841083832,-0.0338859441451934,9.91478086393882e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,40327,0.0261664651951368,0.00236169257253795,0.0215375477529625,0.0307953826373112,2.00439039301194e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,38008,-0.0356111666336053,0.00322941316620376,-0.0419408164393647,-0.0292815168278459,3.7242215994838e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40417,0.0198782510114045,0.00180901673147794,0.0163325782177077,0.0234239238051013,5.4726500543345e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37895,-0.0371442427008181,0.003381342882777,-0.043771674751061,-0.0305168106505752,5.92893028239686e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40484,0.0557656041266941,0.00508711842365416,0.0457948520163319,0.0657363562370562,7.29894754315548e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40300,-0.0398627862810619,0.00364259848783932,-0.047002279317227,-0.0327232932448968,8.97465705127055e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40336,0.0368034929555758,0.00339968856602251,0.0301401033661717,0.0434668825449799,3.24221274192904e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,40367,-0.0170695942558136,0.00157743970477159,-0.0201613760771659,-0.0139778124344613,3.40175687996301e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,37955,-0.0436570722353088,0.00403534718337939,-0.0515663527147324,-0.0357477917558852,3.62942681594577e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,40511,-0.0502792686105516,0.00468719020484233,-0.0594661614120425,-0.0410923758090606,9.37153686668744e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,40391,0.028638383409726,0.00268028082556812,0.0233850329916125,0.0338917338278395,1.47415737663747e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,37985,0.0255187830077904,0.00239244291484909,0.0208295948946861,0.0302079711208946,1.8617149447867e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37666,-0.0351573709243789,0.0033020166277988,-0.0416293235148646,-0.0286854183338933,2.29701971308678e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40531,0.0322814205380283,0.00303700733129245,0.0263288861686951,0.0382339549073615,2.6607617739509e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,37637,-0.0336617862186498,0.00317448054210144,-0.0398837680811686,-0.027439804356131,3.64386787459469e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40391,0.0424575388878194,0.00400583148618916,0.0346061091748887,0.0503089686007502,3.68317923743612e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,40414,-0.0542747301223827,0.00512380900376743,-0.0643173957697669,-0.0442320644749985,3.93591627867266e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,40327,0.0272728621040189,0.00257843284494999,0.0222191337279169,0.0323265904801209,4.63669397681619e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39834,-0.0936456496254514,0.00890941033598417,-0.11110809388398,-0.0761832053669224,9.4117391007673e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39975,-0.0693261395980523,0.00663240436114805,-0.0823256521459024,-0.0563266270502021,1.73156584081235e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37915,-0.0761356043193977,0.00728299373389171,-0.0904102720378255,-0.0618609366009699,1.76054830090232e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40223,-0.0292536199677479,0.00280780376919893,-0.0347569153553778,-0.023750324580118,2.46226503354231e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,40300,-0.0738775106312928,0.00714152713206165,-0.0878749038101336,-0.059880117452452,5.30792933892963e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,40325,0.15797377399478,0.0153603424589283,0.12786750277528,0.188080045214279,9.89465567868705e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37896,-0.0844004692868918,0.00822771568304676,-0.100526792025663,-0.0682741465481202,1.34129790528041e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40037,-0.0755364154197352,0.0073875009806011,-0.0900159173417134,-0.0610569134977571,1.8325931344743e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,40328,-0.07415977532919,0.00725453732990063,-0.0883786684957953,-0.0599408821625848,1.87133637978464e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40466,0.040481597223647,0.00396933744376384,0.0327016958338698,0.0482614986134241,2.38809488060898e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38008,0.0227667964832391,0.00224442650670353,0.0183677205301001,0.027165872436378,4.30845570934785e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40300,0.0211704433886003,0.00208841385933438,0.0170771522243049,0.0252637345528957,4.47858196351656e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,40300,-0.0320013581025329,0.00317308786415235,-0.0382206103162715,-0.0257821058887943,7.57771861086758e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,40340,-0.0274989634767074,0.00272779545062157,-0.0328454425599257,-0.0221524843934891,7.90496772073201e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,40531,-0.0464124027605699,0.00464411283098281,-0.0555148639092962,-0.0373099416118436,1.8989500562132e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,40362,0.0324310090022984,0.00325329595699309,0.026054548926592,0.0388074690780049,2.44712070142059e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,40111,0.0239492803103269,0.00241474071994467,0.0192163884992353,0.0286821721214185,4.06930506616474e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40336,-0.0239265029066344,0.00242665067949976,-0.0286827382384539,-0.0191702675748148,7.22575079362862e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40300,0.0362879812955571,0.00368682615603514,0.0290618020297282,0.043514160561386,8.57542427553351e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40531,0.0134262415556686,0.00136425827554983,0.010752295335591,0.0161001877757463,8.65777126016538e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,37955,-0.0462525831480026,0.00471910476648891,-0.0555020284903209,-0.0370031378056843,1.32429182144755e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37814,-0.0231968766732445,0.00237652556394852,-0.0278548667785836,-0.0185388865679053,1.9700727168723e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,37666,-0.0356468078678664,0.00366497909153292,-0.0428301668872709,-0.0284634488484619,2.76550490394676e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40406,-0.0294384808087775,0.00303264088934236,-0.0353824569518885,-0.0234945046656665,3.23630214324527e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40327,0.0306770640688887,0.00316296755386829,0.0244776476633068,0.0368764804744706,3.51438811906518e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,37896,-0.0934623534850253,0.00968991427653772,-0.112454585467039,-0.0744701215030113,6.05959266291039e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40379,0.0258507363954373,0.00268902875627815,0.0205802400331322,0.0311212327577425,8.04442338940411e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39975,-0.0493914966328308,0.00513905393893727,-0.0594640423531478,-0.0393189509125137,8.2622536655765e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37666,0.025742957297515,0.00267801058049165,0.0204940565597514,0.0309918580352787,8.32738449529097e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,40063,0.0252004954309435,0.00262447840179086,0.0200565177634334,0.0303444730984536,8.99738746124463e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,38008,-0.0183771318828706,0.00191459178753307,-0.0221297317864354,-0.0146245319793058,9.51520258674496e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,37666,-0.0434692154982985,0.00453110514090146,-0.0523501815744654,-0.0345882494221317,1.00205053869269e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40300,-0.0661473022967965,0.00694604812486037,-0.0797615566215228,-0.0525330479720702,1.91984831667282e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,40509,0.0350547487472408,0.00368793445781949,0.0278263972099146,0.042283100284567,2.27134414456503e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37953,0.0122657170229419,0.00129331796063364,0.00973081382009994,0.0148006202257838,2.85251645495011e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37666,-0.030336858146809,0.00320824557128484,-0.0366250194665273,-0.0240486968270907,3.73539716040252e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,40466,-0.0304082483482366,0.00322618042346664,-0.0367315619782312,-0.0240849347182419,4.85469283861845e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40374,0.028429955404092,0.00301636723501721,0.0225178756234583,0.0343420351847258,4.86899275184939e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40353,-0.0825500863766263,0.00877319927992604,-0.0997455569652813,-0.0653546157879712,5.66003518035045e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,37567,-0.0652520703783954,0.00693659675660442,-0.0788478000213401,-0.0516563407354508,5.94673264861524e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37985,-0.0232386080770068,0.00247921550258034,-0.0280978704620643,-0.0183793456919493,8.12307310916296e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40300,-0.0450455268789116,0.00481173127752527,-0.0544765201828612,-0.0356145335749621,8.88544465781494e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,37993,0.0310653752555507,0.00331874438439934,0.024560636262128,0.0375701142489735,9.16130773214538e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,40354,0.0218237345041477,0.00233417190809491,0.0172487575642817,0.0263987114440138,9.93729769956925e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37993,-0.0251189805790841,0.00270825963932971,-0.0304271694721703,-0.0198107916859979,2.04237473169802e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,37623,-0.0441870446731111,0.00476875243270601,-0.0535337994412149,-0.0348402899050073,2.22960635812763e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,40484,-0.0367394470154937,0.00396983984476263,-0.0445203331112284,-0.0289585609197589,2.41540422421279e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,37985,-0.0203122524860238,0.00219955936222966,-0.024623388835994,-0.0160011161360537,2.97037778984525e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,38008,0.0187147187752115,0.00203420003158356,0.0147276867133077,0.0227017508371153,4.09403439755739e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,40531,-0.0403490020289603,0.00439124035970528,-0.0489558331339826,-0.0317421709239379,4.45950653488956e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,40484,-0.0272902678314188,0.00297331853448345,-0.0331179721590063,-0.0214625635038312,4.89892548584094e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,40354,0.0418434116814463,0.00456897513741808,0.0328882204121069,0.0507986029507858,5.90936387299628e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,40300,0.0363067284064837,0.00396616715968839,0.0285330407734945,0.0440804160394729,6.13650926746292e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37985,-0.0475540696748291,0.005230410401093,-0.0578056740609714,-0.0373024652886868,1.10753410702949e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,40300,-0.0394293309205516,0.00435610561054954,-0.0479672979172287,-0.0308913639238745,1.57100853871408e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,40531,0.0129901714807816,0.0014390926540829,0.0101695498787792,0.0158107930827841,1.96698691200244e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37993,0.0167602509560635,0.00185767052357589,0.0131192167298548,0.0204012851822723,2.08882778294775e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,40336,-0.0259726984733525,0.00288134038025897,-0.03162012561866,-0.0203252713280449,2.2070516288241e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,37805,0.0840599195284576,0.00936813238687886,0.065698380050175,0.10242145900674,3.26701973034157e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40352,0.026676422469887,0.00297721592225634,0.0208410792622646,0.0325117656775094,3.59465048399734e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40531,0.0228125951500407,0.0025473567691536,0.0178197758824996,0.0278054144175817,3.74916043184986e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,40371,-0.0234351381177125,0.00262978964480341,-0.0285895258215271,-0.0182807504138978,5.57521472338545e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37955,-0.0447613052426506,0.00502607460283532,-0.0546124114642078,-0.0349101990210934,5.96862016791079e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,40300,0.022162504910183,0.00249286963947949,0.0172764804168032,0.0270485294035628,6.73649096003771e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,40406,0.0213530672949528,0.00241494385035966,0.0166197773482479,0.0260863572416577,1.03639044764628e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40374,0.0186177053937955,0.00210694772629093,0.0144880878502653,0.0227473229373257,1.09072790728779e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,37866,-0.0197658088703283,0.0022405131938264,-0.0241572147302281,-0.0153744030104286,1.26176711281774e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37896,0.0225742409118676,0.00256456487699276,0.0175476937529618,0.0276007880707734,1.50146452332885e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40406,0.0328682450797301,0.00373654733549965,0.0255446123021508,0.0401918778573094,1.55468383004829e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,40466,0.0227320374034341,0.00258784428304354,0.0176598626086688,0.0278042121981995,1.73244733824793e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,37923,0.0146766833424554,0.00167103632919634,0.0114014521372306,0.0179519145476802,1.78214339684048e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37557,-0.0433125786284718,0.00493709962286263,-0.0529892938892826,-0.0336358633676611,1.95471191717647e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,40333,0.0349744067627579,0.00399579366904097,0.0271426511714376,0.0428061623540782,2.28736186401453e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40531,0.0211054149789627,0.00241383105191692,0.0163743061172055,0.0258365238407198,2.47934071364636e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37964,0.0371079333693233,0.00424892744165258,0.0287800355836842,0.0454358311549623,2.75672980717208e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,40511,-0.0208585019938593,0.00239343021395513,-0.0255496252132114,-0.0161673787745073,3.19018483579908e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37593,0.0246683015592405,0.00283176749512298,0.0191180372687994,0.0302185658496815,3.3608943872378e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,40223,-0.0311737456950468,0.00358301338955546,-0.0381964519385755,-0.0241510394515181,3.62834960445869e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,40300,0.0219473145120624,0.00252482951000151,0.0169986486724594,0.0268959803516653,3.88455286157632e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,40253,0.032005161866126,0.00368590396769851,0.0247807900894369,0.039229533642815,4.22157609794138e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,37993,-0.0566353933568214,0.00652351483612161,-0.0694214824356198,-0.0438493042780231,4.3392681106086e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37937,-0.0646678911565723,0.0075634020946039,-0.079492159261996,-0.0498436230511487,1.36100149419932e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40531,0.0214766466429985,0.00251382454571276,0.0165495505334015,0.0264037427525956,1.41849670047552e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,40327,-0.0261648579281226,0.00306985695488,-0.0321817775596874,-0.0201479382965578,1.69064014507287e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40320,0.0167402500573172,0.00196513150760835,0.0128885923024048,0.0205919078122296,1.75755046281202e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,37982,-0.0193661134254994,0.00227629905599584,-0.0238276595752512,-0.0149045672757475,1.9586995754732e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,40466,0.022348119033796,0.00264206218093911,0.0171696771591553,0.0275265609084366,2.93726895876859e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,40336,0.0193335172278336,0.00228611235162762,0.0148527370186434,0.0238142974370237,2.98087372560561e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,40429,-0.0353931058826214,0.00418522621053444,-0.0435961492552689,-0.0271900625099739,2.98616842950197e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,40223,0.0186917681044866,0.00221134485287892,0.0143575321928439,0.0230260040161293,3.09331561944437e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,40355,0.0283480738955764,0.00335996630964486,0.0217625399286724,0.0349336078624803,3.53247321979278e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,40300,-0.0507778112380222,0.00603227965810742,-0.0626010793679128,-0.0389545431081317,4.16481991443724e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,40327,-0.0416486326902745,0.00496170432223911,-0.0513735731618632,-0.0319236922186859,5.09012200547457e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,37937,-0.0957698886659151,0.0114224384802174,-0.118157868087141,-0.0733819092446891,5.60204559384366e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37623,-0.0419085137664473,0.00501374441868433,-0.0517354528270686,-0.032081574705826,6.97148852594535e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,37972,0.0245929438984878,0.0029474560726993,0.0188159299959971,0.0303699578009784,7.88717697558164e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40466,0.0337426897075752,0.00405449730498719,0.0257958749898004,0.0416895044253501,9.31712675198428e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,40484,-0.0196576876387574,0.00236721636522465,-0.0242974317145977,-0.0150179435629171,1.08495555672949e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40398,0.0199468461669244,0.00242171590985851,0.0152002829836017,0.0246934093502471,1.90701230634594e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,40367,0.0193602186471112,0.00235231241445642,0.0147496863147766,0.0239707509794458,2.010978962438e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40314,0.0177592692188153,0.00215871581413633,0.0135281862231081,0.0219903522145224,2.07114401391911e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,40365,0.0204721976525378,0.00248890524853299,0.0155939433654131,0.0253504519396624,2.09475015003012e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40511,0.0209908809411172,0.00255668044905743,0.0159797872609646,0.0260019746212697,2.3743479075133e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37830,-0.0236492159879423,0.00288826932259846,-0.0293102238602353,-0.0179882081156493,2.89458074438122e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37895,-0.0366855002681473,0.00448479774754668,-0.0454757038533388,-0.0278952966829558,3.09248927296142e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37780,0.0299394773264327,0.00367019304934038,0.0227458989497255,0.0371330557031398,3.72573257385287e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39954,0.0335334816814724,0.00411963873315913,0.0254589897644805,0.0416079735984642,4.25413943316289e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37623,0.0451829010445087,0.00557693538001233,0.0342521076996845,0.0561136943893329,5.89230319436548e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,40464,-0.0438990544630933,0.00542146457935765,-0.0545251250386342,-0.0332729838875523,6.02200863352832e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,40406,0.019425943540646,0.00240215212804473,0.0147177253696783,0.0241341617116137,6.55704650568327e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,40328,0.0155717839367625,0.00192618673214033,0.0117964579417674,0.0193471099317575,6.70213665429137e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,40300,-0.0967667838187088,0.011995831079324,-0.120278612734184,-0.0732549549032338,7.7355205062557e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,40354,-0.0503163712435645,0.00627255024046066,-0.0626105697148674,-0.0380221727722616,1.11531202903877e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,40300,-0.0377065670566687,0.00470702582544691,-0.0469323376745447,-0.0284807964387928,1.21936635084687e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37993,-0.0349903902564739,0.00436850868630784,-0.0435526672816373,-0.0264281132313105,1.24341266898351e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,40466,0.0163762931482078,0.00204628683536096,0.0123655709509003,0.0203870153455153,1.29761079816895e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40336,-0.0371951987742411,0.00466536284073565,-0.046339309942083,-0.0280510876063992,1.65835293740953e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40327,0.0169017675717352,0.00212076993790369,0.012745058493444,0.0210584766500264,1.69886629265168e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37623,0.0180920766820918,0.0022764658997695,0.0136302035185436,0.02255394984564,2.05821609947436e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40300,0.0184562666870704,0.00232457152341862,0.0139001065011699,0.0230124268729709,2.16272321377884e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,40511,0.0285611544032504,0.00360333749211379,0.0214986129187074,0.0356236958877935,2.40496449936351e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,39801,-0.0279863457082759,0.00353358221549731,-0.0349121668506507,-0.0210605245659012,2.53483675645033e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40300,-0.053583684077976,0.00677125828483364,-0.06685535031625,-0.0403120178397021,2.66911599381627e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,40325,-0.0205728264664224,0.0026090303219697,-0.025686525897483,-0.0154591270353618,3.34239614184379e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,40336,-0.0269801935081633,0.00342615690103865,-0.0336954610341991,-0.0202649259821275,3.63318158167638e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,40300,-0.0382210395385605,0.00486413287967116,-0.047754739982716,-0.028687339094405,4.16142794251148e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40438,-0.0213049269609993,0.0027113583590675,-0.0266191893447716,-0.015990664577227,4.16156586720207e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40136,-0.101794793927808,0.0130140605157581,-0.127302352538694,-0.0762872353169217,5.53254470196332e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,40354,-0.0436324735248303,0.00561706356956281,-0.0546419181211734,-0.0326230289284872,8.46829974467267e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,40450,0.0296313149411782,0.00385125183477426,0.0220828613450207,0.0371797685373358,1.50954431936774e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40352,0.0269535345815913,0.0035046543611311,0.0200844120337744,0.0338226571294083,1.54771314557561e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,40531,0.0178948035522336,0.00232998675435982,0.0133280295136883,0.0224615775907788,1.67930607001587e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40406,0.0164382964149248,0.00214255786471186,0.0122388830000895,0.02063770982976,1.78700751533638e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,37623,-0.0380313647920776,0.00497868530183043,-0.0477895879836652,-0.0282731416004899,2.34295837008417e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40325,-0.0130791990474672,0.00171655684701008,-0.016443650467607,-0.00971474762732748,2.69124865039576e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40308,-0.0367739056037863,0.004840537221177,-0.0462613585572932,-0.0272864526502794,3.19777616261674e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,40354,-0.0451464318976838,0.0059562713427283,-0.0568207237294312,-0.0334721400659363,3.65559927231271e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,37623,-0.0428211632672901,0.00565076681039044,-0.0538966662156554,-0.0317456603189249,3.74506579933358e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,40531,-0.0374038970064746,0.00495384033591937,-0.0471134240648765,-0.0276943699480726,4.56864218548182e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40372,0.0149821574618407,0.00198672057147017,0.0110881851417591,0.0188761297819222,4.90923880239258e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,40465,-0.0132488026460384,0.00175851602093501,-0.016695494047071,-0.00980211124500574,5.18002844899715e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37985,-0.0525688061080646,0.00697649727304773,-0.0662427407632382,-0.0388948714528911,5.18779234199053e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,40511,-0.0199218883878623,0.00264491973831405,-0.0251059310749578,-0.0147378457007667,5.25685587853517e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37985,0.0217926781710839,0.00290021002965419,0.0161082665129617,0.0274770898292061,6.08620177507376e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,37982,-0.0477105082443388,0.00635456658191601,-0.0601654587448942,-0.0352555577437834,6.37569210931045e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,40354,0.0296898631228926,0.00395936703398428,0.0219295037362834,0.0374502225095018,6.78811169450244e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,40531,0.0192789399886333,0.00259137288569728,0.0141998491326667,0.0243580308446,1.06036223233652e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,40398,0.0308953061490794,0.00416118857399932,0.0227393765440407,0.0390512357541181,1.18799873362058e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40406,-0.0225626310016774,0.00305732860033715,-0.0285549950583382,-0.0165702669450166,1.66268767663363e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,37593,0.0196113338182764,0.00266521312867437,0.0143875160860746,0.0248351515504781,1.97380172128086e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,40377,0.0251564730687104,0.00342111986343311,0.0184510781363815,0.0318618680010393,2.02795087926908e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38008,0.0174371114909673,0.00237167426063164,0.0127886299401293,0.0220855930418053,2.06085323096866e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,37666,0.0346973023543349,0.00473475379492645,0.025417184916279,0.0439774197923907,2.46774381923908e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37557,-0.027682898353718,0.00381187488673706,-0.0351541731317226,-0.0202116235757133,4.02108182726626e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40300,-0.0289937938247022,0.00399852819643051,-0.036830909089706,-0.0211566785596984,4.32443020177868e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,40354,0.0254009827685674,0.00352014070693261,0.0185015069829795,0.0323004585541554,5.59970633708979e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40223,-0.037890458617568,0.00525977833520081,-0.0481996241545616,-0.0275812930805744,6.11993442215671e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40511,0.0165618172886447,0.00230203269962832,0.0120498331973732,0.0210738013799162,6.5491192921807e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,40336,-0.0495151114530036,0.00688662275691292,-0.0630128920565529,-0.0360173308494543,6.76564535486834e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40350,0.0314940504325092,0.00438983672894183,0.0228899704437832,0.0400981304212352,7.58788549349017e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,40531,0.0121763076559871,0.00170698888892414,0.00883060943369583,0.0155220058782785,1.02234977512991e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37666,0.0167414592860774,0.00235209640656931,0.0121313503292016,0.0213515682429533,1.15428133754902e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40531,0.0157887782321781,0.00222210235053963,0.0114334576251204,0.0201440988392357,1.25068564488536e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,40043,0.0259477094880824,0.00365814980649736,0.0187777358673476,0.0331176831088172,1.36755928621146e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,40223,0.0213158702707479,0.00300694972231316,0.0154222488150141,0.0272094917264817,1.409457883222e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40484,0.0202082703026298,0.00285464585495375,0.0146131644269205,0.0258033761783392,1.51130096617688e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40298,-0.0299620552811566,0.0042549291573532,-0.0383017164295688,-0.0216223941327443,1.9766973394088e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,40398,0.0186745973975124,0.00267703325327005,0.0134276122211031,0.0239215825739217,3.15966865695032e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,40306,0.0420319623994918,0.00602939061011923,0.0302143568036581,0.0538495679953255,3.26691178028376e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40484,0.0209417794532998,0.00301165018326078,0.0150389450941087,0.0268446138124909,3.69853443547003e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,40039,0.0248472971938238,0.00358066217395386,0.0178291993328743,0.0318653950547734,4.09566304183499e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40398,-0.0275272317215862,0.00402333609380725,-0.0354129704654485,-0.019641492977724,8.09976812909669e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40300,-0.0626568696858939,0.00921911607190385,-0.0807263371868254,-0.0445874021849623,1.11084475017058e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40154,0.0225987578529566,0.00332686591201091,0.0160781006654152,0.029119415040498,1.13922268690361e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,40531,-0.0341540808877761,0.00503259711382389,-0.0440179712308709,-0.0242901905446813,1.18840810383502e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,37776,-0.0142565352398738,0.00210375709267806,-0.0183798991415228,-0.0101331713382248,1.28119382007172e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40037,0.0124632819151202,0.00184166315574591,0.00885362212985822,0.0160729417003822,1.35786591968427e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,40336,0.0247390401122638,0.00365826786312091,0.0175688351005468,0.0319092451239808,1.40359343029037e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,39752,-0.0552968020196946,0.00819566914565054,-0.0713603135451697,-0.0392332904942196,1.56269360603126e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,40275,-0.0462411997452426,0.00685610984082979,-0.059679175033269,-0.0328032244572162,1.58847235585914e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,40511,0.00512557390555351,0.00076135429537066,0.00363331948662701,0.00661782832448,1.72801851665452e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40039,-0.0329706670466639,0.00490140730864614,-0.0425774253716104,-0.0233639087217175,1.79501274741188e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,40492,0.0281587415114277,0.00419286807909532,0.0199407200764008,0.0363767629464545,1.9323174308412e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40300,-0.0398331887190735,0.00593806826686463,-0.0514718025221282,-0.0281945749160188,2.03840693581475e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40291,0.0282529293125499,0.00421476069574276,0.0199919983488941,0.0365138602762057,2.10603259907086e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,40531,0.0178612091108262,0.00267411852236151,0.0126199368069976,0.0231024814146547,2.4797737465965e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,38008,-0.0119821903594388,0.00181579587328179,-0.0155411502710712,-0.00842323044780653,4.29714129955373e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39881,-0.0318730727725102,0.0048316591371557,-0.0413431246813354,-0.022403020863685,4.34049529686018e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,40354,0.0196386909852643,0.00298828591308193,0.0137816505956238,0.0254957313749049,5.12245511488741e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37985,-0.0372929590120238,0.00572920255612045,-0.0485221960220198,-0.0260637220020277,7.81759013116217e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37593,-0.0246879812007435,0.00379832134694134,-0.0321326910407485,-0.0172432713607385,8.33815461238324e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40398,0.0243039841179989,0.00374984407977621,0.0169542897216375,0.0316536785143603,9.35840816120217e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40406,-0.0121616640180042,0.00188097003906065,-0.0158483652945631,-0.00847496274144536,1.0380497060502e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37937,0.0176087235257905,0.00272715559808299,0.0122634985535478,0.0229539484980331,1.10596859611788e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40300,-0.0336753940499102,0.00522112047195694,-0.0439087901749458,-0.0234419979248746,1.15210690340099e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,40300,-0.0532418390753649,0.00827849806611011,-0.0694676952849407,-0.0370159828657891,1.30105213553559e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,40398,0.0329451987332076,0.0051264246150358,0.0228974064877374,0.0429929909786777,1.34240262762836e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40275,-0.0144094008072932,0.00225265566314108,-0.0188246059070497,-0.00999419570753664,1.63304419497405e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40288,0.03256841356979,0.00509428402181012,0.0225836168870422,0.0425532102525379,1.67073932481657e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,37341,0.0249835127964658,0.0039082884951845,0.0173232673459041,0.0326437582470274,1.68882688562835e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40354,-0.0167534891896219,0.00262726831388676,-0.0219029350848399,-0.0116040432944039,1.85849863200233e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40419,0.0117806667357449,0.00184953843455701,0.00815557140401318,0.0154057620674766,1.94810705819622e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,37896,-0.0581022635916187,0.00912795188840747,-0.0759930492928974,-0.0402114778903401,2.01221339655443e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37666,-0.0271868786701483,0.00427209574867564,-0.0355601863375526,-0.0188135710027441,2.03284429875671e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,37962,-0.0314910939681694,0.00495666120837484,-0.0412061499365841,-0.0217760379997547,2.17520134938455e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37666,0.0160364567542199,0.00252890891796723,0.0110797952750041,0.0209931182334357,2.35319342849505e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,40327,0.0159742210302185,0.00251970891542274,0.0110355915559899,0.020912850504447,2.36416408409189e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40484,-0.0725181827714111,0.0114642540995066,-0.094988120806444,-0.0500482447363782,2.58951062500691e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,40327,0.0496688400089337,0.00788243253897227,0.0342192722325481,0.0651184077853194,3.03122360918809e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37937,0.0363091004041416,0.00576837428562268,0.0250030868043211,0.047615114003962,3.1791806523358e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,40531,0.0129392516719637,0.00205645077001692,0.00890860816273056,0.0169698951811969,3.21446920590653e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40531,-0.0373319121366194,0.0059379599686683,-0.0489703136752092,-0.0256935105980295,3.32022848159556e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,40327,-0.0197388256160295,0.00315034203499552,-0.0259134960046207,-0.0135641552274383,3.80933752628277e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,40412,-0.0368138329535778,0.00587629057397398,-0.0483313624785668,-0.0252963034285888,3.82851062311505e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40354,0.0173403127622644,0.00277460246437639,0.0119020919320867,0.0227785335924421,4.21836076870617e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37666,0.022205826094832,0.00355809766695948,0.0152319546675914,0.0291796975220726,4.48279146610409e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40417,0.0155136800732634,0.00248720140104162,0.0106387653272218,0.0203885948193049,4.56093959069315e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,40336,-0.0503480161649905,0.00807920386214162,-0.0661832557347881,-0.034512776595193,4.72722315254907e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40037,-0.0503378262158962,0.00807886620485874,-0.0661724039774193,-0.034503248454373,4.75972057985958e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,40355,0.0341990223194582,0.00552432891890764,0.0233713376383992,0.0450267070005171,6.13984685641654e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40300,-0.0238782441469151,0.00385862076220074,-0.0314411408408285,-0.0163153474530016,6.2317856751008e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,40336,-0.0394495769294676,0.0063801262579225,-0.0519546243949957,-0.0269445294639395,6.43522567945016e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,40327,0.0131935306042906,0.00213900631808214,0.00900107822084962,0.0173859829877316,7.08056728103705e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37557,-0.0432686912769394,0.00702035235841996,-0.0570285818994425,-0.0295088006544362,7.33236262389316e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37982,-0.012029825376255,0.00195198997462186,-0.0158557257265138,-0.00820392502599613,7.34743703089433e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40478,0.0180535577576421,0.00293178489410481,0.0123072593651967,0.0237998561500875,7.54866113957494e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40327,-0.0285861129775209,0.0046428213995482,-0.0376860429206354,-0.0194861830344064,7.58925818640079e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,40223,0.0229829847841656,0.00373513807005251,0.0156621141668626,0.0303038554014685,7.7778347190694e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40406,0.0129421958153751,0.00210763936157106,0.00881122266669582,0.0170731689640544,8.41513961476747e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39975,-0.0330312756255949,0.00541498649462451,-0.0436446491550589,-0.0224179020961309,1.08602633278823e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37955,0.0142947229915908,0.00234397490720029,0.00970053217347821,0.0188889138097033,1.0999245484461e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,40140,-0.0193379567454742,0.00317171462993453,-0.0255545174201459,-0.0131213960708025,1.10606673791338e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40531,-0.0209193325701181,0.00344168931433576,-0.0276650436262162,-0.01417362151402,1.24270156363784e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,37965,-0.0244720946745795,0.00402853213264228,-0.0323680176545584,-0.0165761716946006,1.27560852284246e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,39720,0.0168691847152431,0.00278026298076103,0.0114198692729515,0.0223185001575347,1.33003581052427e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,40511,-0.0182599153981989,0.0030124930845496,-0.0241644018439161,-0.0123554289524817,1.37961745954651e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37658,-0.0242448962535121,0.00400242260191518,-0.0320896445532658,-0.0164001479537583,1.41961824657397e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,40037,0.0125549023736318,0.00208104590820267,0.00847605239355456,0.016633752353709,1.64607629110611e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40367,0.014344439721696,0.00238133606842235,0.00967702102758821,0.0190118584158038,1.7423368600133e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40336,-0.0346168318761219,0.00574787632467497,-0.0458826694724848,-0.0233509942797589,1.75482324332022e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40446,0.0183359276604514,0.00304749702397185,0.0123628334934665,0.0243090218274362,1.81870806163934e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,40511,-0.0258536170370912,0.0043017231312504,-0.034284994374342,-0.0174222396998404,1.89463775633378e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,37593,-0.0245459071807436,0.00408444767680901,-0.0325514246272893,-0.0165403897341979,1.90901449428776e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,40039,-0.0231157963052336,0.00386997366046232,-0.0307009446797397,-0.0155306479307275,2.37828556902203e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,37623,0.0366301426269096,0.00613984341786595,0.0245960495278923,0.0486642357259269,2.49420006115001e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,40374,0.0175254334050873,0.00293792824495545,0.0117670940449746,0.0232837727652,2.49454748552945e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40352,0.0200469663683423,0.00336463570843621,0.0134522803798073,0.0266416523568772,2.60511872909289e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39956,-0.0290118254840491,0.00487160330536027,-0.0385601679625552,-0.019463483005543,2.65216392614376e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,40341,0.0144500580946788,0.00243209616576757,0.00968314960977433,0.0192169665795832,2.8850002551885e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37593,0.0139903500581739,0.00235449555633143,0.00937553876776434,0.0186051613485835,2.88739881950264e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37993,-0.012054858301244,0.00203052925014756,-0.0160346956315332,-0.00807502097095482,2.9774123467689e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,39956,0.03839006738348,0.00648562803808802,0.0256782364288275,0.0511018983381325,3.3023306578227e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,40327,0.0123245469367597,0.00208476054493365,0.00823841626868971,0.0164106776048296,3.45467739484989e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40275,-0.0393506938033232,0.00666020719385627,-0.0524046999032815,-0.026296687703365,3.52688089351018e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40466,-0.0270749167280869,0.00458478606584899,-0.0360610974171509,-0.0180887360390229,3.58948266328506e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37557,-0.0192010087843062,0.00325915233980561,-0.0255889473703252,-0.0128130701982872,3.92308192141853e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40039,0.0210098660790674,0.00356691158198752,0.0140187193783719,0.0280010127797629,3.93639884387998e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40336,-0.0492150537678047,0.00836953205449391,-0.0656193365946127,-0.0328107709409966,4.17832227771931e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40177,0.0148791057331481,0.00253076010628777,0.00991881592482408,0.0198393955414721,4.20342446819291e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,40327,0.0193988609383722,0.00331266746128138,0.0129060327142607,0.0258916891624838,4.83618358701631e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,37993,0.0268349323015821,0.00458459154585652,0.0178491328717033,0.0358207317314609,4.93105866473144e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40300,-0.0498237170617659,0.0085510316085572,-0.0665837390145381,-0.0330636951089938,5.76541697696758e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,40327,-0.0227784032939852,0.00391840721607177,-0.0304584814374858,-0.0150983251504845,6.24737193181585e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40058,-0.0216732505090105,0.00373183972961334,-0.0289876563790527,-0.0143588446389684,6.45848912851442e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40300,0.0321872077898194,0.00554601983747435,0.0213170089083697,0.0430574066712692,6.61224673714237e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,40327,0.0200060963294205,0.00347201087492595,0.0132009550145657,0.0268112376442754,8.46104935224072e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,40391,0.0262936287830581,0.00457233184684373,0.0173318583632443,0.0352553992028718,9.05589520698332e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40327,0.02454269425927,0.0042760105232306,0.016161713633738,0.032923674884802,9.66189859030101e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37593,-0.0226196326834868,0.00394366844187779,-0.0303492228295672,-0.0148900425374063,9.92595805212178e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,40354,0.042291449502598,0.0073819884804977,0.0278227520808225,0.0567601469243735,1.02849103837e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40429,0.0170239033387832,0.00297201496468407,0.0111987540080024,0.0228490526695639,1.03408938682434e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39848,-0.0447213973615199,0.00780874603733093,-0.0600265395946885,-0.0294162551283512,1.04074708960182e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,40283,-0.0150578320010138,0.00263375431459153,-0.0202199904576131,-0.00989567354441437,1.10213553067926e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40350,0.0182319966557596,0.0031946275527918,0.0119705266522877,0.0244934666592315,1.16979314743924e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37985,-0.0279211571571873,0.00489540387307893,-0.037516148748422,-0.0183261655659526,1.19795599836433e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40466,-0.0328583640182429,0.00576362494310136,-0.0441550689067216,-0.0215616591297643,1.21213303088942e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,40379,0.0284814621529735,0.00499603080057793,0.0186892417838407,0.0382736825221062,1.21346507863161e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39975,-0.0400543005748947,0.00706226690389571,-0.0538963437065303,-0.0262122574432591,1.43997257794746e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37993,0.0178054525661518,0.003139606622947,0.0116518235851757,0.0239590815471279,1.4466893063605e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40271,0.030055043717493,0.00530597120627806,0.019655340153188,0.040454747281798,1.50123127524704e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,40531,-0.0221540782917206,0.00391560285126629,-0.0298286598802025,-0.0144794967032387,1.55849716730521e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39882,-0.00920689126091727,0.00162755091766466,-0.01239689105954,-0.00601689146229453,1.56867774798094e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,40327,-0.0117611654517159,0.00208121270412266,-0.0158403423517963,-0.00768198855163544,1.62151736637976e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,38008,0.010852162759631,0.0019217744554766,0.00708548482689686,0.0146188406923651,1.66599905897779e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37895,-0.0195063244038643,0.00345595868164124,-0.0262800034198811,-0.0127326453878475,1.6924812910711e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,38008,0.0151700692672209,0.00268831909035955,0.00990096385011614,0.0204391746843256,1.70501581497059e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,40336,0.0193123237196662,0.00342353846464735,0.0126021883289574,0.026022459110375,1.71905797859107e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,37954,0.0179663049942973,0.00318523186732891,0.0117232505343327,0.024209359454262,1.7295917435798e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40336,-0.042210001057735,0.00748449069838623,-0.056879602826572,-0.027540399288898,1.73285769522723e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,40354,0.0177298207507285,0.00314428040690568,0.0115670311531933,0.0238926103482636,1.74198081995636e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,38008,0.0164286798502108,0.00291338271920518,0.0107184497205687,0.022138909979853,1.74416744808623e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40223,-0.0346466925635804,0.00615259122837565,-0.0467057713711966,-0.0225876137559641,1.8197423364361e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,40451,-0.029007663799832,0.00516604526470999,-0.0391331125186635,-0.0188822150810004,1.9975792071376e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,40223,-0.0439274591672608,0.00783362308148072,-0.059281360406963,-0.0285735579275586,2.08649237400239e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,37982,-0.0119263861142324,0.00213056540823152,-0.0161022943143662,-0.00775047791409859,2.21365542987634e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,37985,-0.0143447839755785,0.00256441543217596,-0.0193710382226434,-0.00931852972851365,2.26481155460121e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40336,0.0232077703970894,0.00415131287861174,0.0150711971550104,0.0313443436391684,2.30189028879193e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37982,0.0138788400670842,0.002486224628884,0.00900583979447156,0.0187518403396969,2.41930296121272e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37993,0.0161455792738483,0.00289813390761968,0.0104652368149137,0.0218259217327829,2.58072020147525e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37976,0.00912161726045482,0.00163798882386054,0.00591115916568817,0.0123320753552215,2.61402388760779e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40336,0.019634856268324,0.00353322442304304,0.0127097363991597,0.0265599761374884,2.78534460276525e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39975,-0.0307432588511148,0.00553406752926052,-0.0415900312084654,-0.0198964864937642,2.81731995451316e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,40336,-0.0209716199792708,0.00379050476750978,-0.02840100932359,-0.0135422306349517,3.20372623729215e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37599,0.0166768200973527,0.00301771677087733,0.0107620952264331,0.0225915449682722,3.33271844239943e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37875,0.042442003625397,0.00768415266151006,0.0273810644088373,0.0575029428419567,3.38847608787131e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40300,-0.0172987075765818,0.00313275673202947,-0.0234389107713595,-0.011158504381804,3.40662737350131e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40352,-0.0450091693453793,0.0081829024938551,-0.0610476582333353,-0.0289706804574233,3.84795357431459e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40511,-0.0184536799954172,0.00335836544352935,-0.0250360762647348,-0.0118712837260997,3.97015647176222e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,40336,-0.0193007299959931,0.00351276928233647,-0.0261857577893726,-0.0124157022026137,3.9796120315968e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,38008,-0.0084542538871124,0.00154056875018135,-0.0114737686374678,-0.00543473913675694,4.14398453262392e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40039,0.0186190255671579,0.0033978803016047,0.0119591801760127,0.0252788709583032,4.32899836871127e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40173,0.0210145522021581,0.00383660589944894,0.0134948046392381,0.028534299765078,4.38294505354718e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37709,-0.0212600026032144,0.00389098978734572,-0.028886342586412,-0.0136336626200168,4.74178866546793e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,40398,-0.0241049924483294,0.00441763012981884,-0.0327635475027743,-0.0154464373938844,4.92730825054034e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,40406,0.0140617273663558,0.00257953348542301,0.00900584173492673,0.0191176129977849,5.0754606024481e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,40485,0.0129111642151196,0.00236868633752835,0.00826853899356406,0.0175537894366752,5.08929130302118e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40039,-0.0278369651076508,0.0051101166064169,-0.0378527936562279,-0.0178211365590737,5.18795516100153e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,40325,-0.0138343113210488,0.00254404684454193,-0.018820643136351,-0.00884797950574668,5.47044322880374e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,39975,-0.0296036057030959,0.00545144513110641,-0.0402884381600645,-0.0189187732461274,5.70687399727833e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,37937,0.0145834836706834,0.00268653348670849,0.00931787803673478,0.0198490893046321,5.78565681896777e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,40039,-0.0227633880456155,0.00419473963054991,-0.0309850777214933,-0.0145416983697377,5.82787396443921e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40039,-0.0208687184913798,0.00385008837731499,-0.0284148917109172,-0.0133225452718424,6.03761804458957e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40037,0.0153277510962235,0.0028290669850883,0.00978277980545045,0.0208727223869966,6.11801232753723e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37896,0.0484544038368129,0.00895233044558181,0.0309078361634726,0.0660009715101533,6.32203880730677e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,40300,0.010108925060815,0.0018719050138511,0.00643999123366689,0.0137778588879632,6.74728905971961e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40039,0.0198749797900699,0.00369114754700913,0.012640330597932,0.0271096289822078,7.36991213393815e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,37993,0.0145947244178855,0.00271079311152285,0.00928156991930068,0.0199078789164703,7.40920412715146e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40300,-0.0415304767398312,0.00772394142027449,-0.0566694019235692,-0.0263915515560932,7.68740281146795e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37955,0.0428239420810705,0.00797970336828155,0.0271837234792387,0.0584641606829024,8.15565569293229e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40417,-0.0489336679432683,0.00912003766514723,-0.0668089417669569,-0.0310583941195798,8.18459419089596e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,37976,-0.0128970499072964,0.00240535144141932,-0.0176115387324782,-0.0081825610821145,8.37441243278933e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37896,0.025928691077292,0.00485843788219342,0.0164061528281929,0.0354512293263911,9.6117805130389e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37557,-0.0297976675065988,0.00559116373121278,-0.0407563484197759,-0.0188389865934217,1.00158808806297e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40300,-0.0161870796870585,0.00304044520973933,-0.0221463522981475,-0.0102278070759694,1.02940297984028e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,37623,-0.0284947646425077,0.00535237630984084,-0.0389854222097958,-0.0180041070752197,1.03313117475569e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,37929,0.0218372403035759,0.00410574963782075,0.0137899710134472,0.0298845095937045,1.06183291265272e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40305,-0.0318286794339665,0.00598567210314334,-0.0435605967561274,-0.0200967621118055,1.06642475420549e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,37993,-0.0523644941024123,0.00985106431260346,-0.0716725801551151,-0.0330564080497095,1.07983141912638e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37593,-0.0326442058430486,0.0061624441464539,-0.0447225963700982,-0.0205658153159989,1.1943600996106e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,40354,-0.0264775039437305,0.00501317997309496,-0.0363033366909966,-0.0166516711964644,1.29762171116724e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37623,-0.0324160394714285,0.00615240497566231,-0.0444747532237266,-0.0203573257191304,1.39453138075488e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,40319,-0.0384597165507136,0.0073141979989513,-0.0527955446286582,-0.0241238884727691,1.47337450719339e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37985,0.0151023106197804,0.00287580931429587,0.00946572436376052,0.0207388968758003,1.53151457027518e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40484,0.0282872630226457,0.00539546254775807,0.0177121564290399,0.0388623696162515,1.60176300392306e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,40484,0.00755216936269919,0.0014415613248093,0.00472670916607296,0.0103776295593254,1.63597035645649e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,40485,-0.0225757548828617,0.00431184750967434,-0.0310269760018234,-0.0141245337639,1.66390965091856e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,40336,-0.0375203911822711,0.00718098814914083,-0.0515951279545871,-0.023445654409955,1.76392994925189e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,40009,0.0182097929954131,0.00350582024590878,0.0113383853134319,0.0250812006773943,2.08240208110524e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,40406,0.0125384384682411,0.0024156465525559,0.00780377122523159,0.0172731057112507,2.12291141622416e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40273,0.0116793785013463,0.00225319285568112,0.00726312050421127,0.0160956364984813,2.20464481261542e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,40336,0.0194768115603696,0.00375772400231835,0.0121116725158256,0.0268419506049136,2.20854075714502e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37623,0.00933398509962531,0.00180167486763546,0.00580270235905982,0.0128652678401908,2.24286824959274e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40354,-0.016086065603729,0.00310737124934723,-0.0221765132524496,-0.0099956179550084,2.28542085288563e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,39956,-0.0234977224625261,0.00455938725968351,-0.0324341214915058,-0.0145613234335464,2.58530382135234e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40427,0.0126566300111566,0.00245967344123168,0.00783567006634248,0.0174775899559707,2.69747250269845e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,40374,-0.0219950725871792,0.00428362826627674,-0.0303909839890816,-0.0135991611852768,2.85951299577867e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40445,-0.0137132357312154,0.00267112826846778,-0.0189486471374123,-0.00847782432501855,2.87166780096836e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,37993,0.018067830519722,0.00351969104410656,0.0111692360732731,0.0249664249661708,2.88563241298212e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40327,-0.0195645346931666,0.00381592607597144,-0.0270437498020706,-0.0120853195842626,2.97739015382463e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40300,0.0147053545386571,0.00289107555915467,0.00903884644271399,0.0203718626346003,3.68963602208765e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,40306,-0.0407299465626311,0.00803013506029423,-0.0564690112808078,-0.0249908818444544,3.97812814609163e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,40354,0.0136885903186606,0.00269917523465329,0.00839820685874017,0.0189789737785811,3.99346541642251e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37666,-0.0186549333896547,0.00368566573641284,-0.0258788382330239,-0.0114310285462856,4.21601555767369e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,39804,-0.0346446767124377,0.00685057591394951,-0.0480718055037787,-0.0212175479210966,4.30378980069257e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,39929,-0.02775170536209,0.0054905921098548,-0.0385132658974054,-0.0169901448267746,4.36647532541776e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,37593,-0.0196925907119709,0.00389745231248695,-0.0273315972444454,-0.0120535841794965,4.41496980589064e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40531,0.0184716455544218,0.00365904936395955,0.0112999088010611,0.0256433823077825,4.50844285836848e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,40037,0.0223376416427746,0.00442552670038816,0.0136636093100138,0.0310116739755354,4.52782015517495e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,40198,-0.0234963282121408,0.00465528700673999,-0.0326206907453512,-0.0143719656789304,4.53247644209744e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,40406,-0.036638667975283,0.00726109583468022,-0.0508704158112562,-0.0224069201393097,4.56384967008964e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39975,-0.0269923082822521,0.00535044419776491,-0.0374791789098713,-0.0165054376546329,4.58948113536912e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,40336,0.0151101074625639,0.00299786950473455,0.00923428323328421,0.0209859316918437,4.69957131914949e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37993,0.0114339555068142,0.00227532221252072,0.00697432397027357,0.0158935870433548,5.09316443853243e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40485,-0.00926465834768955,0.00184450185125634,-0.012879881976152,-0.00564943471922712,5.14570752453326e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40354,0.0113626020270718,0.00226954458943636,0.00691429463177654,0.0158109094223671,5.60054417591711e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,40367,-0.0148840052085552,0.00297446290831299,-0.0207139525088486,-0.00905405790826174,5.67723754447468e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37937,-0.0204867679469175,0.00409400978723711,-0.0285110271299023,-0.0124625087639328,5.68357227052804e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37666,0.0186347750628764,0.00373158734286849,0.0113208638708542,0.0259486862548987,5.99603044591774e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37895,-0.0209233758271253,0.00419256439165283,-0.0291408020347649,-0.0127059496194858,6.09477892809691e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40268,0.0147936235236886,0.00296492306888688,0.00898237430867036,0.0206048727387069,6.11635499607099e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,39986,-0.0217943501629007,0.00437057950226919,-0.0303606859873483,-0.0132280143384531,6.21125629167063e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37593,0.0188510451637414,0.00378116036215436,0.0114399708539189,0.0262621194735639,6.25837063443369e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40336,-0.0463838953823455,0.00931774954957858,-0.0646466844995195,-0.0281211062651715,6.49127850970152e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40039,-0.0303809677738695,0.00613600587701877,-0.0424075392928263,-0.0183543962549127,7.45051085377143e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,37666,0.0224409659429623,0.00454285255452661,0.0135369749360902,0.0313449569498345,7.91431593915163e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40466,-0.0417611640196523,0.00846354925150595,-0.058349720552604,-0.0251726074867007,8.12724452506463e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37982,0.0112149761058552,0.00227394051475909,0.00675805269692734,0.015671899514783,8.23766040437089e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37896,-0.0130604575628898,0.00264935496927955,-0.0182531933026777,-0.00786772182310184,8.33492596097817e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,40263,-0.0314465916783117,0.00638010693870786,-0.0439516012781792,-0.0189415820784443,8.35527595786798e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40419,-0.0199914290395795,0.00405684972231886,-0.0279428544953245,-0.0120400035838345,8.39850710432288e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,40327,0.0144866416247544,0.00294911423779192,0.00870637771868227,0.0202669055308266,9.0956407308568e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,40336,-0.0228795354800989,0.00466661303741943,-0.0320260970334409,-0.0137329739267568,9.54066438504448e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,37993,0.00990473523780469,0.0020207104901843,0.00594414267704346,0.0138653277985659,9.61553714110571e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39956,-0.0115293459865353,0.00235618005981906,-0.0161474589037807,-0.00691123306928997,1.00187486627832e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,40304,-0.0230007638793307,0.00470089268920616,-0.0322145135501748,-0.0137870142084867,1.00362032531882e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40336,0.0146518119606338,0.00299675695555218,0.0087781683277515,0.020525455593516,1.02224247183987e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40155,-0.0196828222615188,0.00403950566096106,-0.0276002533570025,-0.0117653911660352,1.11223767288025e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40336,0.0225773935417817,0.00464563638288219,0.0134719462313327,0.0316828408522308,1.18557989555863e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40223,0.0215609578254649,0.00444281384248443,0.0128530426941954,0.0302688729567344,1.22773185240978e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40037,-0.0161646139075587,0.00333256603861075,-0.0226964433432357,-0.00963278447188159,1.243397140954e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39975,-0.0262252507109431,0.00541674169874208,-0.0368420644404776,-0.0156084369814086,1.30091862553769e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40327,0.0183566616380831,0.00379278588388252,0.0109228013056734,0.0257905219704929,1.3113328680062e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,40039,0.0122447749178292,0.00253016300238075,0.00728565543316295,0.0172038944024955,1.31399009160132e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40354,-0.0369524462407383,0.00764596898776698,-0.0519385454567616,-0.021966347024715,1.35792695995202e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,37896,-0.0349428317418122,0.00723144483036736,-0.0491164636093323,-0.0207691998742922,1.36614021604807e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40466,0.0116187334127759,0.00240577435224956,0.00690341568236672,0.016334051143185,1.38128183209461e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40497,-0.0160847641614326,0.00333416400849375,-0.0226197256180803,-0.00954980270478484,1.41838367169493e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40403,0.010282040924894,0.00213428612253425,0.00609884012472688,0.0144652417250611,1.46663763855028e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37623,0.0385932645582738,0.00802513460029857,0.0228640007416886,0.054322528374859,1.53328009796951e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40336,-0.0262009299420265,0.00545220119148173,-0.0368872442773306,-0.0155146156067223,1.55722597007669e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,40216,0.0121234878354373,0.00252453912883224,0.0071753911429261,0.0170715845279485,1.58327865044518e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40395,-0.0270550938485383,0.00563753296230878,-0.0381046584546635,-0.0160055292424131,1.60822983067809e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,39956,-0.026277949325119,0.00547733375681179,-0.0370135234884701,-0.0155423751617679,1.62088353783444e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40286,0.012049486959216,0.00251270036323688,0.00712459424727174,0.0169743796711603,1.63800169605698e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,40354,-0.045467933644256,0.00948384090617209,-0.0640562618203533,-0.0268796054681587,1.64759546616157e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40484,-0.0227573760743898,0.00475378952509401,-0.032074803543574,-0.0134399486052055,1.70627386474442e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,40187,0.0213843598381523,0.00447119732459421,0.0126208130819476,0.030147906594357,1.74530139293584e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37666,-0.0311216823932356,0.0065066847812063,-0.0438747845644,-0.0183685802220713,1.74535237383743e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,37666,-0.0134611248519789,0.00281687305498132,-0.0189821960397423,-0.00794005366421553,1.78288930150096e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37926,-0.0455712580425406,0.00953645382714255,-0.06426270754374,-0.0268798085413412,1.78349242643716e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,37666,0.018198497676067,0.00381239637167558,0.0107262007875829,0.0256707945645512,1.82986167136944e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,40374,0.0138309780899615,0.0028979467874288,0.00815100238660105,0.0195109537933219,1.83403396211494e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40328,-0.0256767135090189,0.00538121705069105,-0.0362238989283733,-0.0151295280896644,1.84446050579106e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39956,-0.0205144722587566,0.00430620621275001,-0.0289546364357467,-0.0120743080817666,1.91576433404473e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,40325,-0.015211934217465,0.00319424142259806,-0.0214726474057572,-0.00895122102917276,1.9309029509901e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,40039,0.0143864695812406,0.00302189555143897,0.00846355430042023,0.020309384862061,1.94614281241885e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,37895,-0.00859556410976137,0.00180570267915601,-0.0121347413609071,-0.00505638685861559,1.95385353895569e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,37743,-0.0117966820712975,0.00248564840099096,-0.0166685529372397,-0.00692481120535517,2.09725867266817e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39956,-0.0210105002590552,0.0044275899284944,-0.0296885765189042,-0.0123324239992062,2.09994684817632e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40511,-0.0155811205039786,0.00328658531868729,-0.0220228277286057,-0.00913941327935156,2.14677912344609e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39975,-0.0267242354148224,0.00563982524174235,-0.0377782928886374,-0.0156701779410074,2.17228496410041e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40354,0.00728882061450922,0.00153895865794714,0.00427246164493282,0.0103051795840856,2.19639501438869e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,40327,-0.00989958864885172,0.00209142576842749,-0.0139987831549696,-0.00580039414273383,2.2267708119744e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37937,-0.0266623541523421,0.00563300800499283,-0.0377030498421281,-0.0156216584625562,2.2321432107366e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40354,0.0116586420422541,0.00246375729990103,0.00682967773444812,0.0164876063500602,2.24167434480229e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37895,-0.023874028048643,0.00505147117593072,-0.0337749115534672,-0.0139731445438188,2.31131910227474e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,40288,-0.0130011529534277,0.00275359745985333,-0.0183982039747402,-0.00760410193211514,2.3609919253544e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40354,0.0164480469588036,0.00348634129102138,0.00961481802840167,0.0232812758892055,2.40373393423018e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,40531,0.0166716705251152,0.0035391797182302,0.00973487827738397,0.0236084627728463,2.49050163311206e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37896,0.0361030152965745,0.00766587821195757,0.0210778940011377,0.0511281365920114,2.50717920837806e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39975,-0.0204632449958392,0.00435913721831294,-0.0290071539437325,-0.0119193360479458,2.69763272027224e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,40484,-0.0271322966231657,0.00578224969472275,-0.0384655060248223,-0.0157990872215091,2.72325744300177e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40531,0.0107375978889647,0.00228894920721399,0.00625125744282531,0.0152239383351041,2.74029879476714e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,40341,0.0213091780263683,0.00455624948968047,0.0123789290265946,0.030239427026142,2.93624269104899e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,40430,-0.0181540378396654,0.00389663575950087,-0.0257914439282871,-0.0105166317510437,3.20466712589529e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37896,-0.0429672298155452,0.00922276835084526,-0.0610438557832019,-0.0248906038478884,3.21074818261003e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,40336,-0.0384042842641123,0.008261174310304,-0.0545961859123082,-0.0222123826159165,3.36609555601803e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,40466,0.010609826372445,0.00228462775169472,0.00613195597912337,0.0150876967657667,3.4443250691712e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37895,-0.0276273724484722,0.00596616837707963,-0.0393210624675483,-0.0159336824293962,3.67894634429353e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37896,-0.0234651608790374,0.00507034650463163,-0.0334030400281154,-0.0135272817299594,3.72807963957044e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40250,-0.0181672539760295,0.00393755495451047,-0.02588486168687,-0.0104496462651889,3.98400085364258e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40300,0.0157811853321112,0.00342286893960012,0.00907236221049498,0.0224900084537274,4.0481185546053e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,40327,0.0185575380093413,0.00403680320327516,0.010645403730922,0.0264696722877606,4.31740925162106e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,37955,-0.0176116448343092,0.00383196037517559,-0.0251222871696534,-0.0101010024989651,4.34605700140644e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40466,0.012019043397258,0.00261645163909427,0.00689079818463323,0.0171472886098828,4.38895030876329e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,37676,0.00851488040257015,0.0018536959683393,0.00488163630462511,0.0121481245005152,4.39979637603764e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,40327,0.0112803507625748,0.00245601114615053,0.00646656891611972,0.0160941326090298,4.40369459360315e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,40367,0.00968655302263721,0.00211193701107504,0.00554715648093012,0.0138259495643443,4.54016199039625e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40300,0.0080359023331977,0.00175316230806554,0.00459970420938925,0.0114721004570062,4.60393472268481e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,40258,-0.0342208732015686,0.0074741914784542,-0.0488702884993388,-0.0195714579037984,4.7180624603119e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,40391,0.0334097573585804,0.00729964199966542,0.0191024590392362,0.0477170556779246,4.75472088031494e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,40300,-0.0455942061909199,0.00998935749675668,-0.065173346884563,-0.0260150654972768,5.04981964389295e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,40466,0.0119615552730125,0.00262418558185809,0.00681815153257068,0.0171049590134544,5.19762766450399e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37536,-0.0247384388737227,0.00543065612991185,-0.0353825248883499,-0.0140943528590954,5.27757607782497e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,40024,-0.0154103188594136,0.00338344313189711,-0.022041867397932,-0.00877877032089529,5.28768802542698e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39975,0.0217064121258639,0.00476832869703798,0.0123604878796695,0.0310523363720583,5.34895801293347e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37557,-0.0296629669525715,0.00652380638973569,-0.0424496274764534,-0.0168763064286895,5.4934756776115e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40406,-0.00968619993351661,0.00213478134431414,-0.0138703713683723,-0.0055020284986609,5.73875338081633e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37666,-0.00847590069884855,0.00187094810597303,-0.0121429589865557,-0.00480884241114141,5.94243763642821e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40327,-0.00911800891741511,0.0020171225150008,-0.0130715690468167,-0.00516444878801353,6.21969013752973e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37937,0.0141701429361472,0.00313689776892776,0.00802182330904875,0.0203184625632456,6.31806325369293e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37937,-0.0298884386373802,0.00661738320357478,-0.0428585097163868,-0.0169183675583737,6.33571847095337e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40484,0.0241396050146817,0.00534732957104148,0.0136588390554404,0.034620370973923,6.39697939881507e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37623,0.0135573647838427,0.00300536413276344,0.00766685108362639,0.0194478784840591,6.50636258546149e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,40211,-0.0149289215579472,0.00331415612294952,-0.0214246675589283,-0.00843317555696615,6.69782840125216e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40223,-0.0292605663590189,0.00650500272494748,-0.042010371699916,-0.0165107610181219,6.90322969830511e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39975,-0.0276545032275762,0.00615151090954135,-0.0397114646102772,-0.0155975418448752,6.98883815928332e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40354,-0.0253216430482794,0.00563471733102972,-0.0363656890170977,-0.0142775970794612,7.04363094556834e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37993,0.0102309382856112,0.00227783184630134,0.00576638786686061,0.0146954887043619,7.12999887929612e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40531,0.0115582961005031,0.00258033241327459,0.0065008445704849,0.0166157476305213,7.53750797339649e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40328,-0.0382278971760055,0.00853655259397686,-0.0549595402602002,-0.0214962540918109,7.58203379360164e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,37976,0.0142572026257425,0.00318946146119499,0.00800585816180028,0.0205085470896846,7.88198256709353e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,37937,0.0153753682090209,0.00344322252597655,0.00862665205810689,0.022124084359935,8.05681653202895e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,37666,-0.02759977102256,0.00618226560490613,-0.039717011608176,-0.015482530436944,8.09789405985534e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,40531,-0.0168803949277784,0.00378930730485474,-0.0243074372452937,-0.00945335261026314,8.45599148372133e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40300,-0.0213731724141054,0.00480022321870287,-0.0307816099227631,-0.0119647349054478,8.54413134574237e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,40349,0.0153983607955714,0.00346179242162312,0.00861324764919006,0.0221834739419527,8.72254600703612e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,40336,-0.0322521958634636,0.00725777378178201,-0.0464774324757564,-0.0180269592511709,8.89759859619307e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40417,-0.0111201577451941,0.00250708710340844,-0.0160340484678747,-0.00620626702251358,9.24773535348788e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,40417,0.00799351629188091,0.00180449912970654,0.0044566979976561,0.0115303345861057,9.49609080480764e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,40257,0.00944701383405687,0.00213584909280006,0.00526074961216875,0.013633278055945,9.79572720398711e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,40511,-0.017357621774062,0.00392475818208077,-0.0250501478109404,-0.00966509573718374,9.81624867428337e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40406,0.0143970417783212,0.00325831270897639,0.00801074886872743,0.0207833346879149,1.00016702490874e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,40354,0.027151268513093,0.00614785016940432,0.0151014821810605,0.0392010548451254,1.01027966941769e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40409,-0.0225962071550885,0.00512141007858867,-0.0326341709091223,-0.0125582434010547,1.03040438974449e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40223,-0.021323010246813,0.00483403169719431,-0.0307977123733138,-0.0118483081203121,1.03566288056597e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,40187,-0.0213071842147903,0.00483752113916688,-0.0307887256475574,-0.0118256427820232,1.06695285425955e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,40531,-0.0216631945892526,0.00492437041240805,-0.0313149605975724,-0.0120114285809329,1.09359049382128e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,40511,-0.0145527402401079,0.0033121295382896,-0.0210445141351555,-0.00806096634506024,1.12114729678547e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,40374,0.00926520031583018,0.00212058042213736,0.00510886268844096,0.0134215379432194,1.25502065344187e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,38008,-0.00771809495043279,0.0017671368851577,-0.0111816832453419,-0.00425450665552369,1.26568717237382e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37617,-0.0109622084140702,0.00251810099423744,-0.0158976863627755,-0.00602673046536477,1.35076683457096e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37937,-0.029161880432153,0.00670373189584927,-0.0423011949480175,-0.0160225659162884,1.37077500725535e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,40171,0.0101994072327415,0.00234650624946954,0.00560025498378119,0.0147985594817018,1.39110099003917e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39975,-0.0227554191722663,0.00523535238637148,-0.0330167098495544,-0.0124941284949782,1.39211717438156e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,40417,0.0165685543108709,0.00381510720477875,0.00909094418950453,0.0240461644322372,1.41493565699028e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40267,0.008859034902922,0.00204118499978232,0.00485831230334866,0.0128597575024953,1.43273935688949e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,38008,-0.0112878018113372,0.00260666719481393,-0.0163968695131725,-0.00617873410950193,1.49936511077861e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37557,0.0125079419604624,0.00289384030157162,0.00683601496938197,0.0181798689515427,1.55575597601962e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40037,-0.0217263972447714,0.00505751994060361,-0.0316391363283545,-0.0118136581611884,1.75071570578453e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37955,-0.0232806171932938,0.00542227444030754,-0.0339082750962966,-0.012652959290291,1.77093799620641e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40301,-0.0261420654069563,0.00609326545413923,-0.0380848656970691,-0.0141992651168434,1.79472455412588e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40511,-0.0293260479738718,0.00683816092567056,-0.0427288433881861,-0.0159232525595575,1.8086357519596e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,40492,0.0112746044237736,0.00263105201175186,0.00611774248073993,0.0164314663668072,1.83632864452734e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39952,0.0106422097380772,0.00248480821848781,0.00577198562984107,0.0155124338463133,1.85575550365964e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,40484,0.0229320492565059,0.0053584774872453,0.0124294333815051,0.0334346651315067,1.88330472202761e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,40198,0.0117761709565371,0.00275432642274635,0.00637769116795422,0.0171746507451199,1.91816549501175e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37623,-0.0213875783204603,0.00500797317798792,-0.0312032057493166,-0.011571950891604,1.96221894582462e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,40354,-0.00970166465790206,0.00227565366642549,-0.014161945844096,-0.0052413834717081,2.02642967313098e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,40391,0.0110121041477542,0.00258479094265609,0.00594591390014826,0.0160782943953601,2.05281722418102e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39975,-0.0134501422128746,0.00316452971904323,-0.0196526204621993,-0.00724766396354985,2.1474866005191e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,40398,0.0174059677800769,0.00409665558478866,0.00937652283389117,0.0254354127262627,2.16115704113975e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,40354,-0.0238728116389889,0.00562037577198976,-0.0348887481520888,-0.0128568751258889,2.17352410378759e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,39956,-0.0132564287879321,0.00312451541272942,-0.0193804789968818,-0.00713237857898246,2.22113990839678e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,40374,0.0110871410912878,0.00261359367473424,0.00596449748880865,0.0162097846937669,2.22683453836683e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37985,-0.0275389141766396,0.00650880848712557,-0.0402961788114057,-0.0147816495418734,2.34163376726216e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",40484,0.0274387938264526,0.00650877521941032,0.0146815943964083,0.0401959932564968,2.50411673918644e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,40072,0.0126871307849227,0.00301135805589592,0.00678486899536671,0.0185893925744787,2.53311089448103e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37955,0.0286069502231928,0.00679765405356679,0.0152835482782019,0.0419303521681837,2.58898212324137e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37567,0.0116394617098546,0.00276661106460225,0.00621690402323416,0.017062019396475,2.60367034384853e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37896,0.025567360867538,0.00607770435324,0.0136550603351876,0.0374796613998884,2.60753569034649e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40336,0.0124135611776058,0.00295736348900403,0.00661712873915791,0.0182099936160537,2.71334654663506e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,37981,-0.0134660125198666,0.00320922931090891,-0.019756101969248,-0.00717592307048513,2.7337140751821e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,40466,-0.00871816931665696,0.00208065730896938,-0.0127962576422369,-0.00464008099107698,2.80321906113615e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37593,-0.0133042077759837,0.00318597105215672,-0.0195487110382109,-0.00705970451375657,2.98761389374911e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37557,-0.024915271569982,0.00598772899290864,-0.0366512203960829,-0.013179322743881,3.18801851431199e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,40484,0.0163621894647254,0.00394950924461045,0.00862115134528892,0.0241032275841619,3.44788523988841e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40398,0.0121175859400804,0.00292985807079587,0.00637506412132051,0.0178601077588403,3.55384783819663e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,37172,-0.0449238387126523,0.0108638838236672,-0.06621705100704,-0.0236306264182645,3.5699328874809e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40336,-0.0222291814822687,0.00538815081620688,-0.0327899570820342,-0.0116684058825032,3.71705101558563e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40223,0.0148388328081469,0.00360081952667706,0.00778122653585986,0.0218964390804339,3.79224680459642e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37623,0.0131153973330378,0.0031837362386584,0.00687527430526732,0.0193555203608082,3.82018001422187e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40198,0.0121557181633884,0.00295782953083892,0.00635837228294409,0.0179530640438327,3.98222695041718e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,40037,-0.0194207871829595,0.0047267036380138,-0.0286851263134666,-0.0101564480524525,3.99860597904378e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40336,-0.0197681630681055,0.00482073959071759,-0.029216812665912,-0.010319513470299,4.14043193281577e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,40328,0.0237047598221305,0.00579216462151211,0.0123521171639668,0.0350574024802943,4.28752618109212e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40300,0.0138994518233676,0.00339777615341456,0.00723981056267502,0.0205590930840601,4.32106665108289e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40325,-0.0175087251958831,0.00428145538674045,-0.0259003777538944,-0.00911707263787181,4.34560658848898e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,40187,-0.0288450686219682,0.00705519060960761,-0.0426732422167991,-0.0150168950271373,4.36349707327325e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,40198,-0.0163885199197169,0.00401301716863593,-0.0242540335702433,-0.00852300626919043,4.45165457230467e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,37896,0.0405911308360041,0.00996553634609638,0.0210586795976552,0.060123582074353,4.66473899666717e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,39956,-0.0215001800985614,0.00528261327191975,-0.0318541021115241,-0.0111462580855986,4.7248320122363e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,40039,-0.0182634754446931,0.00448891887368824,-0.0270617564371221,-0.00946519445226419,4.75356981822391e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40187,-0.026211142495242,0.00644410426069213,-0.0388415868461985,-0.0135806981442854,4.77597447443674e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37623,0.0161679863537652,0.00397595763238763,0.00837510939428544,0.0239608633132449,4.80148214153892e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40406,-0.0326038439990661,0.00802415382870269,-0.0483311855033233,-0.0168765024948088,4.86335495233914e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,40406,-0.00920893776821783,0.00226647725550892,-0.0136512331890153,-0.00476664234742036,4.86557385270804e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37895,-0.0205857791568167,0.00506759095634537,-0.0305182574312537,-0.0106533008823798,4.88796473909484e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40336,-0.0370115503036861,0.00911500624569992,-0.0548769625452579,-0.0191461380621143,4.92009955798685e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,40406,0.0076843762062455,0.00189688631033176,0.00396647903799525,0.0114022733744957,5.1230181628009e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,37637,0.0113866179928144,0.00281200489121114,0.00587508840604061,0.0168981475795883,5.16674504319799e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39975,0.0128076091185557,0.00316752484182589,0.00659926042857691,0.0190159578085344,5.29332413616015e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40531,-0.0174179706883809,0.00431987273199041,-0.0258849212430821,-0.00895102013367968,5.55459217210707e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37567,-0.0255621436517625,0.00634995188015267,-0.0380080493368617,-0.0131162379666632,5.71582560255942e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,38008,-0.0147857100973006,0.00367561503329208,-0.0219899155625531,-0.00758150463204817,5.78593038370447e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,37666,0.040238650047791,0.010025649864037,0.0205883763142785,0.0598889237813036,6.01371630943112e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37895,0.0144916773328488,0.00361673487156078,0.00740287698458971,0.021580477681108,6.1868163048218e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,37955,0.0114820362906549,0.00287881689860649,0.00583955516938621,0.0171245174119237,6.68551696819935e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,37895,-0.0169339256489787,0.00424941072035319,-0.0252627706608709,-0.00860508063708644,6.78346861028604e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,40484,-0.0135818666662713,0.00341051849882605,-0.0202664829239703,-0.00689725040857222,6.85393272504894e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40300,0.00791453359658089,0.00198781351271833,0.00401841911165296,0.0118106480815088,6.87793480041385e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,40354,0.0117828026023336,0.00296112714224752,0.00597899340352846,0.0175866118011387,6.94655851437873e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40327,0.0417269151600404,0.0104925409439056,0.0211615349099854,0.0622922954100954,7.0153530650144e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38480,0.0109730779921542,0.00275992642059318,0.00556362220779157,0.0163825337765168,7.04772937862722e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40466,0.00806089589675014,0.00202776966555727,0.00408646735225788,0.0120353244412424,7.06132329371736e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40279,0.01221127007062,0.00307318315373604,0.0061878310892974,0.0182347090519427,7.11403736234154e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37623,0.0239288132821175,0.00602840698018277,0.0121131356009593,0.0357444909632757,7.24536815349616e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37985,0.0094589840558053,0.00238377090444025,0.00478679308310241,0.0141311750285082,7.28290355625535e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37593,0.0154804932228446,0.00390187903305034,0.0078328103180659,0.0231281761276232,7.3032811367162e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37844,0.0101083179161248,0.00254970304184858,0.00511089995410158,0.015105735878148,7.39296344788976e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37666,-0.0289977378796545,0.00731482264219371,-0.0433347902583542,-0.0146606855009548,7.40166966663202e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37993,0.0113356451264282,0.00287175776522295,0.00570699990659123,0.0169642903462652,7.94420954872132e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40327,0.014109251678542,0.00357575326232162,0.0071007752843916,0.0211177280726924,7.98721543474047e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39975,0.0172101131225522,0.00437606471972493,0.00863302627189136,0.0257871999732131,8.43330292823238e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40336,0.0158119178052841,0.00402061420720841,0.00793151395915558,0.0236923216514125,8.43496250903404e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,40352,0.00803714516564372,0.00204508872925997,0.00402877125629418,0.0120455190749933,8.53146692878099e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37666,-0.0137649724997801,0.00350629492393194,-0.0206373105506867,-0.00689263444887352,8.68846658257852e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,40300,-0.0265509564798983,0.00676565817170056,-0.0398116464964314,-0.0132902664633652,8.73236892240886e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,37709,-0.0189166829874046,0.00482220752370381,-0.0283682097338641,-0.00946515624094514,8.79575332939132e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37593,-0.011650893663879,0.00297065356380706,-0.0174733746489408,-0.00582841267881712,8.82645752803438e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37982,0.0135880774409451,0.00346756223939892,0.00679165545172317,0.0203844994301669,8.94936228567211e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,40037,-0.0204450725791462,0.00521999386268153,-0.030676260550002,-0.0102138846082904,9.01575745737478e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,39955,-0.0135622500257311,0.00346804143507729,-0.0203596112384826,-0.00676488881297965,9.24453561399012e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37623,0.0267883962730606,0.00685057651713308,0.0133612662994798,0.0402155262466414,9.26110017436676e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37955,0.01208313017876,0.00309662699511583,0.00601374126833296,0.018152519089187,9.58523338598366e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37895,-0.0152555996162832,0.00390992806878958,-0.0229190586311107,-0.00759214060145559,9.59612581248864e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,37869,0.0195169731068419,0.00501038295626685,0.00969662251255891,0.0293373237011249,9.85507840416046e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,40037,0.00783180000833189,0.00201175889530735,0.00388875257352948,0.0117748474431343,9.9420062256407e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39956,-0.0218960199362335,0.00564225047718868,-0.0329548308715233,-0.0108372090009437,0.000104576739140977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40198,-0.0303224421690245,0.00781882442611824,-0.0456473380442163,-0.0149975462938328,0.000105688935665404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,37895,0.040116982494796,0.0103481536806898,0.019834601280644,0.060399363708948,0.000106373829193902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,37895,-0.0334768532028265,0.00864320915698531,-0.0504175431505177,-0.0165361632551353,0.000107925910989306
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,37643,-0.019529552723962,0.00504414038667683,-0.0294160678818485,-0.00964303756607537,0.000108586529774064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40223,-0.0184706006248936,0.00477411882735101,-0.0278278735265016,-0.00911332772328561,0.000109765981416455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37593,-0.0268648475692934,0.00694456582204967,-0.0404761965805107,-0.013253498558076,0.000110048736007372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37993,-0.0157130489678328,0.00406206005858981,-0.0236746866826688,-0.00775141125299679,0.000110134134826096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37558,-0.016779904523952,0.00433841434902312,-0.0252831966480373,-0.00827661239986667,0.00011037507071713
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40300,-0.0351149964746673,0.00908525264209523,-0.052922091653174,-0.0173079012961607,0.000111507222216209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40417,-0.0142740271341521,0.00369382688329881,-0.0215139278254178,-0.00703412644288645,0.000111852315193823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39690,0.0160375823592115,0.00416111039990355,0.00788180597540059,0.0241933587430225,0.000116604428946798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40187,-0.0378238324438672,0.0098147693835725,-0.0570607804356693,-0.018586884452065,0.000116776338103802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37896,0.0383407500360313,0.00995261598953101,0.0188336226965505,0.057847877375512,0.000117542956826231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,39951,0.0411749842297906,0.0106926872279637,0.0202173172629818,0.0621326511965994,0.000118224704967814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,38008,-0.00934207614260839,0.00242866452422049,-0.0141022586100806,-0.00458189367513623,0.00012032165433257
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40300,-0.0230007922965188,0.00598183410895512,-0.0347251871500708,-0.0112763974429668,0.000120970978983653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,40353,-0.0194691246049766,0.00506860771452243,-0.0294035957254406,-0.00953465348451267,0.000122950194875995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37896,-0.0174596208007005,0.00454705290175025,-0.026371844488131,-0.00854739711327002,0.000123716223529284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40460,0.0137020528437693,0.00357109134892916,0.00670271379986811,0.0207013918876704,0.000125056725290688
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,40327,0.017135376148034,0.00447018374657049,0.00837381600475581,0.0258969362913121,0.00012694408970574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37593,-0.0190442714827572,0.00497122235889176,-0.028787867306185,-0.00930067565932932,0.000128267578640837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40300,-0.0187782096762589,0.00490886869505465,-0.028399592318566,-0.00915682703395182,0.000131079720544525
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37896,-0.0170835926974169,0.00447291637616174,-0.0258505087946939,-0.00831667660013992,0.000134410119508222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,40327,-0.0304722492191482,0.00798026622154335,-0.0461135710133731,-0.0148309274249232,0.000134803273078445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37993,0.00750842325355044,0.00196706221049378,0.00365298132098264,0.0113638651861182,0.000135644596315631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,39797,0.00885043651606851,0.00231888599957281,0.0043054199569058,0.0133954530752312,0.000135792736808563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39934,-0.0193731044416346,0.00509262162625693,-0.0293546428290982,-0.00939156605417101,0.000142838010510751
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37896,0.016898475072812,0.0044502591151336,0.00817596720715017,0.0256209829384739,0.000146989684513336
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39975,-0.018419916184485,0.00485436359685582,-0.0279344688343224,-0.00890536353464755,0.000148498920472661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,40147,-0.0123398216352713,0.00325824289402491,-0.0187259777075601,-0.00595366556298251,0.000152883995004542
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40531,0.0075333509564266,0.00198995720207531,0.00363303484035898,0.0114336670724942,0.000153842804997
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40203,0.0134071670457123,0.00355006581356683,0.00644903805112127,0.0203652960403032,0.00015957025835039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37982,-0.0200289069097954,0.00530801584649137,-0.0304326179689185,-0.00962519585067236,0.000161768848109785
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40278,0.010706594552348,0.00283899938311204,0.00514215576144839,0.0162710333432476,0.000163018785997168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,37895,-0.0128867570948876,0.00342324608322581,-0.0195963194180101,-0.00617719477176497,0.000167603314016129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,40354,0.012561878958512,0.00334057891971792,0.00601434427586487,0.0191094136411591,0.000170256572301655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37593,-0.0117515742028468,0.00312757942390876,-0.0178816298737079,-0.00562151853198558,0.000172428630221246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,40304,-0.0220686652883397,0.0058932499978137,-0.0336194352840546,-0.0105178952926249,0.000181222469931424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37623,-0.0245073631906752,0.00657351479927469,-0.0373914521972536,-0.0116232741840968,0.000193661830881693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37937,-0.0131603744819628,0.00353138645518789,-0.020081891934131,-0.00623885702979452,0.000194805112595895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,39975,0.0184905957911574,0.00496291411877467,0.00876328411835904,0.0282179074639557,0.000195422700373719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39975,-0.0168517023510866,0.00453075286331662,-0.0257319779631872,-0.00797142673898607,0.000200396372379546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40223,-0.0122120176305865,0.00330085154443435,-0.0186816866576779,-0.00574234860349521,0.000216624827479295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39975,-0.0278374009049539,0.00753061820073734,-0.0425974125783991,-0.0130773892315087,0.000219290517972796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,40437,0.015842647767275,0.00429123914259102,0.00743181904779664,0.0242534764867534,0.000223361685880647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37917,-0.0271592649407129,0.00736275931183533,-0.0415902731919102,-0.0127282566895157,0.000226259332737764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,37666,-0.00857512010746448,0.00232716137465854,-0.0131363564017952,-0.00401388381313374,0.000229798335603157
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40375,-0.0153738413661617,0.0041803162077548,-0.0235672611333611,-0.00718042159896232,0.000236144809773998
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37623,-0.011785720226595,0.00321485600580199,-0.0180868379979669,-0.0054846024552231,0.000247325217765039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40336,0.0106080144174522,0.00289788580605829,0.00492815823757796,0.0162878705973264,0.000252436388633633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,37982,-0.0219203198005816,0.00598803670320595,-0.0336568717388652,-0.0101837678622979,0.000252498813563312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37666,0.0122738251761864,0.00335292119034925,0.00570209964310191,0.018845550709271,0.000252570255037739
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37993,-0.00893153687653769,0.00244197172210334,-0.0137178014518602,-0.00414527230121516,0.000255642523365057
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,40193,0.0108916736082604,0.00298156297102163,0.00504781018505806,0.0167355370314628,0.000260027345123936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37593,-0.0138400394158498,0.00379193768910916,-0.0212722372865038,-0.00640784154519586,0.000263400956968325
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40336,0.0195150555744013,0.00534737260273021,0.00903420527305008,0.0299959058757525,0.000263628005162167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,40223,-0.0197675242563536,0.00541986184740323,-0.0303904534772639,-0.00914459503544329,0.000265928386349953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,40300,-0.0163838924552038,0.00449314680752961,-0.0251904601979618,-0.00757732471244575,0.000266772543987132
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,39306,0.0154998758166589,0.00425306077783062,0.00716387669211086,0.0238358749412069,0.000268924938243846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39956,-0.0252970184717096,0.00695163040486869,-0.0389222140652522,-0.0116718228781669,0.000274582428906292
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,40406,-0.0226808487514656,0.0062331025979875,-0.0348977298435211,-0.0104639676594101,0.000274804078127062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,37593,-0.0266612733765651,0.00732837090351378,-0.0410248803474521,-0.0122976664056781,0.00027571923553231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,37937,-0.0231979697925573,0.00637704721301963,-0.0356969823300757,-0.0106989572550388,0.0002760786154498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40406,0.00906936656461311,0.00249456131430867,0.00418002638856811,0.0139587067406581,0.000278146471933745
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37895,-0.0364280795720721,0.0100404196890028,-0.0561073021625176,-0.0167488569816267,0.000286524716459749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,40327,0.0125343824834876,0.00345510749343516,0.0057623717963547,0.0193063931706205,0.000286761054324584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39975,-0.0214486477133963,0.0059231375320175,-0.0330579972761506,-0.009839298150642,0.000294215546165376
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37623,-0.0190200395143867,0.00525356486628263,-0.0293170266523007,-0.00872305237647279,0.000295244227097151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,37896,0.0226005936612537,0.00625134465345375,0.0103479581404843,0.034853229182023,0.000301076857108682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,40354,0.025063001787929,0.00694199619657875,0.0114566892426346,0.0386693143332233,0.000306730035900588
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37937,-0.0280915780774496,0.00778549978594793,-0.0433511576579075,-0.0128319984969916,0.000309453849946182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37955,-0.0138783696676014,0.00384736684370053,-0.0214192086812544,-0.00633753065394835,0.000310590300810936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,40448,0.00990219236021028,0.0027461796792132,0.0045196801889524,0.0152847045314682,0.000312131651449667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39975,-0.0183150970734569,0.00508828776929694,-0.0282881411012789,-0.00834205304563485,0.000319869588659682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,40484,-0.0143880806895652,0.0040037857001339,-0.0222355006618276,-0.00654066071730275,0.000327093834391914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39975,-0.0143680148642761,0.00399915693029005,-0.0222063624476446,-0.00652966728090755,0.00032820455965527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39956,-0.0269247810872467,0.00749654136706939,-0.0416180021667027,-0.0122315600077907,0.000329636142994434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,40010,0.0152785355783143,0.00425452544716719,0.00693966570186658,0.023617405454762,0.000330266993875554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,40406,-0.0165176390419098,0.00460173036353138,-0.0255370305544313,-0.00749824752938826,0.000332381637939593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37567,0.0102446580838567,0.00285611879167357,0.00464666525217651,0.0158426509155369,0.000335829656640484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,40336,0.0126877776796184,0.00354488780282788,0.00573979758607573,0.019635757773161,0.000345706157402
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39975,-0.0173116952471114,0.00483736316920357,-0.0267929270587504,-0.00783046343547246,0.000346298645351293
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39956,-0.0192930088308447,0.0053915782345128,-0.0298605021704898,-0.00872551549119966,0.000346811340498415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37785,-0.017641073022291,0.00493195064804596,-0.0273076962924611,-0.00797444975212094,0.000348930328199701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37623,-0.0193280250310057,0.00540806404810778,-0.0299278305652969,-0.00872821949671442,0.000352924253069898
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40466,0.0139621925685516,0.00393398650125455,0.00625157902609268,0.0216728061110105,0.00038762682297601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40039,-0.0215579929830247,0.00607756151795821,-0.0334700135582228,-0.00964597240782662,0.000390573293190162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40354,0.00881586918437296,0.00248771537145497,0.00393994705632123,0.0136917913124247,0.00039559349152149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,40300,0.00474092956508367,0.00134050842072193,0.00211353306046868,0.00736832606969866,0.000406370099783431
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,37896,-0.033182426586773,0.0093927662642469,-0.0515922484646969,-0.014772604708849,0.000412618335543376
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40531,0.00918227232501811,0.00259995119493306,0.00408636798294931,0.0142781766670869,0.00041403874734921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37536,0.00889720165232181,0.00251917234324688,0.00395962385955791,0.0138347794450857,0.000414169021420497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40531,-0.0127421962833942,0.00361250103157338,-0.019822698305278,-0.00566169426151039,0.000421069389197022
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,40431,0.0124002874168716,0.00351744621786157,0.00550609282986289,0.0192944820038802,0.000424080668384195
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37895,-0.0223685915911897,0.00635728623236263,-0.0348288726066204,-0.0099083105757589,0.000435303559289541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37985,-0.0089624667164137,0.00255225240617006,-0.013964881432507,-0.00396005200032039,0.000446883655502345
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40429,-0.0223494178961626,0.00636600448110172,-0.034826786679122,-0.00987204911320328,0.000448084450148808
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40327,-0.00923511510864629,0.00263453733631525,-0.0143988082878242,-0.00407142192946841,0.000457173965120629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,40336,0.0107463166651765,0.0030781411243241,0.00471316006150127,0.0167794732688517,0.000482214139226486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37623,-0.0136763810079511,0.00391934973676162,-0.0213583064920038,-0.00599445552389831,0.000485594829872231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37623,-0.00982296525065435,0.0028162134491071,-0.0153427436109043,-0.00430318689040443,0.000488228009203982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37557,0.0152416439610795,0.00437416256706871,0.00666828532962481,0.0238150025925342,0.000494721616509971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,37623,-0.0151806086861432,0.00435830807165639,-0.0237228925065897,-0.00663832486569664,0.00049717313778927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40039,-0.0184175678116496,0.00530042699543846,-0.028806404722709,-0.00802873090059023,0.000512752374034613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,40448,0.0158710541674409,0.00456942019529101,0.00691499058467048,0.0248271177502112,0.00051542344476371
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40300,-0.0373793576412411,0.0107648320810439,-0.0584784285200872,-0.0162802867623949,0.000517282400849288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,37572,0.0210792555693249,0.00607188819531303,0.00917835470651135,0.0329801564321384,0.000519003904318179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,40349,-0.0235884187436619,0.00679583037434342,-0.036908246277375,-0.0102685912099488,0.000519874415763186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,40453,0.00916025121639609,0.00264039347606621,0.00398508000330633,0.0143354224294859,0.000523238656721827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,40336,-0.0277692444455975,0.00800546296903164,-0.0434599518648995,-0.0120785370262955,0.000524199818335075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40177,0.0124769018672172,0.00360659962252925,0.00540796660705989,0.0195458371273746,0.000542686063878353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39956,0.0101948043062991,0.00295023519442488,0.00441234332522634,0.0159772652873719,0.000550559104344866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,37895,-0.0198026391339372,0.00574877863012616,-0.0310702452489844,-0.00853503301888991,0.000573504118103691
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,37623,-0.0159251096652557,0.00463043953786432,-0.0250007711594698,-0.00684944817104167,0.000585195051982425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40531,-0.0217212449334945,0.00632759732467413,-0.0341233356898558,-0.00931915417713323,0.000598932839599842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37895,0.0134912511008,0.0039308732035781,0.00578673962178691,0.0211957625798131,0.000600672783610393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37985,0.0102625141074125,0.00299128599528624,0.00439959355665148,0.0161254346581735,0.00060359374537801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,37929,-0.0253336244780069,0.00738576644522087,-0.0398097267106398,-0.010857522245374,0.000605255155095666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40256,0.0185619785970698,0.00542834494637381,0.00792242250217719,0.0292015346919625,0.000629052881481334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,37623,-0.0205626026838998,0.00601538125775775,-0.032352749949105,-0.00877245541869459,0.000631956757423923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,40223,0.0106499067243598,0.00311901331592327,0.00453664062515019,0.0167631728235694,0.000640573424567112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37955,0.0141746904840721,0.0041614910117359,0.00601816810106973,0.0223312128670744,0.00066076316866943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,40478,-0.0208922304018348,0.00613509282074887,-0.0329170123305026,-0.00886744847316697,0.000662377221932464
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37623,-0.0125508069496021,0.00368767220404753,-0.0197786444695353,-0.00532296942966896,0.000667388387981667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,37982,0.00668653093796445,0.00196645748494387,0.00283227426747447,0.0105407876084544,0.000675082533852575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37774,0.00242604554433021,0.000714602808484804,0.0010254240397,0.00382666704896043,0.00068839715383752
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40354,0.00851396383724211,0.00250850614707297,0.00359729178897909,0.0134306358855051,0.000690383959756449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,40336,-0.0251915468657435,0.00744033631955055,-0.0397746060520626,-0.0106084876794245,0.00071141023068801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,40460,-0.00786088183106919,0.00232649297946889,-0.0124208080708282,-0.00330095559131015,0.000729620527485221
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37623,0.0111792975094775,0.00330913989644027,0.00469338331245457,0.0176652117065004,0.000731443577156989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,40511,-0.0101187943923737,0.00299553255609614,-0.0159900382023221,-0.00424755058242525,0.000731986742492186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,40417,-0.0185372124609389,0.00550075696161275,-0.0293186961056999,-0.00775572881617786,0.000753630100250331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37557,0.0171130243237402,0.00508086151091176,0.00715453576235317,0.0270715128851272,0.000758966181001302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,39956,0.0130792199060444,0.00389833205427103,0.00543848907967315,0.0207199507324156,0.000795320653805593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37623,-0.0248357526231751,0.0074139064052674,-0.0393670091774992,-0.010304496068851,0.000810713781097765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40484,-0.0102247490806966,0.00305346310847224,-0.0162095367733021,-0.00423996138809097,0.000814154774503805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,37623,-0.0215234333525155,0.00646652981822589,-0.0341978317962383,-0.00884903490879279,0.000875743848333856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39975,-0.0289189081601345,0.0086918632225696,-0.0459549600763709,-0.0118828562438981,0.000879510685607811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40391,-0.0224113367543313,0.00674475432787821,-0.0356310552369726,-0.00919161827169002,0.000893257037103902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40372,0.0116505379915328,0.00350910609799073,0.004772690039471,0.0185283859435947,0.000901915586055139
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,40246,-0.016928198919053,0.00510600214262944,-0.0269359631186067,-0.00692043471949929,0.000917337092066526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40300,-0.0080882050785321,0.00243991957886875,-0.0128704474531149,-0.00330596270394935,0.000918660757713814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37603,-0.023431065028918,0.00707025485133249,-0.0372887645375297,-0.00957336552030636,0.000922088066756529
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40484,-0.00831390207560227,0.00251422048426077,-0.0132417742247534,-0.00338602992645117,0.000945920953835996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,40336,-0.0206979732946022,0.00626307390802154,-0.0329735981543245,-0.00842234843488002,0.000952672648442883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,37985,-0.0186584716755147,0.00564618896831654,-0.0297250020534151,-0.00759194129761426,0.000953546032074794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,40300,0.00851388614966033,0.00257860063777063,0.0034598288996299,0.0135679433996908,0.000962972693646034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37145,-0.0322398161464671,0.00977462641612487,-0.0513980839220719,-0.0130815483708624,0.000975338286038511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40268,0.00784863210534291,0.0023806478443508,0.00318256233041534,0.0125147018802705,0.000979921537187676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,37593,0.00825039186273868,0.00250516943815554,0.00334025976395381,0.0131605239615235,0.000992638399176152
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,40300,-0.00958159030597997,0.00291000732374866,-0.0152852046605273,-0.0038779759514326,0.000994706803491406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,40027,-0.0125798375100071,0.00382666624239496,-0.0200801033451012,-0.00507957167491299,0.00101335816940804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,37666,-0.0130738989008525,0.00399216306693838,-0.0208985385120517,-0.0052492592896533,0.00105974768100004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,40336,0.00967753173863855,0.00296018918997671,0.00387556092628421,0.0154795025509929,0.00108070947646933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37709,-0.0191622689882014,0.00586311343673031,-0.0306539713241928,-0.00767056665221004,0.00108480533755533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37386,-0.0100681020830725,0.00308278149570884,-0.0161103538146618,-0.00402585035148318,0.00109395001212087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,37982,0.0136198539999151,0.00418628981826987,0.00541472595610618,0.0218249820437241,0.00114295395537577
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37536,0.0177235766678726,0.00545294309864084,0.0070358081945366,0.0284113451412087,0.00115583968051415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39975,-0.00972028855962638,0.00299113092394559,-0.0155829051705597,-0.00385767194869301,0.00115771322481926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,40223,-0.0191209356875579,0.00588876938869312,-0.0306629236893965,-0.00757894768571942,0.00116864932736876
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37666,-0.0225764697277078,0.00695318277160982,-0.036204707960063,-0.00894823149535251,0.00116949570379933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,40484,0.00815723720823852,0.00251748005209727,0.00322297630612788,0.0130914981103492,0.00119673043375942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40466,-0.0187879956401936,0.00580193331664803,-0.0301597849408237,-0.00741620633956346,0.00120518677949164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,40417,-0.0121233197125308,0.00374515370746826,-0.0194638209791686,-0.00478281844589302,0.00121010732468364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40037,0.00944072926802013,0.00291659599356314,0.00372420112063637,0.0151572574154039,0.00121088285611083
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37896,0.00611139423368862,0.00188896694258387,0.00240901902622424,0.009813769441153,0.00121804426523737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,39956,0.0107611334246045,0.00332841444212413,0.0042374411180412,0.0172848257311678,0.00122706058861157
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,37557,-0.0112349085956359,0.00347689612310194,-0.0180496249969157,-0.00442019219435608,0.00123531075837918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37557,-0.0101687750197085,0.00314834939924617,-0.016339539842231,-0.00399801019718602,0.00124149678834324
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,40336,-0.0251891514875805,0.00780614615004365,-0.0404891979416661,-0.00988910503349497,0.001254209714471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,37536,0.00792184032533161,0.00245580400485203,0.00310846447582163,0.0127352161748416,0.00125946381059028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40511,0.00755844988850012,0.00234553705460408,0.00296119726147612,0.0121557025155241,0.00127338846135117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,40177,0.0197038203029684,0.00612116375390281,0.00770633934531891,0.0317013012606179,0.00128914595842746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,37593,-0.0162979092429268,0.00506459160389815,-0.0262245087865672,-0.00637130969928643,0.00129396155530651
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37939,0.00626038196433404,0.00194789362567356,0.00244251045801386,0.0100782534706542,0.00131242328050968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,40327,0.00719004444919101,0.00224409710904826,0.00279161411545642,0.0115884747829256,0.00135809182670073
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37709,-0.00950839072769246,0.00296800126372171,-0.015325673204587,-0.00369110825079791,0.0013602563935642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37985,0.00959333350722232,0.00299535518243233,0.00372243734965494,0.0154642296647897,0.00136443480156981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40300,0.0101206598600114,0.00316337327913783,0.0039204482329012,0.0163208714871215,0.00138020809241708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40300,0.00977381071246762,0.00305555467923053,0.00378492354117579,0.0157626978837595,0.00138319004504193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40037,-0.0137669474586207,0.00430861129537574,-0.0222118255975571,-0.00532206931968422,0.00140004137623054
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40286,0.00970472337756138,0.00303929996119073,0.00374769545362754,0.0156617513014952,0.00141039978966203
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,40327,-0.0149382508140491,0.00468484257723117,-0.0241205422654222,-0.00575595936267602,0.00143223901560438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40307,-0.00569327386815846,0.00178961708415359,-0.0092009233530995,-0.00218562438321742,0.00146908115019993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40037,-0.0257476808046977,0.00811791856421152,-0.0416588011905523,-0.00983656041884315,0.00151838198317983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,40354,0.0126251624422931,0.00398254602765198,0.00481937222809523,0.020430952656491,0.00152663153866305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,37666,-0.0141429453869638,0.00446215808798254,-0.0228887752394096,-0.00539711553451799,0.00153033765024338
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40437,0.00776936690511302,0.00245301930611683,0.00296144906512402,0.012577284745102,0.00154168336805315
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39956,-0.0167952383805601,0.00530332819733587,-0.0271897616473384,-0.00640071511378183,0.00154359016079814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,39920,-0.0124570206309239,0.0039337631388435,-0.0201671963830572,-0.00474684487879065,0.00154482333255255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40336,-0.0104564530607163,0.00331921249661638,-0.0169621095540844,-0.00395079656734816,0.00163415922117236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,40223,-0.0145375433548132,0.00462332846395867,-0.0235992671441722,-0.00547581956545422,0.00166742849442261
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37557,-0.0187769341377914,0.00597450847774494,-0.0304869707541715,-0.00706689752141135,0.00167689318427335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39956,0.0111402392662955,0.00354480437763183,0.00419242268613716,0.0180880558464539,0.00167715479285719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,40382,0.0084247706282416,0.00268225329981164,0.00316755416061079,0.0136819870958724,0.00168720249136456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,37666,-0.0172570422805976,0.00549663674914418,-0.0280304503089202,-0.00648363425227503,0.00169572160032743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40452,0.00722912867852265,0.00230351923914839,0.00271423096979182,0.0117440263872535,0.00170240906600888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40466,0.0147689120790777,0.00471332125789467,0.00553080241360417,0.0240070217445513,0.00173081598601248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,40167,0.0193983575096676,0.00619099526694848,0.00726400678644857,0.0315327082328866,0.00173159735938891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,37773,-0.030097561772009,0.00960747733953784,-0.0489282173575032,-0.0112669061865148,0.00173568374452317
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,39866,0.0193027302917341,0.00616751161223013,0.00721440753176303,0.0313910530517051,0.0017528543612422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,37985,-0.0251906836345163,0.00805171229419748,-0.0409720397311433,-0.00940932753788919,0.00176006940774584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40391,-0.0239974133547684,0.00768286290527764,-0.0390558246491126,-0.00893900206042426,0.00179034753578445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,40255,-0.0155523346450014,0.00498369493365391,-0.0253203767149631,-0.00578429257503972,0.00180781412660063
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37985,-0.0173972434204509,0.0055762350970939,-0.028326664210755,-0.00646782263014687,0.0018129839652896
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37937,-0.0189043170241838,0.00605954178701749,-0.030781018926738,-0.00702761512162948,0.00181379988294703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,37716,-0.00691161438459813,0.00221637094507547,-0.0112557014369461,-0.00256752733225021,0.00182201804915533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39975,-0.0183467789835808,0.00588802487729482,-0.0298873077430786,-0.00680625022408293,0.00183688956988463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37870,0.0074002345051225,0.00238075612498306,0.00273395250015571,0.0120665165100893,0.0018852545814203
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40039,0.0197268951025608,0.00634857201114618,0.00728369396071431,0.0321700962444073,0.00189146337803752
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37536,0.0221742899456092,0.00713790889238069,0.00818398851654303,0.0361645913746753,0.00189687568041051
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40037,-0.0148805214244739,0.00479719334534698,-0.024283020381354,-0.00547802246759384,0.00192611800116079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,40531,-0.0144592410077675,0.00466810059349079,-0.0236087181710095,-0.00530976384452554,0.00195524846516804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40517,0.0150702603856145,0.00487018940495294,0.00552468915190669,0.0246158316193222,0.0019755744988169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,37593,-0.0113906250061924,0.00368349687597553,-0.0186102788831044,-0.00417097112928033,0.00199001186694237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,40354,0.00755235844411678,0.00244405638783852,0.00276200792395328,0.0123427089642803,0.00200440096112183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37682,-0.0175357356251159,0.00567579629808826,-0.0286602963693689,-0.00641117488086288,0.00200866240403661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,37993,0.0136102112957225,0.0044054744162138,0.0049754814399434,0.0222449411515015,0.00200976912430332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40325,-0.0198410989074754,0.00643100064954634,-0.0324458601805862,-0.00723633763436453,0.00203746359687494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40414,0.00864101971563098,0.00280240532659943,0.0031483052754961,0.0141337341557659,0.00204978612818037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40336,0.0223461177851928,0.0072490950111896,0.00813789156326114,0.0365543440071244,0.00205546782887622
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,37536,0.0205090630589161,0.00665429928196096,0.00746663646627266,0.0335514896515596,0.00205988857533504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37567,-0.0164612471042937,0.00535187678009804,-0.0269509255932858,-0.00597156861530152,0.00210377978474962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37623,0.0124802283658533,0.00405868836259907,0.00452519917515908,0.0204352575565474,0.00210975021189086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,40386,0.0107200698368016,0.00348898041627068,0.00388166822091106,0.0175584714526921,0.00212595735786951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,40199,0.0139136307976204,0.00453123762914117,0.00503240504450366,0.022794856550737,0.00213991021311067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39975,0.0129310023575605,0.00421378909974541,0.00467197572205953,0.0211900289930615,0.00215337744113098
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,40307,-0.0165008981769481,0.0053830420632855,-0.0270516606209877,-0.00595013573290857,0.0021778222488283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37855,-0.0291615726526415,0.00951439947159342,-0.0478097956169646,-0.0105133496883184,0.00218107444926961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,37593,0.00455569955551744,0.00148652567920095,0.00164210922428358,0.0074692898867513,0.00218357402585354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40336,-0.0406108644829157,0.0132521596149205,-0.0665850973281599,-0.0146366316376715,0.00218420517674701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,40283,-0.0236983969941848,0.00773382607815001,-0.0388566961073588,-0.00854009788101073,0.0021858145657921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,37955,0.0119987092396723,0.00391583415677379,0.00432367429239568,0.0196737441869489,0.00218718608008819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37593,-0.0130996955239993,0.00427608037256472,-0.0214808130542261,-0.00471857799377242,0.0021922011241258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,40466,-0.0162728626144171,0.00531405718381,-0.0266884146946847,-0.00585731053414949,0.00220059243461572
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37567,-0.0321062353505512,0.0104885860929871,-0.0526638640928059,-0.0115486066082965,0.00220997779660998
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,39956,-0.0193583767594657,0.00632763381187513,-0.0317605390307409,-0.0069562144881904,0.00222204620750309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,37557,0.0137951407564526,0.00450929760836175,0.0049569174440636,0.0226333640688417,0.00222328103964543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,40012,0.0150851413439614,0.00493135784344363,0.00541967997081191,0.024750602717111,0.00222436970902882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,40198,-0.014031393451416,0.00458733348025537,-0.0230225670727166,-0.00504021983011551,0.00222654081587892
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39956,-0.0124102681443629,0.00405995858808275,-0.0203677869770051,-0.00445274931172072,0.00224133422096048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37666,-0.00603889920014628,0.00198048170406956,-0.00992064334012263,-0.00215715506016994,0.00229900109612936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,37993,0.0125984584249407,0.0041397846001519,0.00448448060864299,0.0207124362412384,0.00234475385683129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40406,0.00890151413799298,0.00292857795702938,0.00316150134221539,0.0146415269337706,0.00237327734684646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,40187,-0.017244644891829,0.00568550839868585,-0.0283882413532533,-0.00610104843040475,0.0024245979738846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,37226,0.0186663377519944,0.00615789690836787,0.00659685981159342,0.0307358156923955,0.00244003432315927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37937,-0.00776917160767566,0.00256440545194194,-0.0127954062934819,-0.00274293692186945,0.00245326061098511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,40406,-0.0153901249674185,0.00508236521271556,-0.025351560784341,-0.00542868915049601,0.00246455320169821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40301,0.00959148488628679,0.00317138086291643,0.00337557839497059,0.015807391377603,0.00249535894683199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,40256,-0.0206728037720083,0.00684533880561866,-0.0340896678310209,-0.00725593971299577,0.00253192937507433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,40531,0.00854885649058751,0.00284544607429802,0.00297178218496338,0.0141259307962116,0.00266515606014303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,40286,-0.0186659879722778,0.00621644756772216,-0.0308502252050133,-0.00648175073954238,0.00268033453430012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37623,-0.0217105500186523,0.00723470718785927,-0.0358905761068564,-0.00753052393044811,0.00269697117243674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37982,0.0156289990288347,0.00520833478873928,0.00542066284290568,0.0258373352147637,0.00269791359663533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,39929,-0.0182461772826238,0.0060811775912753,-0.0301652853615234,-0.00632706920372422,0.00270023725714078
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,37955,-0.0174210713375223,0.00581571194967892,-0.028819866758893,-0.0060222759161516,0.00274476029503104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,37623,0.0111660027549634,0.00372905169300089,0.00385706143668165,0.0184749440732451,0.00275561282411631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37623,-0.0203959829871418,0.00681339730104202,-0.0337502416971842,-0.00704172427709947,0.00276298919725805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37536,0.012328898468068,0.00412309165303302,0.00424763882812326,0.0204101581080127,0.00279306934803093
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,37895,-0.00935907060747371,0.00313058528665818,-0.0154950177693237,-0.00322312344562369,0.00279885647467404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,40406,-0.00831510163196449,0.00278219217005814,-0.0137681982852785,-0.00286200497865053,0.00280605647656583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39929,-0.0183196838561108,0.00613398972035287,-0.0303423037080024,-0.00629706400421915,0.00282553806675823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,37472,0.0163055226148128,0.00546358763537536,0.00559689084947713,0.0270141543801485,0.00284663964390923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40466,-0.017488414512755,0.005863703904719,-0.0289812741660042,-0.00599555485950573,0.00286348281492918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,40406,0.00803087245246358,0.00269504109533505,0.00274859190560689,0.0133131529993203,0.00288805060537795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37955,-0.014359008961169,0.004842025998953,-0.0238493799191169,-0.0048686380032211,0.00302723776336186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,39975,0.0220800456134657,0.00744637819187166,0.00748514435739727,0.0366749468695342,0.00302940276620624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,37673,0.00821429432596187,0.00277303977474997,0.00277913636745192,0.0136494522844718,0.00305994205183778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,40369,-0.0122101576982573,0.00412414332758231,-0.0202934786203187,-0.00412683677619602,0.00307440268568071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40374,0.00863224008888098,0.00291619291320112,0.00291650197900679,0.0143479781987552,0.00307986345564599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40300,0.00624426491403867,0.00210995264157801,0.00210875773654576,0.0103797720915316,0.00308660883093199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37666,-0.0152749798313999,0.00516138119529614,-0.0253912869741804,-0.00515867268861951,0.00308710183719836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,40398,-0.0150138407338594,0.00507614514684828,-0.024963085221682,-0.00506459624603679,0.00310373219607809
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39975,-0.0214183673272391,0.00724239465242419,-0.0356134608459905,-0.00722327380848769,0.00310753092476436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39956,-0.0142618590777907,0.00482310450386186,-0.02371514390536,-0.00480857425022146,0.00311129118448301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37536,0.0150741569098828,0.00509888473001469,0.00508034283905397,0.0250679709807115,0.00311845562101921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40327,-0.0118927725096454,0.00402692472928814,-0.0197855449790501,-0.00400000004024063,0.00314842880455233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,37896,-0.0181965481823115,0.00616594797510211,-0.0302818062135116,-0.00611129015111133,0.00317154389693568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,37623,-0.00755520472488574,0.00256022135125114,-0.012573238573338,-0.00253717087643351,0.00317308238073137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39929,0.0139536808572743,0.00473295388294686,0.00467709124669849,0.0232302704678502,0.00320110644924703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,40484,0.0118005349579065,0.00401059534460267,0.00393976808248528,0.0196613018333277,0.00326208423306345
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37536,0.00862974083850338,0.0029349506026666,0.00287723765727684,0.0143822440197299,0.00328430253329205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40511,-0.00842133305388679,0.00286668440862278,-0.0140400344947874,-0.00280263161298615,0.0033117348805631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,40327,0.00864613629043135,0.00294346711647837,0.00287694074213373,0.014415331838729,0.00331453935521071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,37937,0.00948382454133949,0.00323210509188272,0.00314889856124936,0.0158187505214296,0.00334911468376892
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37557,0.00522501547158471,0.00178368050989505,0.00172900167219041,0.00872102927097902,0.00340262662044109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,40344,-0.0109936785031611,0.00375323128835947,-0.0183500118283456,-0.00363734517797651,0.00340402104912245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37593,-0.0139633447758375,0.00477400778857656,-0.0233204000414475,-0.00460628951022743,0.00345190852406253
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37593,-0.0115234357398328,0.00394611542422623,-0.0192578219713162,-0.00378904950834939,0.00350404233307446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,37985,-0.0110639004920958,0.00379194584705833,-0.0184961143523302,-0.00363168663186151,0.00353161652504229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40354,0.0198322699394225,0.00680831885038688,0.00648796499266418,0.0331765748861808,0.00358533916485163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,40417,0.0173413300643275,0.00596719037989915,0.00564563691972517,0.0290370232089299,0.00366452065954695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37557,0.0168505708855839,0.00580162028117088,0.00547939513448893,0.0282217466366788,0.0036850252341583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40531,0.00889938579165396,0.00306954337406801,0.00288308077848067,0.0149156908048273,0.00374557814244906
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,39852,0.0169696992370481,0.00585443072818683,0.00549501500980189,0.0284443834642943,0.00375352309137902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37623,-0.00827723807693146,0.0028558655808473,-0.0138747346153922,-0.00267974153847075,0.00375775715600021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40374,0.00852401427792302,0.0029434115188556,0.00275492770096604,0.01429310085488,0.00378509848870598
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40223,0.0297736537091672,0.0102885815163085,0.00960803393720259,0.0499392734811319,0.00381066283210151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37937,0.0101582632910273,0.00351252903151713,0.00327370638925374,0.0170428201928009,0.00383399692419519
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,39872,-0.0216584229369161,0.00749929395139929,-0.0363570390816587,-0.00695980679217347,0.00388163131406551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40284,0.00698919083138344,0.00242042346942417,0.00224516083131207,0.0117332208314548,0.00388731040341031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,37567,-0.0117299697000495,0.00406410958263307,-0.0196956244820103,-0.00376431491808865,0.00390518857113918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40406,0.00691513114682897,0.00239634255103293,0.00221829974680442,0.0116119625468535,0.00391064913264827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37955,0.00881692978838535,0.00305555441426818,0.00282804313641972,0.014805816440351,0.00391359402808551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,38008,0.00388031502142516,0.00134690137589483,0.0012403883246713,0.00652024171817903,0.00397138170493592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,37896,-0.0262163247642711,0.00911449763613439,-0.0440807401310945,-0.0083519093974477,0.00402958320826077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,40466,0.019414155681172,0.00675445323589923,0.00617542733880952,0.0326528840235345,0.00405489329958332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,40406,-0.0173931963858086,0.00605492879226438,-0.0292608568186468,-0.00552553595297041,0.00407686894315496
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40417,-0.0263660389969425,0.00919004549660813,-0.0443785281702945,-0.00835354982359059,0.00412340460915476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37557,0.00649945392234432,0.00226615957726006,0.0020577811509146,0.010941126693774,0.00413672362927501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37567,-0.0178042306872123,0.00620889198127093,-0.0299736589705033,-0.00563480240392125,0.00414339085141213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39975,-0.010184070079969,0.00355217412313836,-0.0171463313613202,-0.00322180879861781,0.00414945441394365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40223,-0.0113498156804754,0.00396246001995321,-0.0191162373195837,-0.00358339404136716,0.00418436474355885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40466,-0.0121858715723276,0.00425553002190325,-0.020526710415258,-0.00384503272939728,0.00419482708208172
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,37623,-0.0103923845909873,0.00363640848440675,-0.0175197452204245,-0.00326502396155005,0.00427163019172973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,37710,0.00966286562904183,0.00338286607641988,0.00303244811925887,0.0162932831388248,0.00429122279481114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,37895,-0.0159452775054325,0.00558468158475217,-0.0268912534115467,-0.00499930159931824,0.00430781319464872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39975,-0.0232832319715105,0.0081576302033946,-0.0392721871701639,-0.00729427677285706,0.00432070834098842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37536,0.015482570750219,0.00542448008412005,0.00485058978534371,0.0261145517150943,0.00432126404864134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,40417,0.0169000372761426,0.00594284934682594,0.00525205255636379,0.0285480219959215,0.00446412529338046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,40336,-0.0165358921836155,0.00582807102271465,-0.0279589113881363,-0.00511287297909483,0.00455567483249936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40336,-0.0112782824746517,0.0039768762078048,-0.0190729598419491,-0.00348360510735433,0.0045745182769544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,37937,-0.015529839809251,0.00547830305019096,-0.0262673137876253,-0.0047923658308767,0.00459239726974885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,40371,-0.0229732082562174,0.00810531724559555,-0.0388596300575847,-0.00708678645485017,0.00459785453299922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37477,-0.0126331037239138,0.00445977701514591,-0.0213742666735998,-0.0038919407742278,0.00462310038745755
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37623,-0.017995178466222,0.00635442750035631,-0.0304498563669204,-0.00554050056552365,0.00463407876239797
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,40484,-0.00908833931795165,0.00321251908861082,-0.0153848767316289,-0.00279180190427444,0.00467460833389676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37985,-0.0203669770433799,0.00721177603303143,-0.0345020580681216,-0.00623189601863834,0.0047478772983989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,40511,-0.0233300072737546,0.00826238815539406,-0.039524288058327,-0.00713572648918226,0.00475401703306746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,37852,0.0177962089542699,0.00630585754303574,0.00543672816991985,0.0301556897386199,0.00477699538841341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40037,0.0139319095465071,0.00494114811192981,0.00424725924712463,0.0236165598458895,0.00481488184670549
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40511,-0.016844180361009,0.00597855915107275,-0.0285621562971116,-0.0051262044249064,0.0048468565598839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40354,0.00870403860239514,0.00309498446463358,0.00263786905171333,0.014770208153077,0.00492481798184448
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37993,-0.00862961198117572,0.00306998319502782,-0.0146467790434302,-0.0026124449189212,0.00494642675693254
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40336,-0.0197944493190105,0.00704857371643502,-0.0336096538032231,-0.00597924483479785,0.00498658991216775
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40037,-0.0217319482773698,0.00774402024936265,-0.0369102279661206,-0.00655366858861897,0.00501780966717011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37666,-0.00618439625368599,0.00220647254341222,-0.0105090824387739,-0.00185971006859804,0.0050728091663305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37955,-0.0192642896729763,0.00688725948044744,-0.0327633182546533,-0.00576526109129931,0.00516380052382712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,40350,0.0097349411743143,0.00348644885517213,0.00290150141817693,0.0165683809304517,0.0052409843229219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37896,-0.0204032469562177,0.00731224645568504,-0.0347352500093604,-0.00607124390307502,0.00527359453940669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,40406,-0.0136943754938144,0.0049164517459168,-0.0233306209158113,-0.00405813007181743,0.00535217350611628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40306,0.00995494737119664,0.00357406345951644,0.00294978299054442,0.0169601117518489,0.00535366770247921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,37985,0.0238047110455177,0.00855491765453183,0.00703707244263527,0.0405723496484001,0.00540038996932722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40037,-0.00858872309117959,0.00308892101519175,-0.0146430082809554,-0.00253443790140376,0.00543415558330621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,40300,0.0210261412073162,0.00756302075656094,0.00620262052445672,0.0358496618901756,0.00544020972826519
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37666,0.00534394508414635,0.00192438574037051,0.00157214903302015,0.00911574113527255,0.0054946969679995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37567,-0.012154007697128,0.00437680871416648,-0.0207325527768943,-0.0035754626173617,0.00549561053472542
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38008,0.00436295798529384,0.0015726910436169,0.00128048353980471,0.00744543243078297,0.0055413518968251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40305,-0.0154029704203057,0.00555382315825981,-0.026288463810495,-0.00451747703011651,0.00555387992415213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,37926,0.0156772511641433,0.00566138513308323,0.0045809363033002,0.0267735660249865,0.00562787994217533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39975,-0.00853658754851155,0.00308776216016339,-0.0145886013824318,-0.00248457371459131,0.00570508070072403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37623,-0.00735381255279857,0.00266490435013351,-0.0125770250790603,-0.00213060002653689,0.00579692602841072
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,40300,0.0068432820425434,0.00248164104332695,0.00197926559762257,0.0117072984874642,0.00583006390160557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,40354,-0.0144286217549882,0.0052346350567205,-0.0246885064661604,-0.00416873704381607,0.00585123896903141
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,40456,0.00827342563538117,0.00301017039709045,0.0023734916570839,0.0141733596136784,0.00599374064713102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37955,0.0103186087881355,0.00375450505739832,0.00295977887563481,0.0176774387006362,0.00599797232468109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37672,-0.0160036006276575,0.00582574050012472,-0.027422052007902,-0.00458514924741308,0.00602153883999264
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37593,-0.0203448610517473,0.00740925652445092,-0.0348670038396711,-0.00582271826382351,0.00604326133443012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,37937,-0.0137272482454914,0.00499986892744492,-0.0235269913432835,-0.00392750514769938,0.00604948260609574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,39898,0.0103385493084371,0.00376894063534225,0.00295142566316632,0.017725672953708,0.00609338799296566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,37557,0.00880941900762595,0.00321266671399663,0.00251259224819256,0.0151062457670593,0.00611325959448119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40406,0.0108132079023311,0.00395252513119279,0.00306625864519319,0.0185601571594689,0.00623029155425269
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40300,-0.0183230629811763,0.0067038695278051,-0.0314626472556743,-0.00518347870667834,0.00627904724363169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,40189,0.0068647556331938,0.00251372051367765,0.00193786342638561,0.011791647840002,0.00632292034563701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,37593,0.0107565273816545,0.00394230438565558,0.00302961078576954,0.0184834439775394,0.00637101303221854
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37982,0.0346580358460947,0.0127076038675676,0.00975113226566229,0.0595649394265272,0.00639283175875144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39975,0.00743571572832839,0.00272683579382642,0.0020911175724286,0.0127803138842282,0.00640108080455527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,40511,-0.00629576502416914,0.00231258672463628,-0.0108284350044563,-0.00176309504388203,0.00648813711116939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",38008,-0.00391471718113307,0.00143965117794673,-0.00673643348990866,-0.00109300087235748,0.00655209012870449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,40466,-0.0139388157311341,0.00512868468509146,-0.0239910377139134,-0.00388659374835486,0.00657852714600688
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37982,0.0172443751829772,0.00634667948137309,0.00480488339948589,0.0296838669664684,0.00659463612347492
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,37623,-0.0162620231108233,0.00598571103124621,-0.0279940167320659,-0.00453002948958077,0.00660010773804823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,37877,0.00856163944959384,0.00315857130608433,0.00237083968966855,0.0147524392095191,0.00672459207675855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37567,0.0188031579135575,0.00694612220177357,0.00518875839808128,0.0324175574290337,0.006798201654086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,39975,0.0127523849401952,0.00471446582193093,0.00351203192921053,0.0219927379511798,0.0068389607415179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37895,-0.0103573361422031,0.0038304912561004,-0.0178650990041599,-0.0028495732802463,0.00686133068257717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,39975,-0.023062700095634,0.00853215401941874,-0.0397857219736947,-0.00633967821757323,0.00687845409793554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,39956,-0.0159890114911382,0.00592298225306512,-0.0275980567071459,-0.00437996627513059,0.00695218492293119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40417,-0.0203423013761942,0.00754112434336112,-0.035122905089182,-0.00556169766320644,0.00699323618433061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40368,0.00638811401099055,0.00236919761178096,0.00174448669189986,0.0110317413300812,0.00701841040912767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,39975,0.0201607927506449,0.0074773155168254,0.00550525433766712,0.0348163311636227,0.0070198361210575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,37593,0.0062119554276541,0.00230713541635123,0.00168997001160569,0.0107339408437025,0.00710090477103946
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37955,-0.0219179945806243,0.00815978117540662,-0.0379111656844213,-0.00592482347682733,0.0072379701752236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37477,-0.00979245989498481,0.00364831948532686,-0.0169431660862255,-0.00264175370374416,0.00728169899032357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,40466,0.00529803335247643,0.0019739778469392,0.0014290367724756,0.00916702993247726,0.00728355081562353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,39942,-0.0205364749520075,0.00765175445372999,-0.0355339136813182,-0.00553903622269668,0.00728481854237752
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,40179,0.0156570238136354,0.00583509736555822,0.0042202329771413,0.0270938146501295,0.00729867832581117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,37955,-0.00865716783890322,0.00322704429007165,-0.0149821746474437,-0.00233216103036278,0.00731210075760526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37988,0.00456787685038149,0.00170629033043265,0.0012235478027335,0.00791220589802949,0.00743562838371053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40352,0.00698433340303237,0.00261277777983115,0.00186328895456332,0.0121053778515014,0.00752205132906555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37709,-0.0124288395727116,0.0046503845065496,-0.0215435932055488,-0.00331408593987441,0.00753473165358546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40307,0.0208630380333271,0.00781528180211434,0.00554508570118304,0.0361809903654712,0.0076037515044616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,40300,-0.0129137719578872,0.00483776450763657,-0.0223957903928549,-0.00343175352291948,0.00760716635566842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,40466,-0.0139941379895465,0.00524495505843825,-0.0242742499040855,-0.00371402607500754,0.00763551688988095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39956,-0.0197080665634599,0.0073912419469556,-0.0341949007794929,-0.00522123234742696,0.00767461341937845
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,40401,0.00945979552249601,0.00354911319649226,0.00250353365737117,0.0164160573876208,0.00769749453006495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37985,-0.0180542013375017,0.00677408432047682,-0.0313314066056363,-0.00477699606936717,0.00770368414452282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40336,-0.012005034368047,0.00451019761891963,-0.0208450217011294,-0.0031650470349645,0.00778130110111326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37896,0.0222271224983919,0.00836867834260739,0.0058245129468814,0.0386297320499024,0.00791693607234553
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40223,-0.0134490223384508,0.00506412572938617,-0.0233747087680477,-0.00352333590885388,0.0079213189785307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,40187,0.00728798261520633,0.00274815848319945,0.0019015919881354,0.0126743732422773,0.00801083085132303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37557,0.00942099692163242,0.00355798103555268,0.00244735409194916,0.0163946397513157,0.00811026556828895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,40039,0.0341077358938074,0.0128825768582687,0.00885788525160071,0.0593575865360141,0.00811502013060916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,40369,-0.0155211389732958,0.00586594014699849,-0.0270183816614128,-0.00402389628517873,0.00815355951483501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40330,0.00412549669680949,0.00155956683073254,0.00106874570857371,0.00718224768504527,0.00817028281599784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40147,-0.0270170416124068,0.0102299619016656,-0.0470677669396714,-0.00696631628514215,0.00827504571740126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37593,-0.0082052598394016,0.00311075390523534,-0.0143023374936629,-0.00210818218514033,0.00835667709013977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,37929,-0.0225435803472052,0.00856302151913422,-0.0393271025247083,-0.00576005816970214,0.00848140973632269
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,40285,-0.0101418376447704,0.00385313013969653,-0.0176939727185756,-0.00258970257096521,0.00849403025471571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,40223,0.0129587174041908,0.00492871771713412,0.00329843067860794,0.0226190041297737,0.00856622461573182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,40327,-0.016993572847524,0.0064946144430621,-0.0297230171559257,-0.00426412853912226,0.00889039069735463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,40327,-0.015282801641408,0.00584245071411058,-0.0267340050410647,-0.00383159824175125,0.00890976031582043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37993,0.00888496952005222,0.00340683295988372,0.00220757691868013,0.0155623621214243,0.00911768952136785
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,40412,0.02593337753015,0.00994558592214411,0.00644002912274754,0.0454267259375524,0.00912839221891933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,37536,0.0219081048444751,0.00840436913523906,0.00543554133940651,0.0383806683495436,0.00915092364621027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37937,-0.00823209061373848,0.00315930117599529,-0.0144243209186892,-0.00203986030878772,0.00917959870735148
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37937,-0.00690568195604964,0.00265131614500297,-0.0121022616002555,-0.00170910231184381,0.00920760141415867
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40300,-0.019564442740239,0.00751285598515618,-0.0342896404711451,-0.00483924500933292,0.00921941310717517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40037,-0.0221107503961913,0.00850087180862308,-0.0387724591410926,-0.0054490416512901,0.0093040804322545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39975,-0.0118117594959682,0.00454150878477368,-0.0207131167141247,-0.00291040227781183,0.00930826896213972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,40531,0.00390721902793714,0.00150286916580396,0.000961595462961386,0.00685284259291289,0.00933525544100024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,40398,-0.0229073941631411,0.00882137650150434,-0.0401972921060896,-0.00561749622019258,0.00941817113309606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,40466,0.00779073860024203,0.00300186572465781,0.00190708177991273,0.0136743954205713,0.00945949146027501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37666,0.00583680233835999,0.00225291111107621,0.00142109656065063,0.0102525081160694,0.00958632355449973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,37993,-0.00930852751238265,0.00359446412870703,-0.0163536772046484,-0.00226337782011687,0.00961668046770443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,40263,0.00852530050804255,0.00329278616310338,0.00207143962835993,0.0149791613877252,0.00963197195785618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,39975,-0.0222347528654917,0.00858897714339868,-0.0390691480665531,-0.00540035766443026,0.00964135805915796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37709,-0.025475469917758,0.00984363672439752,-0.0447689978975771,-0.00618194193793887,0.00966363560269928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37557,-0.0151935238165485,0.00587353332689946,-0.0267056491372715,-0.00368139849582559,0.00969848583122736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,40352,0.00818916205435385,0.00317167717348288,0.00197267479432741,0.0144056493143803,0.00983279256803413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,40336,-0.012088803654223,0.00468734716723902,-0.0212760041020115,-0.00290160320643451,0.00991676042590736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,40336,-0.0177528442025882,0.00689628890425863,-0.0312695704549351,-0.00423611795024129,0.0100544347174167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39956,-0.0105525855028147,0.00409945390956505,-0.0185875151655622,-0.00251765584006726,0.0100580341355825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39975,-0.0148554548096546,0.00577145029767248,-0.0261674973930927,-0.00354341222621657,0.0100635148408348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,37805,0.00685790524655446,0.00266638711327598,0.00163178650453354,0.0120840239885754,0.010122466124632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,37666,0.00813408318146948,0.00316384768788834,0.00193294171320833,0.0143352246497306,0.0101529410226582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39956,0.014835277085175,0.00577452877244252,0.00351720069118763,0.0261533534791623,0.0102058992573922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40223,0.00640390961137503,0.0024954932548041,0.00151274283195899,0.0112950763907911,0.0102914005804317
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,37807,0.0225597191596113,0.00879611219679587,0.00531933925389136,0.0398000990653312,0.0103362156361224
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40466,-0.00784056355286497,0.00305904937174263,-0.0138363003214805,-0.00184482678424942,0.0103841077560102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40223,-0.00510329327948678,0.00199628481028583,-0.00901601150764701,-0.00119057505132655,0.0105855705574399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,40290,-0.0143253919394686,0.00561441161456299,-0.0253296387040121,-0.00332114517492514,0.0107341338179953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37896,-0.00887472349478223,0.00347911556422029,-0.015693790000654,-0.00205565698891046,0.010756846288833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,40345,0.00721173450280684,0.00283082135814999,0.00166332464083286,0.0127601443647808,0.0108567343964885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37623,0.0118164090467071,0.0046393699645784,0.00272324391613345,0.0209095741772808,0.0108770607076579
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,40336,-0.0185199569455147,0.0072736989042842,-0.0327764067979117,-0.00426350709311766,0.010901073746606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40286,0.00966247503404394,0.00379939499073374,0.00221566085220581,0.0171092892158821,0.0109948737471084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40336,-0.012110242656293,0.00476370679077744,-0.0214471079662168,-0.00277337734636922,0.0110254742326315
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,40037,-0.00803251426454184,0.0031657369043506,-0.014237358597069,-0.00182766993201466,0.0111798727159412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40336,-0.00958358754908495,0.00377707127382165,-0.0169866472457754,-0.00218052785239453,0.0111803906188926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37477,0.0129097831637785,0.00509025211113142,0.0029328890259609,0.0228866773015961,0.0112185707790827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40417,0.00618927880942549,0.00245285497503795,0.00138168305835112,0.0109968745604999,0.0116356802967406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37896,-0.024117180201947,0.00955962996314039,-0.0428540549297022,-0.00538030547419187,0.0116533945921353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,37536,0.0122041378594564,0.00484167808008249,0.00271444882249472,0.0216938268964181,0.0117258825792388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37666,-0.0149163852981598,0.00592619501346958,-0.0265317275245602,-0.00330104307175941,0.0118467548579222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40300,-0.00468520767908581,0.00186476021287591,-0.0083401376963226,-0.00103027766184903,0.0119978021695341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40327,0.0116555355379022,0.00464137021619974,0.00255844991415072,0.0207526211616537,0.0120410704149176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,40511,0.00863389613071733,0.00344119316877736,0.00188915751991371,0.015378634741521,0.0121176895756702
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37982,0.0138599207094551,0.00552492104851483,0.00303107545436601,0.0246887659645441,0.0121320213370972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40306,-0.0193448859851465,0.00771885610665971,-0.0344738439541996,-0.00421592801609352,0.0122140879533217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40223,-0.0208655873154411,0.00832878637225154,-0.0371900086050541,-0.00454116602582813,0.0122469215567034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40037,-0.0122484318843813,0.00489290490830713,-0.0218385255046633,-0.00265833826409932,0.0123141029847995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,40350,0.0406962881223121,0.0162572810761816,0.00883201721299622,0.072560559031628,0.0123152727473575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40531,0.00728701776882449,0.0029129725391782,0.00157759159203522,0.0129964439456138,0.0123741021308719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40511,0.0161474746742782,0.0064588503508939,0.00348812798652614,0.0288068213620302,0.0124273300325936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,40354,-0.00800641732172202,0.00320586448858172,-0.0142899117193422,-0.00172292292410184,0.0125197963061138
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,37557,0.0243976678460228,0.00977229262468356,0.00524397430164303,0.0435513613904026,0.0125506259665902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,40269,-0.0107383456650063,0.00430308319162709,-0.0191723887205953,-0.00230430260941716,0.0125880710167595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37985,-0.0159337236579189,0.00638501446259232,-0.0284483520045999,-0.00341909531123801,0.0125902342404095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,37593,-0.00958373886662455,0.00384044201009987,-0.0171110052064203,-0.0020564725268288,0.0125909200972831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,40336,0.0129662199334964,0.00520846668617641,0.00275762522859068,0.0231748146384022,0.0128042250574426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37557,-0.013577844201441,0.00546066044449878,-0.0242807386726586,-0.00287494973022336,0.012913596533822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37666,0.0194220568723052,0.00783893842853333,0.0040577375523799,0.0347863761922305,0.0132379054703053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37937,0.00580374029106095,0.00234346657480368,0.00121054580444575,0.0103969347776762,0.0132776311117028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37623,-0.00511838951125262,0.00206697434351615,-0.00916965922454427,-0.00106711979796096,0.0132887288004275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39975,0.0127944995933631,0.00516849248187276,0.0026642543288925,0.0229247448578337,0.0133163131769417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37896,0.0253126441648362,0.0102288527933929,0.00526409268978614,0.0453611956398862,0.0133496035531736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39975,-0.0114746798504229,0.00463984326614698,-0.0205687726520709,-0.00238058704877478,0.0134062326639493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,37536,0.0159399511046625,0.00644969531561763,0.00329854828605196,0.0285813539232731,0.0134701378317246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,40198,-0.00640278697585732,0.00259414823032024,-0.011487317507285,-0.00131825644442965,0.0135912999149506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,37536,0.010525723916435,0.0042670304336288,0.00216234426652257,0.0188891035663475,0.0136470302661153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40511,0.00792720520618071,0.00321686543433398,0.00162214895488611,0.0142322614574753,0.0137398955360951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,37536,0.00977091520038343,0.00396577511953319,0.00199799596609837,0.0175438344346685,0.0137596750801299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40531,0.0132319987647921,0.00537314385184093,0.00270063681518384,0.0237633607144003,0.0138030979431801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37955,0.0157439890529611,0.00639385203090287,0.00321203907239151,0.0282759390335307,0.0138148583291263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,40319,-0.0222638194382115,0.00904484994810844,-0.039991725336504,-0.00453591353991897,0.0138466363407773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37536,0.0124241661682837,0.00504829980879755,0.00252949854304054,0.0223188337935269,0.0138655544563851
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,40336,0.0149275442308216,0.00606760846340389,0.00303503164254995,0.0268200568190932,0.0138964404829179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37955,0.00915651878370034,0.00372489997268742,0.00185571483723299,0.0164573227301677,0.0139763210174279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,37593,0.00591526752878858,0.00240683952116281,0.00119786206730947,0.0106326729902677,0.0139961659029591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40345,-0.0106824204986727,0.00434895575256881,-0.0192063737737075,-0.0021584672236378,0.0140474863350712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40432,-0.0175540209787493,0.00714884911540365,-0.0315657652449405,-0.00354227671255814,0.0140793265124434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,40484,-0.00884912573688223,0.00360407885240729,-0.0159131202876005,-0.00178513118616394,0.0140869097595996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40531,-0.00676605296059575,0.002757794727872,-0.0121713306272249,-0.00136077529396664,0.0141606914725362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37858,-0.0114904792930782,0.0046879657711734,-0.0206788922045781,-0.00230206638157832,0.0142563495499683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39956,-0.0139369613562869,0.00569048681033027,-0.0250903155045343,-0.0027836072080396,0.0143296318439015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40327,0.00700510322189872,0.00286255607151028,0.00139449332173856,0.0126157131220589,0.0144098636457196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,40354,-0.0115248217181156,0.0047150238876492,-0.0207662685379081,-0.0022833748983232,0.0145250857693415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37536,0.0124319474565178,0.0050895096401809,0.00245650856176322,0.0224073863512723,0.0145925550831562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40223,-0.00633529605016955,0.00259369146874546,-0.0114189313289107,-0.00125166077142845,0.0145936405612934
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37895,-0.0141155308026204,0.00578400766584929,-0.025452185827685,-0.00277887577755574,0.0146821554489109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37937,-0.00847691773916252,0.00347529780908374,-0.0152885014449667,-0.00166533403335838,0.0147329594508654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,40427,-0.0148277403812179,0.00608044812761512,-0.0267454187113435,-0.00291006205109227,0.0147553666343932
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,37536,0.00726871241673846,0.0029921581944587,0.00140408235559941,0.0131333424778775,0.0151432973834159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37955,-0.013258919737401,0.00546392018389969,-0.0239682032978444,-0.0025496361769576,0.0152527354072701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37896,-0.0217834912186185,0.00901133705545261,-0.0394457118473056,-0.00412127058993135,0.0156475000279887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,39956,-0.00935515939646962,0.00388319003121092,-0.016966211857643,-0.00174410693529621,0.016001621502426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,40039,-0.0148742022145623,0.0061954487383309,-0.0270172817416909,-0.00273112268743373,0.0163697004637881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,37896,-0.00958426608428132,0.00400034965372988,-0.0174249514055919,-0.00174358076297076,0.0165951397670785
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37993,-0.0173783463998905,0.00726340398999488,-0.0316146182202804,-0.00314207457950052,0.0167434773269628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,37895,0.0074702187123832,0.00312254523199465,0.00135003005767369,0.0135904073670927,0.0167545515007936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40309,0.00594860359732339,0.0024879611166537,0.00107219980868213,0.0108250073859646,0.0168161925730848
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37985,-0.0153756027822645,0.00643837747015734,-0.0279948226237729,-0.00275638294075611,0.0169485491719856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40466,-0.00990699283780782,0.00415170578005358,-0.0180443361667128,-0.0017696495089028,0.017032888214869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40302,-0.0137394372261709,0.0057612530925055,-0.0250314932874816,-0.00244738116486008,0.017100086772226
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40327,0.00778597709330723,0.0032655138358914,0.00138556997496008,0.0141863842116544,0.0171231428565061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39975,-0.0227810736771484,0.00955839004497959,-0.0415155181653084,-0.00404662918898844,0.0171674138436523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,37593,0.012407940404187,0.00521349312587204,0.00218949387747777,0.0226263869308962,0.0173283786660228
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,37896,-0.0142097322098564,0.00597935096513697,-0.0259292601015248,-0.00249020431818792,0.0174932295055382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,40223,0.00906455132991106,0.00381627090248401,0.0015846603610424,0.0165444422987797,0.0175495263056092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37414,-0.0112291153972078,0.00472832169618713,-0.0204966259217345,-0.00196160487268098,0.0175699399650638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40448,-0.0122963998625762,0.00517857925314377,-0.022446415198738,-0.00214638452641443,0.0175857196770397
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37985,-0.00810608126333223,0.0034148362144295,-0.014799160243614,-0.00141300228305042,0.0176207538868335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,40417,0.00685209569288305,0.0028893391311246,0.00118899099587884,0.0125152003898873,0.0177273770111525
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40511,-0.0157653624092165,0.00665036898198698,-0.0288000856139109,-0.00273063920452198,0.0177709937769331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,40406,0.0120733614065405,0.00509710004979585,0.00208304530894066,0.0220636775041404,0.0178638902420503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,40223,-0.015053831361464,0.00635945968339709,-0.0275183723409223,-0.00258929038200567,0.0179373921304248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40223,-0.0123349594658226,0.00521123208013983,-0.0225489743428966,-0.00212094458874853,0.017945188189281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,37912,-0.00614304575577582,0.00259732961560661,-0.0112338118023648,-0.00105227970918688,0.0180374006191849
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,37536,0.00721731008582916,0.00305155499767791,0.00123626229038045,0.0131983578812779,0.0180384738427779
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,37985,-0.0155185288934936,0.00656154575762543,-0.0283791585784394,-0.00265789920854772,0.0180405846792508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,37937,-0.0155739237345167,0.00659009439861636,-0.0284905087558048,-0.00265733871322863,0.018130417231316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,40162,0.00806033998370425,0.00342208982247294,0.00135304393165729,0.0147676360357512,0.0185157336256323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37896,0.0213081144988161,0.00905990250598477,0.00355070558708594,0.0390655234105462,0.0186914208295255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40300,-0.0127054862779529,0.00540230791427982,-0.0232940097899414,-0.00211696276596448,0.0186918395694002
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40328,-0.0153890607841487,0.00654358972574961,-0.028214496646618,-0.0025636249216795,0.0186961447210567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37955,-0.0186359670683144,0.00793461713284716,-0.0341878166486948,-0.00308411748793397,0.0188538509634335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40300,-0.00636383656444707,0.00271010120630372,-0.0116756349288024,-0.00105203820009178,0.0188770435208957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39956,-0.0139870641355391,0.00595707654451308,-0.0256629341627847,-0.00231119410829343,0.0188883084602043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40391,0.0183344266141444,0.00781491851833548,0.00301718631820685,0.0336516669100819,0.0189842022228177
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37937,-0.0128536676455422,0.00547893449036608,-0.0235923792466597,-0.00211495604442464,0.0189896987662758
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,40354,-0.00876576562456411,0.00373789190265175,-0.0160920337537615,-0.00143949749536667,0.0190337215655266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,37895,-0.00821900816220787,0.00351059282588137,-0.0150997701009354,-0.00133824622348038,0.0192362773290592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,40417,-0.00843635893361914,0.00360723337881569,-0.0155065363560979,-0.00136618151114039,0.0193614817044253
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37557,0.0101630590897995,0.00434628562781675,0.00164433925927867,0.0186817789203203,0.0193849852824094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,37536,0.0103352274075744,0.0044221029000646,0.00166790572344777,0.019002549091701,0.0194450990619936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37955,-0.0162463745188643,0.00696453243871065,-0.0298968580987372,-0.00259589093899144,0.0196769274229917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37536,0.00697246477085047,0.0029922114490743,0.00110773033066484,0.0128371992110361,0.0198104674423338
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,40354,-0.00721707548596679,0.00310256314765818,-0.0132980992553768,-0.00113605171655675,0.0200222250764407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,40398,0.00625008002862584,0.00268843041246263,0.000980756420199091,0.0115194036370526,0.0200948078898487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40325,-0.0210926042701114,0.00907285174008131,-0.0388753936806708,-0.00330981485955205,0.0200949764836294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,40336,0.0181611696886156,0.007822369049566,0.00282932635146622,0.0334930130257649,0.0202618475246609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40417,0.00847891615807264,0.00365599945032056,0.00131315723544434,0.0156446750807009,0.0203979037458276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,40294,0.0161710859558646,0.00697735076668589,0.00249547845316027,0.029846693458569,0.0204808010793586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,37937,-0.00752644708942515,0.00324757536795427,-0.0138916948106155,-0.00116119936823478,0.0204882017375706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40325,0.00643478525355725,0.0027773840040281,0.000991112605662169,0.0118784579014523,0.0205245062775424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,37436,-0.0145702007565694,0.00629145149618521,-0.0269014456890924,-0.00223895582404634,0.0205807191873638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40300,-0.0280843284131294,0.0121278664124832,-0.0518549465815965,-0.00431371024466237,0.0205881289847147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,37536,0.0186236744049959,0.00805203911132423,0.00284167774680039,0.0344056710631914,0.0207427980391671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37709,-0.0120747834379573,0.00523031198328039,-0.0223261949251869,-0.00182337195072777,0.0209801901768284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37593,-0.00990524647835688,0.00429539983036537,-0.018324230145873,-0.00148626281084076,0.0211254118752111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,40511,-0.0110659960643315,0.00480529434566132,-0.0204843729818277,-0.00164761914683531,0.0212985510394309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40039,0.00990993929313962,0.00430971359039881,0.00146290065595796,0.0183569779303213,0.0214929710571473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40429,-0.0148674715438715,0.00647603474964122,-0.0275604996531683,-0.00217444343457472,0.0217020535398751
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37593,0.0122299801193109,0.00533805369996302,0.00176739486738339,0.0226925653712384,0.0219737584551856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37896,-0.0170282249374318,0.00743252883023324,-0.0315959814446889,-0.00246046843017463,0.0219764661490188
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37895,-0.00964830378659835,0.00421801922729124,-0.0179156214720892,-0.00138098610110752,0.0221878565570917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40149,-0.00707693528996514,0.00309572762549885,-0.0131445614359429,-0.0010093091439874,0.0222655936469387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40187,-0.0148807030273817,0.00652044679792381,-0.0276607787513124,-0.00210062730345102,0.0224931806748792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37557,-0.0136523285290102,0.00598454846645051,-0.0253820435232532,-0.00192261353476719,0.0225488623046747
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40484,0.00712394924029936,0.00312574455047193,0.000997489921374377,0.0132504085592243,0.0226729730265191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37220,0.0216563618844357,0.00952777962071729,0.00298191382782976,0.0403308099410415,0.0230444994197627
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37709,0.0148200857014205,0.00652641642867866,0.00202830950121032,0.0276118619016307,0.0231759915432016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,40336,-0.0133536520311121,0.0058912807071943,-0.0249005622172129,-0.00180674184501129,0.0234231281412862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37593,-0.00700739375045181,0.00309689186071818,-0.0130773017974594,-0.00093748570344418,0.0236693143784955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40511,-0.0198924983699119,0.00880179915062163,-0.0371440247051303,-0.00264097203469354,0.0238315396013563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,40354,0.00482110158931841,0.00213452698236591,0.000637428703881221,0.00900477447475559,0.0239200475865615
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,37900,-0.0191104849357998,0.00846431888951286,-0.0357005499592451,-0.00252041991235463,0.0239759704013211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40511,0.00878353238507176,0.0038917421283735,0.0011557178134597,0.0164113469566838,0.0240235367378096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,40354,-0.023960511722345,0.0106193228476014,-0.0447743845036438,-0.00314663894104613,0.0240645848139117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,39797,-0.00704806828848074,0.00312770233664405,-0.0131783648683031,-0.000917771708658404,0.0242459049003535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37896,-0.00533299792277286,0.002367788931425,-0.00997386422836586,-0.000692131617179851,0.0243186662390618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37895,0.0108860936797208,0.00483584776217832,0.00140783206585134,0.0203643552935903,0.0243937606562653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40162,0.00639102487195803,0.00283932630890777,0.000825945306498798,0.0119561044374173,0.024405967494547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,37557,0.00960317830131837,0.00427020087651496,0.00123358458334904,0.0179727720192877,0.0245365379827322
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37982,-0.00478227879302676,0.00212746834016897,-0.00895211673975794,-0.000612440846295572,0.0246003219324203
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39975,0.0158423439012325,0.00706359479729292,0.00199769809853836,0.0296869897039266,0.0249227308737074
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37593,-0.0192704438601206,0.00859192880580039,-0.0361106243194894,-0.00243026340075186,0.0249228159085491
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,37873,-0.00822989794831521,0.00367144830465124,-0.0154259366254316,-0.00103385927119878,0.0250038734254279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40417,0.0052153669910957,0.00232755512688666,0.000653358942397853,0.00977737503979355,0.025058812324925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37648,-0.0107065654555776,0.0047975690454875,-0.0201098007847331,-0.00130333012642204,0.0256538573668814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37536,0.0114126663387774,0.00511628503336934,0.00138474767337347,0.0214405850041813,0.0257208822850562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,40223,-0.0258392708202613,0.0115846385177996,-0.0485451623151486,-0.00313337932537409,0.0257297979481969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,40511,0.00896584798575646,0.00402736757715164,0.00107220753453925,0.0168594884369737,0.0260125755472163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37896,-0.00585029033050301,0.00262910021506319,-0.0110033267520268,-0.000697253908979163,0.0260839191925813
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40198,0.00473068446718601,0.00213260181633601,0.000550784907167431,0.00891058402720459,0.0265507080375142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,37709,0.00821341473889766,0.00370577280357299,0.000950100043894609,0.0154767294339007,0.0266821406211109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37895,-0.00684141932919236,0.00309121596865922,-0.0129002026277644,-0.000782636030620293,0.0269019257429298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37623,-0.0109001574520004,0.00492660889942686,-0.0205563108948771,-0.0012440040091238,0.0269487306914486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40512,0.00530309913620129,0.00239749718364789,0.000604004656251424,0.0100021936161512,0.0269854324427165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,40350,0.0087483114513439,0.00397784546212448,0.000951734345579922,0.0165448885571079,0.0278738747117678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39956,-0.0102190835667729,0.00464892720759891,-0.0193309808936668,-0.00110718623987907,0.0279524672659909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40354,-0.0140138950526047,0.00637726384852478,-0.0265133321957133,-0.00151445790949613,0.0280007154837527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40327,-0.0100695836515616,0.00459106208603308,-0.0190680653401864,-0.00107110196293676,0.0283001104653579
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37534,-0.00794640120795726,0.00362382592906398,-0.0150491000289227,-0.000843702386991854,0.0283378313294779
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37895,0.0110749632552341,0.00505447440688763,0.00116819341773431,0.0209817330927338,0.0284601652136632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40354,-0.0148227758694049,0.0067658406629797,-0.0280838235688452,-0.00156172816996474,0.0284788885917886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37982,-0.00521269978184484,0.0023804857438735,-0.0098784518398369,-0.000546947723852775,0.0285584391413797
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,38008,0.00434736516565396,0.0019914435806135,0.000444135747651503,0.00825059458365641,0.0290512834677497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37955,-0.00760486513790022,0.00349257435301805,-0.0144503108698156,-0.000759419405984842,0.0294651350299565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40354,-0.0127370563514492,0.00585081803068917,-0.0242046596916,-0.00126945301129847,0.0294974501521654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37623,0.0111074961114247,0.00510448892134344,0.00110269782559153,0.0211122943972578,0.0295710951452387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40354,0.00845238258342769,0.00388701016340946,0.000833842663145153,0.0160709225037102,0.0296807728087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,40391,-0.010900700455304,0.00502050606664657,-0.0207408923459313,-0.00106050856467675,0.0299280869146608
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,37593,0.0197999357852596,0.00913172527735489,0.00190175424164399,0.0376981173288752,0.0301569520363613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37895,-0.0151858775618352,0.00700838709950252,-0.0289223162768601,-0.00144943884681021,0.0302664781779895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,40245,0.00971457143791972,0.00448957694754273,0.000915000620735972,0.0185141422551035,0.0304942214586966
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40497,0.00968060044741292,0.00448207874251319,0.000895726112087063,0.0184654747827388,0.0307993468762367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,37477,0.0119430342478807,0.00553094747862491,0.00110237718977585,0.0227836913059855,0.0308442647102768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37709,0.0055466645750446,0.00256990261159394,0.000509655456320483,0.0105836736937687,0.0309210861740521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,37593,0.00639872451707891,0.00296823066706272,0.000580992409635972,0.0122164566245218,0.0311223074615397
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40354,-0.00528699996930644,0.00245368905855658,-0.0100962305240773,-0.000477769414535549,0.0311991321380201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,40336,0.0109364713119209,0.00508391702154913,0.000971993949684577,0.0209009486741571,0.0314762422447681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40446,0.00565551196074125,0.00262988850966612,0.000500930481795664,0.0108100934396868,0.0315325276571656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,37557,-0.0152067007721433,0.00707653384370184,-0.0290767071057989,-0.00133669443848766,0.0316612923233153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40223,0.00657462828814389,0.00306085107159374,0.000575360187820167,0.0125738963884676,0.0317310135126294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,40298,0.00515219970125641,0.00240391620313256,0.000440523943116596,0.00986387545939623,0.0321079990392266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37666,0.0119259402497555,0.005570395615077,0.0010079648442046,0.0228439156553064,0.0322962868183222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,37709,0.00556984888043851,0.00260887105474262,0.000456461613142973,0.010683236147734,0.0327821350119454
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37895,0.0115299118994055,0.00540282490087508,0.000940375093690366,0.0221194487051207,0.032856527829193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37623,0.0121606139238483,0.00570066044615808,0.00098731944937841,0.0233339083983181,0.0329272555146743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37937,-0.0116887695942941,0.00548270818318027,-0.0224348776333275,-0.000942661555260812,0.0330303295010517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,37761,0.00620358844620923,0.00291325063259253,0.000493617206327866,0.0119135596860906,0.0332362869183338
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,38008,0.00388453450971878,0.00182642891877016,0.000304733828929254,0.0074643351905083,0.0334508218512591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,40039,0.0111668319506127,0.00525203108149455,0.000872851030883384,0.021460812870342,0.0335028594898082
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,37993,-0.00521749087133255,0.00245475946881265,-0.0100288194302053,-0.000406162312459752,0.0335663726966355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,37477,0.0177033403231304,0.00833284825427301,0.0013709577447553,0.0340357229015055,0.0336450897082355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37666,-0.0131676487980214,0.00619950168127554,-0.0253186720933214,-0.00101662550272133,0.0336899157301671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,37896,-0.0104245340201784,0.00491990179006369,-0.0200675415287032,-0.000781526511653571,0.0341214299404026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,37567,0.00805732863844814,0.00380471073797323,0.000600095592020611,0.0155145616848757,0.0342171814112428
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39956,-0.0124126121734342,0.00586555170000337,-0.0239090935054408,-0.000916130841427601,0.0343446849716075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39975,-0.00983141928236821,0.00464824434848658,-0.0189419782054019,-0.000720860359334522,0.0344388238502114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37666,-0.00585203074507433,0.00276700071346975,-0.011275352143475,-0.000428709346673615,0.0344540297276708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40037,0.00636332051805629,0.00301257109500293,0.000458681171850548,0.012267959864262,0.0346803866530589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40210,0.0175241308853671,0.00829733865783455,0.0012613471160114,0.0337869146547228,0.0347005755944016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37637,-0.015895938433533,0.00753011664902725,-0.0306549670656265,-0.00113690980143963,0.0347926583521332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,40300,-0.0190412418072406,0.00902151495970527,-0.036723411128263,-0.00135907248621832,0.0348182084820047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,37593,0.00647031973237445,0.00306737151142798,0.000458271569975612,0.0124823678947733,0.0349287552353627
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,37993,0.0168876605842535,0.00801957253520594,0.00116929841524982,0.0326060227532571,0.0352396053469895
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,40327,0.0103563596911902,0.00493009832855414,0.000693366967224071,0.0200193524151563,0.035688347390225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,37557,-0.0124161434661758,0.0059122246484073,-0.0240041037770541,-0.000828183155297521,0.0357408882254861
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,37666,0.00547003187380185,0.00260872665395195,0.000356927632056023,0.0105831361155477,0.0360284161982134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40511,0.0108101599613915,0.00516387409165371,0.000688966741750181,0.0209313531810327,0.036327278038837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39975,-0.0110824688980025,0.00529629142167599,-0.0214632000844874,-0.000701737711517523,0.0364103625803305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,37536,0.018140614372653,0.00867122563322428,0.00114501213153336,0.0351362166137726,0.0364535077002933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37593,0.00649494662015369,0.00310655359713201,0.000406101569774964,0.0125837916705324,0.0365719619026486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40300,0.00571169784297167,0.00273262992295778,0.000355743193974426,0.0110676524919689,0.0366172201515075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40300,-0.0101158290035107,0.00484332800815789,-0.0196087518995002,-0.000622906107521212,0.0367586558138523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,39660,0.00414461869438178,0.00198759332256548,0.000248935782153437,0.00804030160661013,0.0370637163579869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37623,0.0158695107656772,0.0076212918564175,0.000931778727098884,0.0308072428042555,0.0373379859541053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40354,0.00894279503228986,0.00430022946283619,0.000514345285130937,0.0173712447794488,0.0375774106781753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39975,-0.00811871693619808,0.00391408913875795,-0.0157903316481637,-0.000447102224232485,0.0380744979116997
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37955,-0.0119636723836335,0.00577161056742782,-0.023276029095792,-0.000651315671474957,0.038205336807124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37709,0.0127187907052175,0.00614492236540689,0.000674742869019975,0.024762838541415,0.0384899371378903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40039,-0.00798984613078062,0.00386634181730123,-0.015567876092691,-0.000411816168870203,0.0387965318031019
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40484,-0.005997010236972,0.00290262973925352,-0.0116861645259089,-0.000307855948035103,0.0388387420067543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37895,-0.00985707564955634,0.00477226054103789,-0.0192107063099906,-0.000503444989122071,0.0388954015473192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,39975,-0.00757369638447902,0.00366981720867964,-0.0147665381134911,-0.000380854655466932,0.0390551355366958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40223,-0.0141528711161497,0.00686274424378111,-0.0276038498339606,-0.000701892398338707,0.0391978298382243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,40327,0.00575204078355003,0.00279050054956309,0.00028265970640637,0.0112214218606937,0.0392912893644116
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,37895,-0.00927977647938114,0.00450315940026484,-0.0181059689039002,-0.000453584054862059,0.0393484067346939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37593,-0.00552671204614529,0.00268205843467235,-0.0107835465781031,-0.000269877514187488,0.0393586308618496
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37993,0.0249707148000219,0.0121199987272617,0.00121551729458893,0.0487259123054548,0.0393898663364232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,37895,0.00615541385535351,0.00298773506186366,0.000299453134100736,0.0120113745766063,0.0393960013040822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,40336,0.0101913735982968,0.00495129857188048,0.000486828397411038,0.0198959187991825,0.0395753765856681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,37536,0.00832091866990134,0.00405528650608609,0.000372557117972605,0.0162692802218301,0.0402022052775348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,40223,-0.00605545230341214,0.00295380014816477,-0.0118449005938151,-0.000266004013009187,0.0403755768732185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,37895,0.0105735651497501,0.00516583650252655,0.000448525604798048,0.0206986046947021,0.0406946380419871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37593,-0.00955286048675812,0.00467065140496886,-0.0187073372404971,-0.000398383733019167,0.0408456447669266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40039,0.00701099383687783,0.00342926592079554,0.000289632632118566,0.0137323550416371,0.0409249808284664
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37567,0.00815738956150069,0.00398996836499377,0.000337051566112894,0.0159777275568885,0.0409265940404154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,40300,0.0134655472641776,0.00658726383040308,0.000554510156587537,0.0263765843717676,0.0409523458345233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,40304,-0.00620448635775319,0.00303596305546058,-0.0121549739464559,-0.000253998769050454,0.0410033128420751
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37623,-0.00663194124516649,0.00324572264921835,-0.0129935576376345,-0.000270324852698525,0.0410439436617324
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37557,0.00939736102037401,0.00459976489350288,0.000381821829108373,0.0184129002116396,0.0410715102723236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37593,-0.0103232233615208,0.00505885117251612,-0.0202385716596524,-0.000407875063389185,0.0413079566649712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,37955,-0.0148320376140231,0.00727036552103467,-0.0290819540352511,-0.000582121192795186,0.041363003654479
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,39975,-0.013201811121667,0.00647421024538152,-0.0258912632026148,-0.000512359040719248,0.0414531125496973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,40245,0.00514766146941574,0.00252548530250858,0.00019771027649892,0.0100976126623326,0.0415379576334037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37666,-0.0140547521759909,0.00689987502715303,-0.0275785072292109,-0.000530997122771003,0.0416741896806218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37985,-0.00547044816327161,0.00268824702368992,-0.0107394123297039,-0.000201483996839365,0.0418753575733412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40484,0.0112891861635107,0.00555262207762421,0.000406046891367216,0.0221723254356541,0.0420561281089679
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37593,0.00900096480680933,0.0044519562910196,0.000275130476410926,0.0177267991372077,0.0432172530928397
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,40451,0.00769509198201516,0.00380711768061074,0.000233141328018109,0.0151570426360122,0.0432717243054413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37985,-0.00844012273995925,0.004185092241736,-0.0166429035337618,-0.000237341946156685,0.043745364445963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,40204,-0.0120321259168761,0.00596629261383384,-0.0237260594399905,-0.000338192393761809,0.0437454529648181
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37593,-0.015532017503552,0.007704091455272,-0.0306320367558851,-0.000431998251218851,0.0438125615389809
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,40511,-0.00904867554616667,0.00449428985247726,-0.0178574836570221,-0.00023986743531124,0.0440922030269068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37623,-0.00891805717204544,0.00442972207545969,-0.0176003124399464,-0.000235801904144442,0.0441105587788045
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,37895,-0.0143275714433079,0.00712327050107424,-0.0282891816254135,-0.000365961261202427,0.0443057349470109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40336,0.0216779450417359,0.010785821878203,0.000537734160457996,0.0428181559230138,0.0444633467130982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,40304,-0.00539240047133355,0.00268480439266662,-0.0106546170809601,-0.000130183861706982,0.0446082671401067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,37955,0.0120771841412845,0.00604223500452096,0.000234403532423367,0.0239199647501455,0.0456506379001108
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,40223,-0.016988579875428,0.00850283127266983,-0.0336541291698609,-0.000323030580995153,0.0457347837212685
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,40039,0.0096454609117241,0.00483025455379744,0.000178161986281126,0.0191127598371671,0.0458550783900242
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39975,-0.0101517193917241,0.00509561338573517,-0.020139121627765,-0.000164317155683179,0.0463614721503279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,40484,-0.0044094817089339,0.00221809266083905,-0.00875694332417844,-6.20200936893725e-05,0.0468329828198772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,40283,0.0189687487125886,0.00956374565790656,0.000223807223091708,0.0377136902020854,0.047339833879128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40511,-0.00575296660194392,0.00290302283907816,-0.0114428913665371,-6.30418373507241e-05,0.0475280663412275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,39998,-0.0109168148825735,0.00551234832239182,-0.0217210175944614,-0.000112612170685492,0.0476729356231823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,37567,-0.0139636483949475,0.00705487326810724,-0.0277912000004377,-0.000136096789457304,0.047804110936727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,37937,0.00475574194069807,0.00240639079904875,3.9215974562524e-05,0.00947226790683362,0.048141541046476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39956,-0.0127567407678792,0.0064558552828657,-0.025410217122296,-0.000103264413462454,0.0481729905855745
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,37896,-0.00534690313147291,0.00270645100951642,-0.0106515471101251,-4.22591528207198e-05,0.0482189027759718
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37937,0.0183114329023602,0.00927555511016693,0.000131344886433044,0.0364915209182874,0.048383890356365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37593,0.00511603988975876,0.00259243885894193,3.48597262325792e-05,0.0101972200532849,0.0484656103942044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37536,0.00873277483398767,0.0044306117645583,4.87757754534072e-05,0.0174167738925219,0.0487439106774038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,37937,-0.0235602593303256,0.0119808253129641,-0.0470426769437353,-7.78417169159627e-05,0.0492616837850044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,40429,-0.0104113928176143,0.0053006398633913,-0.0208006469498612,-2.2138685367332e-05,0.0495269241102404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,37477,-0.0062177955407995,0.00316684808071646,-0.0124248177790038,-1.0773302595247e-05,0.0496207362591183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37955,-0.0165272500679428,0.00841894801269033,-0.0330283881728159,-2.6111963069772e-05,0.0496548681367647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40300,0.0120004146920283,0.00613690373822334,-2.79166348894667e-05,0.024028746018946,0.0505474067680952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37593,0.0100912683819694,0.00516528661499694,-3.2693383424624e-05,0.0202152301473634,0.0507613770300795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,40092,-0.00719834756842437,0.00368496530695523,-0.0144208795700566,2.41844332078732e-05,0.0507856396902285
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40037,0.00566585762151571,0.00290618891163651,-3.02726452918534e-05,0.0113619878883233,0.0512437050955678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40300,-0.00554883393955634,0.00284829527599432,-0.0111314926805052,3.38248013925279e-05,0.0514176913066912
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39975,0.00518138789506899,0.00266137477732205,-3.49066684822291e-05,0.0103976824586202,0.0515666585175193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,37955,-0.00438969506124715,0.00225511778242233,-0.00880972591479492,3.03357923006273e-05,0.0516096558672925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40300,0.003767273890669,0.00193698956798361,-2.92256625788723e-05,0.00756377344391688,0.0518032570809192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37993,-0.0100609770304572,0.00518060049795275,-0.0202149540064446,9.2999945530154e-05,0.0521519483322634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37567,0.0136476194684047,0.00702889329561895,-0.000129011391008464,0.0274242503278178,0.052201411116692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,37982,0.00421265202997576,0.00216969386118614,-3.99479379490798e-05,0.0084652519979006,0.0522077033467168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,40231,0.0118498480874614,0.00610656509388159,-0.000119019496546557,0.0238187156714693,0.0523355798262175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,40336,0.0102082156035528,0.00528032026327177,-0.000141212112459819,0.0205576433195655,0.0532223072844902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,37593,0.00590494058444382,0.00305463894927389,-8.2151756133006e-05,0.0118920329250207,0.0532446093605065
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37895,-0.00565707491788161,0.00292643986109563,-0.0113928970456291,7.87472098658275e-05,0.0532459478857773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,37895,-0.013929868888338,0.00722218837769073,-0.0280853581086119,0.000225620331935792,0.0537816780838599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37962,0.0179315754877158,0.00929713698328292,-0.000290812999518702,0.0361539639749504,0.0537865375622768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40406,-0.00450168781978703,0.00233739739120416,-0.00908298670654719,7.96110669731348e-05,0.054129577815593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,37781,-0.0092303305681461,0.00479811399279543,-0.0186346339940252,0.000173972857732945,0.054408276283032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,37709,0.00586472986839431,0.00305367673569308,-0.000120476533564133,0.0118499362703528,0.0548102619104279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40484,0.00640982669703231,0.00333789050495708,-0.000132438692683576,0.0129520920867482,0.0548348789050639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40306,-0.00320165356321959,0.00166934884922241,-0.0064735773076955,7.02701812563301e-05,0.0551409219214948
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,37347,0.00653916444469182,0.00341698906281033,-0.000158134118416425,0.0132364630078001,0.0556779023591175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39703,0.00630954311154884,0.00329798026253993,-0.000154498203029432,0.0127735844261271,0.0557470845356457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40497,0.0063943722474766,0.00334499522309604,-0.000161818389791636,0.0129505628847448,0.055942267671947
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,37477,-0.00618546358225785,0.00323571985996854,-0.0125274745077962,0.000156547343280484,0.0559470001102861
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40327,0.00608424877868869,0.00319762035360273,-0.000183087114372657,0.01235158467175,0.0570922021904586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37993,0.00493568339699679,0.00259853642281205,-0.000157447991714829,0.0100288147857084,0.0575319537859014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,40039,-0.0132230017448027,0.00698630021012857,-0.0269161501566547,0.000470146667049301,0.0584156893235758
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37559,-0.00475323260454701,0.00251202591924186,-0.00967680340626105,0.000170338197167039,0.0584875675108659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37937,-0.00470787573179327,0.00248876890284959,-0.00958586278137847,0.000170111317791934,0.0585592488140151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,37557,0.00891904364209938,0.00471888885269242,-0.000329978509177764,0.0181680657933765,0.0587702658686645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40327,0.00572324276396019,0.0030316838359464,-0.00021885755449475,0.0116653430824151,0.0590696969831282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40336,0.0198161219649945,0.0105005888423008,-0.000765032165915145,0.0403972760959041,0.0591591938395319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,37937,-0.00621048494232038,0.00329409812461484,-0.0126669172665655,0.000245947381924716,0.0594058383985112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40531,0.00379990465302818,0.00201731282362554,-0.000154028481277864,0.00775383778733423,0.0596308097489969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37985,0.00553329124385173,0.00294033812104381,-0.000229771473394139,0.0112963539610976,0.0598770901194768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,37567,-0.0113784576948192,0.00604709819285584,-0.0232307701528167,0.000473854763178221,0.0599071325155054
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37709,0.00685741286762259,0.00364473111360033,-0.000286260115034052,0.0140010858502792,0.0599313739905474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,37993,0.00723655627699478,0.00384974319548962,-0.000308940386164864,0.0147820529401544,0.0601635572583589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39975,0.0073053362006527,0.00389055354635257,-0.000320148750198342,0.0149308211515037,0.060439408958023
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37955,-0.0125074138552168,0.00666198673067469,-0.0255649078473392,0.000550080136905622,0.0604807198090563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37666,-0.0090046250287639,0.0048033590554523,-0.0184192087774504,0.000409958719922599,0.0608627026423623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37709,0.00608480011821956,0.00324610419493009,-0.000277564103843419,0.0124471643402825,0.0608844553692161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,40484,-0.00984927307914855,0.00526750724229202,-0.0201735872740409,0.000475041115743795,0.0615274863308522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37623,-0.0120584379101934,0.00645402632878568,-0.0247083295146133,0.000591453694226574,0.0617342375969379
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39975,-0.00666675819850154,0.00357857341886605,-0.013680762099479,0.000347245702475913,0.0624860178206419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37955,-0.00957282963410983,0.0051413004461908,-0.0196497785086438,0.000504119240424133,0.0626322496599858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,40204,0.0209106664338494,0.0112514618537806,-0.0011421987995606,0.0429635316672595,0.0631188949921625
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37593,-0.0150967022422159,0.0081234667176765,-0.0310186970088618,0.000825292524430048,0.0631336733069903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37452,-0.0146488197522702,0.00788270029133002,-0.030098912323277,0.000801272818736683,0.0631418487123326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40417,-0.0204426957843173,0.0110011807569542,-0.0420050100679476,0.00111961849931291,0.0631551182784666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40223,0.0113745098227603,0.00613779088452448,-0.000655560310907691,0.0234045799564283,0.0638733951663524
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37896,-0.0105722372995731,0.00571052062445854,-0.0217648577235118,0.000620383124365678,0.0641394967179526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40336,-0.00996296486084452,0.00538381245992953,-0.0205152372823064,0.000589307560617367,0.0642541919271625
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,40300,-0.0143567158668571,0.00775902788486366,-0.0295644105211899,0.000850978787475669,0.064285458270515
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,39975,-0.00701085406807205,0.00379060894776258,-0.0144404476056867,0.000418739469542601,0.0643999695159568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37623,-0.00871920700758407,0.00471521478030337,-0.0179610279769787,0.000522613961810537,0.0644564787162433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,39941,0.00920351299755429,0.00497809203073123,-0.000553547382678921,0.0189605733777875,0.0645052640800838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,37666,0.00622145998816854,0.00336732905165222,-0.00037850495306981,0.0128214249294069,0.0646833033381982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37896,0.0089097113632011,0.00483603609507434,-0.000568919383144602,0.0183883421095468,0.0654447603470424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40531,0.00439094971986534,0.00238382612340778,-0.000281349482013916,0.0090632489217446,0.0654971125410199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37709,0.00585256939073431,0.00317775098538502,-0.000375822540620334,0.012080961322089,0.0655365137893099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40039,0.00474953567357624,0.0025807327794199,-0.000308700574086756,0.00980777192123924,0.0657310863216024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40465,0.00476831040042232,0.00259151370808948,-0.000311056467433062,0.0098476772682777,0.0657909727868674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37557,-0.00453381052148305,0.00246735408447375,-0.0093698245270516,0.000302203484085505,0.0661559098482544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39971,-0.0126047217092415,0.00686535188696195,-0.0260608114076869,0.000851367989203967,0.0663781628974672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,40037,0.00536235934185471,0.00292450292408102,-0.000369666389344089,0.0110943850730535,0.0667329199279925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37567,0.00521625600473156,0.00284495072485803,-0.00035984741599018,0.0107923594254533,0.0667488694073442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40398,-0.00667377269645831,0.003645362117192,-0.0138186824461546,0.000471137053238018,0.0671554527728928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,37976,0.00237027604583843,0.00129698853479474,-0.000171821482359269,0.00491237357403612,0.0676432328634831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37895,-0.00973875640325964,0.00533764954843838,-0.0202005495181989,0.00072303671167958,0.0680926227972936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40336,-0.0167800908332326,0.00920073262265594,-0.0348135267736382,0.00125334510717305,0.0682044704898873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,39956,-0.00572447714247754,0.00314581447877742,-0.0118902735208813,0.000441319235926198,0.0688221123259507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40354,0.00508625571734549,0.00279516653193373,-0.00039227068524463,0.0105647821199356,0.0688294290046522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40398,-0.00436035947590036,0.00239678197617448,-0.00905805214920234,0.000337333197401618,0.0688911603950118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,38008,-0.00523458284165166,0.00287819049150492,-0.0108758362050013,0.000406670521697998,0.0689783227909915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39975,0.00798331485760492,0.00439039993209123,-0.000621869009293884,0.0165884987245037,0.0690288347979553
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37567,0.00580156655617151,0.00319106599814289,-0.000452922800188548,0.0120560559125316,0.0690769460979427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,40039,-0.00984249552294764,0.00541909734798905,-0.0204639263250062,0.000778935279110894,0.0693495355553552
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37567,0.0105937549667983,0.00583742003633836,-0.000847588304424926,0.0220350982380215,0.0695773504678971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37711,-0.00673228903637789,0.00371636422027757,-0.0140163629081219,0.000551784835366147,0.070082142056495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37477,0.00928022063594558,0.00512347479875559,-0.000761789969615375,0.0193222312415065,0.0701153149226346
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,37477,0.00964191319978054,0.00532411447412646,-0.000793351169507321,0.0200771775690684,0.0701655694515976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37709,-0.0123294257863757,0.00681363619705265,-0.0256841527325989,0.00102530115984746,0.070392557230989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40406,-0.0139720098116758,0.00774734610860418,-0.02915680818454,0.00121278856118839,0.071335244886241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40162,-0.00445725269136542,0.0024769807461377,-0.00931213495379531,0.000397629571064476,0.0719635371955815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37955,-0.0170228713223446,0.00946989912803752,-0.0355838736132982,0.00153813096860889,0.0722664247340438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37623,-0.00838983038696418,0.00467041383809423,-0.0175438415096289,0.000764180735700509,0.0724572685838643
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,37536,0.00574252488023435,0.00320528641852217,-0.00053983650006909,0.0120248862605378,0.0732234790832607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,37709,0.00561979721429368,0.00313978605250186,-0.000534183448609968,0.0117737778771973,0.0734982243461452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,37709,0.00625124264838526,0.0034944983615894,-0.000597974140329971,0.0131004594371005,0.0736567633924179
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37557,0.0058668756056485,0.00328204477268856,-0.000565932148821074,0.0122996833601181,0.0738689600885964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,37477,0.0066601181371839,0.00372755242410879,-0.000645884614069326,0.0139661208884371,0.0740048904004074
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,37557,-0.00739534500658953,0.00413913641061813,-0.0155080523714011,0.000717362358221999,0.0740110507616502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37557,0.0139927816276191,0.00783314620280531,-0.00136018492987935,0.0293457481851175,0.0740648712149373
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,37985,-0.0108648448794455,0.00608682739649597,-0.0227950265765776,0.00106533681768658,0.0742874926018049
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37536,0.0111785268729893,0.00627395079277193,-0.00111841668084365,0.0234754704268223,0.0748154054103076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39975,-0.00465260055709134,0.00261290242412878,-0.00977388930838376,0.000468688194201073,0.0749932109716283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37567,-0.00678259498300303,0.00381171467437034,-0.0142535557447689,0.000688365778762825,0.0751960736714003
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37536,0.00538176989945864,0.00302453411684087,-0.000546316969549468,0.0113098567684667,0.0752020779249629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39975,0.00650933741759155,0.00365860598829357,-0.000661530319463853,0.0136802051546469,0.0752289754251966
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,37477,-0.00886469416032751,0.00498929742274429,-0.0186437171089063,0.000914328788251293,0.0756340369421608
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,40409,-0.00928743894123869,0.0052295065426003,-0.0195372717647353,0.000962393882257885,0.0757571597117541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39975,0.0197829144148942,0.0111535707424406,-0.00207808424028942,0.0416439130700779,0.0761349691657052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37557,0.0112243837884508,0.00632857578713134,-0.00117962475432663,0.0236283923312282,0.0761519861191544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,37593,0.0064921384298084,0.00366147521666737,-0.000684352994859637,0.0136686298544764,0.0762363496869037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,37623,-0.00791043911668148,0.00446566166306251,-0.016663135976284,0.000842257742921043,0.0765185916027763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,40369,-0.0166080516587546,0.00937993423962278,-0.0349927227684153,0.00177661945090603,0.076647441055471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37477,0.0221363658029188,0.0125188918129354,-0.00240066215043454,0.0466733937562722,0.0770447208025489
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,40039,0.00778677545301382,0.00440694393074206,-0.000850834651240606,0.0164243855572683,0.0772589857378154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39975,-0.00546822757883103,0.00309500329729997,-0.011534434041539,0.000597978883876917,0.0772826890723232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,37557,0.00625171886687523,0.00354767422754489,-0.00070172261911275,0.0132051603528632,0.0780584719385981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,40037,-0.00764487524143109,0.00434133354595356,-0.0161538889915001,0.000864138508637887,0.0782663211816628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40039,0.00589800517010727,0.00335642782881553,-0.000680593374371167,0.0124766037145857,0.0788987770543501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37593,0.00650689017791261,0.00371027552774814,-0.00076524985647375,0.013779030212299,0.0794969197838798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37557,-0.00738936021288588,0.00422803915278039,-0.0156763169523354,0.000897596526563678,0.0805387450175536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,40039,-0.00865411871781865,0.00495201037014675,-0.0183600590433063,0.00105182160766899,0.0805535172855535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,40172,0.00517947230502294,0.00297075595609473,-0.000643209368922736,0.0110021539789686,0.081268254776851
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37179,0.0075056092799699,0.00430598447672963,-0.000934120294420176,0.01594533885436,0.0813464740506281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40223,-0.00898188706995027,0.0051605636205994,-0.0190965917663251,0.00113281762642456,0.0817932765662358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37567,0.00755119447967943,0.00434211478142831,-0.000959350491920054,0.0160617394512789,0.0820478211766252
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,37557,0.00770427292413115,0.00443045257109313,-0.000979414115211378,0.0163879599634737,0.0820695251872927
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,37536,-0.00599173968809699,0.0034462264784943,-0.0127463435859458,0.000762864209751838,0.0821220120624875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37937,0.00927345197102334,0.00534206523263741,-0.00119699588494599,0.0197438998269927,0.0825990313568671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40123,0.0266982438150616,0.015407818133656,-0.00350107972690408,0.0568975673570273,0.083155782471396
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37937,-0.00859601742466565,0.00497249221121217,-0.0183421021586415,0.0011500673093102,0.0838831643347698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37557,0.00673570830109196,0.00389909178361593,-0.000906511594795267,0.0143779281969792,0.084100211847914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37709,0.00771822170346411,0.0044748005343496,-0.00105238734386111,0.0164888307507893,0.0845833753624436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37557,-0.00957161006502029,0.00555085780455023,-0.0204512913619387,0.00130807123189816,0.0846686360224268
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,37536,0.00887476940400568,0.00514819666815412,-0.0012156960655764,0.0189652348735878,0.0847567738868897
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37666,-0.00437204688224513,0.00253630125197033,-0.00934319733610697,0.000599103571616712,0.0847694252133782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,37937,0.0143873481318816,0.00835710844271268,-0.00199258441583527,0.0307672806795984,0.0851703551642329
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,37546,-0.0104148893565571,0.00607087286895993,-0.0223138001797185,0.00148402146660439,0.0862679908561733
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,37895,0.00571519166497735,0.00333252381487309,-0.00081655501217391,0.0122469383421286,0.0863730420491578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,39956,0.00685980164485441,0.00400481999060466,-0.000989645536730714,0.0147092488264395,0.0867534367128299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37536,0.00934875237430681,0.0054625567604162,-0.00135785887610895,0.0200553636247226,0.0870265151895272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40300,0.0048759634985931,0.00285514021591628,-0.000720111324602811,0.010472038321789,0.0876959671381267
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,40393,0.0224556029162111,0.0131522326605504,-0.00332277309846774,0.0482339789308899,0.0877745347639041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,37976,0.00335115004614807,0.00196754942307941,-0.000505246823087574,0.00720754691538372,0.0885517339510693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37955,-0.011509585669816,0.00676095816097423,-0.0247610636653255,0.00174189232569352,0.0887108945338913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39975,-0.00806103322303646,0.00473767381446022,-0.0173468738993785,0.00122480745330557,0.0888738674421503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,37536,0.0118904463697714,0.0069892622646518,-0.00180850766894611,0.0255894004084889,0.0889207811967252
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37955,-0.00777195118942433,0.00457559257175295,-0.0167401126300601,0.00119621025121145,0.0894238099073611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,37536,0.00743169991492815,0.00437589537340886,-0.00114505501695321,0.0160084548468095,0.0894698963500232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40039,-0.00955395596560317,0.00564805755908767,-0.020624148781415,0.00151623685020867,0.0907523302167551
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37557,0.00583118067966285,0.00344993849706197,-0.000930698774578608,0.0125930601339043,0.0910082351994922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39918,0.0112946256689923,0.00669024296603944,-0.00181825054444505,0.0244075018824296,0.091388486900801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,40424,0.00381606758760457,0.00226277691338105,-0.000618975162622288,0.00825111033783144,0.0917280529491288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37557,0.00424366809685963,0.00252595627736528,-0.000707206206776322,0.00919454240049558,0.0929764094047684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,37961,-0.00657207915173465,0.00391754447779026,-0.0142504663282036,0.00110630802473426,0.0934480201350151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39975,0.00690333922799709,0.00412311428758794,-0.00117796477567527,0.0149846432316695,0.0940913719686632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37536,0.00629240477778191,0.00375878870334652,-0.00107482108077727,0.0136596306363411,0.0941444368552389
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,37567,-0.00657624710801577,0.00393004288969733,-0.0142791311718225,0.00112663695579099,0.0942867769128176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,40336,0.00424497446312077,0.00253819847035237,-0.000729894538769869,0.00921984346501141,0.0944580752570483
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39892,0.00842494008223047,0.00503987149582895,-0.00145320804959426,0.0183030882140552,0.0946121001248992
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,39975,0.00600668067020397,0.00359779521746897,-0.00104499795603522,0.0130583592964432,0.0950296026168119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37985,-0.00690069424893714,0.00413443437886389,-0.0150041856315104,0.00120279713363608,0.095125015655578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,37985,-0.00824855471898895,0.00494363591159037,-0.0179380811057061,0.00144097166772817,0.0952357050576269
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,37955,0.00550393084919805,0.00329955636419854,-0.000963199624631103,0.0119710613230272,0.095322619949007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40398,0.00618437218735891,0.0037081175412344,-0.00108353819346051,0.0134522825681783,0.0953764766938826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37567,-0.00496123353530318,0.00297618121868518,-0.0107945487239261,0.000872081653319777,0.0955423279673446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37557,0.0079622301263379,0.00477747675890664,-0.00140162432111911,0.0173260845737949,0.095614227487962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37993,0.00588380910128494,0.0035381742431515,-0.00105101241529201,0.0128186306178619,0.0963454604952213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37895,-0.00661055956684723,0.00399088595125861,-0.0144326960313141,0.00121157689761964,0.097661335466578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,40511,-0.00587808163656272,0.00355429807495031,-0.0128445058634653,0.0010883425903399,0.0981886454020843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,40351,-0.00762046563286637,0.00461310521018016,-0.0166621518448195,0.00142122057908675,0.0985712763279728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40374,-0.00387451359466097,0.00234809837011914,-0.00847678640009449,0.000727759210772542,0.0989494839816318
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,40300,0.0110674945182037,0.00671161431376679,-0.00208726953677917,0.0242222585731866,0.0991661570916206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40511,0.0100612392071424,0.00610831017586583,-0.00191104873755461,0.0220335271518394,0.0995489330712618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,40327,0.00360784093781709,0.0021910638889808,-0.000686644284585272,0.00790232616021945,0.0996567856912217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40406,-0.0138015406155498,0.00839401640581241,-0.0302538127709421,0.0026507315398425,0.100152168255556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,40019,-0.00613037837005664,0.00373333806414891,-0.0134477209757885,0.00118696423567521,0.100597032698771
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39975,0.00543231729432053,0.00330963404173496,-0.00105456542747999,0.0119192000161211,0.100741940469394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37666,-0.0150025094215218,0.00915039812342652,-0.0329372897434378,0.00293227090039414,0.101123157870337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,40039,0.00737924434338015,0.00450604504207929,-0.00145260393909526,0.0162110926258556,0.101518632580334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40395,-0.0102803031506059,0.00627891366663016,-0.022586973937201,0.00202636763598917,0.101592931719344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37709,0.00933351770978418,0.00570668617652197,-0.00185158719619889,0.0205186226157672,0.101959482448789
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37741,0.00801021332433207,0.00489822165069773,-0.00159030111103548,0.0176107277596996,0.102003378429509
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,40223,-0.00519181823739739,0.00317867032713435,-0.0114220120785807,0.00103837560378594,0.10241953032323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37750,0.00194845907365656,0.00119408627143161,-0.000391950018349388,0.00428886816566251,0.102754287702026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,37895,-0.00459333995321791,0.00281610454829937,-0.0101129048678847,0.000926224961448848,0.102893258336836
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37567,0.00785755271039655,0.0048231740470841,-0.00159586842188828,0.0173109738426814,0.10331060790466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39956,0.00396773197400165,0.0024374380122885,-0.000809646530083801,0.00874511047808711,0.103581495795517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,37985,-0.00666319748208942,0.00410115796038706,-0.0147014670844481,0.00137507212026922,0.104247386261721
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37955,-0.00689425375864526,0.00424394962261902,-0.0152123950189785,0.00142388750168802,0.104294610868601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40531,-0.00491133665940748,0.00302368787658454,-0.0108377648975132,0.00101509157869823,0.104334189142566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40352,0.00380842046851493,0.00234481264905469,-0.000787412323632255,0.00840425326066212,0.104355158057011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37666,0.00549978444481163,0.00339106072079583,-0.00114669456794819,0.0121462634575715,0.104859793414735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,37955,-0.00782128227654611,0.0048225254550802,-0.0172734321685033,0.00163086761541108,0.1048646179893
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37557,0.00755567261675225,0.00466354144095592,-0.00158486860752136,0.0166962138410259,0.105222463763246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,40439,-0.00605369764318477,0.00373858427252577,-0.0133813228173353,0.00127392753096574,0.105413493028535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37860,-0.00445798160224946,0.00275525267887623,-0.00985827685284688,0.000942313648347954,0.105687467597826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,37937,-0.0151929566420185,0.00939355051547693,-0.0336043156523533,0.00321840236831625,0.105819304078585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37567,0.0119336636697862,0.00740742388474383,-0.00258488714431174,0.0264522144838841,0.107194848146006
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37896,-0.011664146001329,0.0072496117653138,-0.025873385061344,0.00254509305868606,0.107654279744128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37557,-0.00997289026049945,0.00620622341857408,-0.0221370881609047,0.00219130763990575,0.108096514748267
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,40252,0.00943003263273747,0.00587119710114002,-0.00207751368549697,0.0209375789509719,0.108260587863925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40300,0.0103806739623574,0.00646671509477762,-0.00229408762340677,0.0230554355481215,0.108459418041417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37557,0.0053613131366407,0.00334295207436725,-0.00119087292911911,0.0119134992024005,0.108789722560796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40039,-0.0119688828956501,0.00746555067638734,-0.0266013622213692,0.00266359643006913,0.10890745466033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,40039,-0.00935897016401147,0.00584524252292795,-0.0208156455089503,0.00209770518092733,0.109369265176535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,40304,-0.016146038144842,0.0100974421393896,-0.0359370247380456,0.00364494844836158,0.109835511428226
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,37955,-0.0144830653101201,0.00906416873959781,-0.0322488360397318,0.00328270541949163,0.110102628754789
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37709,0.0107301498745401,0.00671573988131626,-0.00243270029283973,0.02389300004192,0.110119923678829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37477,0.00426479271429292,0.00267002784784823,-0.000968461867489606,0.00949804729607545,0.110226677750098
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37896,-0.00597102747434412,0.00374018781543308,-0.013301795592593,0.00135974064390472,0.110411587478567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,37557,-0.00878056171441422,0.00550577065402909,-0.0195718721963112,0.00201074876748279,0.110782760305611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40336,0.00481952806743049,0.0030289625775893,-0.00111723858464454,0.0107562947195055,0.111596148540641
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,37623,-0.00400898126186289,0.0025198009579383,-0.00894779113942196,0.000929828615696178,0.111635545525287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,37700,-0.00313827707705759,0.00197351441493521,-0.0070063653303306,0.000729811176215415,0.111814224690696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,40302,-0.00961949964466535,0.00606401157937836,-0.0215049623402469,0.00226596305091624,0.112685310156682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,39597,-0.00391099927868487,0.00246754648890557,-0.00874739039693979,0.000925391839570059,0.112992912878142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37536,-0.0120535858464623,0.00761123386445894,-0.0269716042208019,0.00286443252787719,0.113295902206647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37567,-0.0113295684271521,0.00715937222241617,-0.0253619379830878,0.00270280112878362,0.113563985811035
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,37985,0.00901806478296427,0.00570157996892241,-0.00215703195612364,0.0201931615220522,0.113746419218914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,40417,-0.0145452820764406,0.00919647343396124,-0.0325703700070047,0.00347980585412341,0.113757253464703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40039,-0.00444474278125135,0.00281330643369721,-0.00995882339129789,0.00106933782879519,0.114150064758877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37536,0.0109482185641852,0.00694134243771131,-0.00265681261372891,0.0245532497420994,0.114762644881244
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40466,-0.0113922803933705,0.0072237159938724,-0.0255507637413604,0.00276620295461937,0.114799980240438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37666,0.017366076884386,0.0110329945494551,-0.00425859243254597,0.0389907462013179,0.115508383768511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,40039,0.00618872866232742,0.00393248186220027,-0.00151893578758511,0.0138963931122399,0.115566416101243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39956,-0.00569067334598263,0.00361743238455589,-0.0127808408197122,0.00139949412774691,0.115710280521458
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37623,-0.0106635452585244,0.00679450148494615,-0.0239807681690189,0.00265367765197005,0.116570059461985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,37895,-0.00556670378417212,0.00355152756293376,-0.0125276978075223,0.00139429023917805,0.117042164108088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37593,-0.0123718326310837,0.00789801455391828,-0.0278519411567635,0.00310827589459613,0.117267747055463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37477,-0.00847977603317581,0.00542201041228618,-0.0191069164412567,0.00214736437490511,0.117852615258123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40354,-0.0093393133254236,0.00597780733335527,-0.0210558156987999,0.00237718904795273,0.11822994704547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,37593,0.0122364413728917,0.0078394799567032,-0.00312893934224658,0.02760182208803,0.118577535434029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,37526,0.0121021849415624,0.00775539783921703,-0.00309839482330303,0.0273027647064277,0.11866942640083
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39956,0.0116716334551691,0.00749008905892915,-0.00300894110033204,0.0263522080106702,0.119188011362302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,37536,0.0126101774057992,0.00809436535810586,-0.00325477869608827,0.0284751335076867,0.119282148554854
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,40283,0.00494803451409469,0.00317637572532431,-0.00127766190754096,0.0111737309357303,0.119309882167632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,37567,-0.00618122853754288,0.00398463746651538,-0.013991117971913,0.00162866089682726,0.120862326096639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,37955,-0.0041029867283231,0.00265266576158354,-0.00930221162102684,0.00109623816438063,0.121949162245502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,40336,-0.00836378688329907,0.00541688936137903,-0.018980890031602,0.00225331626500383,0.122603347637442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37557,0.0076440627217269,0.00495938835718832,-0.00207633845836221,0.017364463901816,0.123260210640516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37557,0.00816371930933798,0.00529742413355417,-0.0022192319924282,0.0185466706111042,0.123323072511467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,37985,-0.00727481639909403,0.00472170975158535,-0.0165293675122013,0.00197973471401326,0.123409165692145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37557,-0.00896257289358425,0.00582839372501407,-0.0203862245946118,0.00246107880744334,0.124135555823158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,40327,-0.0048066470750379,0.00312589173815487,-0.0109333948818214,0.00132010073174564,0.124144781803999
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37593,0.00944951240028457,0.00614824495127662,-0.00260104770421761,0.0215000725047867,0.124330931517677
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37955,-0.00442885965972396,0.00289348916279247,-0.0101000984187972,0.00124237909934927,0.12588443014938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,40039,0.00834403955907993,0.00545297128397489,-0.00234378415751086,0.0190318632756707,0.125991930920898
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37955,0.00361663441394006,0.00236775629202319,-0.00102416791842539,0.00825743674630551,0.126672042203886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37557,0.00844133438927395,0.00553207739797148,-0.00240153731075014,0.019284206089298,0.12706171744034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39956,-0.00933993423503131,0.00612356870305626,-0.0213421288930216,0.00266226042295895,0.127218736247355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,39956,0.00612946085466857,0.00402275944337759,-0.0017551476543515,0.0140140693636887,0.127605165606816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37937,-0.00517575828935392,0.00340197127367574,-0.0118436219857584,0.00149210540705053,0.128182995136638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37567,0.00506986173556734,0.00333289256222943,-0.00146260768640234,0.011602331157537,0.128243882465996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,37650,0.00495640058390863,0.00326254277573959,-0.00143818325654097,0.0113509844243582,0.128740310953348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37539,0.00541421224692542,0.00356545570737275,-0.00157408093952518,0.012402505433376,0.128907768537493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37567,-0.00914231061818821,0.0060231141455406,-0.0209476143434478,0.00266299310707137,0.129071011720165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,37557,0.0113747534231095,0.00750264817350134,-0.00333043699695318,0.0260799438431721,0.129518574137137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37955,0.0152076100520766,0.0100333433318602,-0.00445774287836944,0.0348729629825226,0.12961683101865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37895,-0.0143929424155744,0.00949767778487311,-0.0330083908739257,0.00422250604277688,0.129690345641305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40300,0.0076219213989801,0.00503651653359878,-0.00224965100687351,0.0174934938048337,0.130215301388053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,40039,0.00631161357709087,0.00417314837062373,-0.00186775722933164,0.0144909843835134,0.130443637066743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40104,0.00275976237103863,0.00182696300393703,-0.000821085116677955,0.00634060985875522,0.130917270942774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37985,0.0071951204877281,0.00476513539279389,-0.00214454488214793,0.0165347858576041,0.131079299268634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37593,0.0143148899834151,0.00949145350976915,-0.00428835889573241,0.0329181388625627,0.131530627482856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37623,0.0129309385529666,0.0085787968027884,-0.00388350318049864,0.0297453802864319,0.131754233166625
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,40134,-0.0101520906895754,0.00675128598124424,-0.0233846112128141,0.00308042983366331,0.132671824143346
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37955,-0.00889275397065781,0.00591804061114487,-0.0204921135685018,0.00270660562718614,0.132952260887404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37937,-0.00942560511718491,0.00627294416433376,-0.0217205756792791,0.00286936544490926,0.13297060778809
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40466,0.00370602872724835,0.0024668950747949,-0.00112908561934964,0.00854114307384635,0.133038083820849
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37937,0.00437368011069366,0.0029144758721654,-0.00133869259875053,0.0100860528201379,0.133463140497605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,40336,0.00649311635543746,0.00432765443329826,-0.00198908633382714,0.014975319044702,0.133536459374935
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,40039,0.00427106182962179,0.0028476078930739,-0.00131024964080305,0.00985237330004663,0.133666497964086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40466,-0.00849657572371965,0.0056666513851054,-0.0196032124385262,0.00261006099108692,0.133789668603789
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40336,-0.0132318521351395,0.00884316865336505,-0.030564462695735,0.004100758425456,0.134600698282922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37477,0.00840335130930124,0.00561696181337443,-0.00260589384491264,0.0194125964635151,0.134660420441599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,37536,-0.00842894653053128,0.00563482795911013,-0.0194732093303871,0.00261531626932457,0.13471274458961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40327,-0.00379938978061329,0.00254750157829474,-0.00879249287407098,0.00119371331284441,0.135871647567988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40448,0.00869050745121843,0.00582799218715233,-0.00273235723560015,0.020113372138037,0.135937472191938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,37557,0.00626450728602202,0.00420378964619126,-0.00197492042051285,0.0145039349925569,0.136194475110807
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,37567,-0.0171666398905576,0.0115201511089546,-0.0397461360641086,0.00541285628299331,0.136211432842689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,40288,-0.00621142058175983,0.00416985421208387,-0.0143843348374442,0.00196149367392456,0.136348994264343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,37536,0.00981250978264555,0.00660724070796223,-0.00313768200496043,0.0227627015702515,0.137537555061544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,37666,-0.00403856354190707,0.00271949092507348,-0.00936876575505109,0.00129163867123695,0.137556036831193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,37567,0.00516118073453235,0.00347972282093448,-0.00165907599449923,0.0119814374635639,0.138041047789664
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,37536,0.00575672959506254,0.00388280573215282,-0.00185356963995698,0.0133670288300821,0.138199200016405
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,37895,-0.00646543664584127,0.00436217271579768,-0.0150152951688047,0.00208442187712219,0.138321244306487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37666,-0.00539651108527736,0.00364868951925459,-0.0125479425430164,0.00175492037246164,0.1391568793846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37557,0.00781485075967845,0.00529322611341917,-0.00255987242262312,0.01818957394198,0.139864030630084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40484,0.00329190789098366,0.00223015707243595,-0.00107919997099081,0.00766301575295813,0.139939934061799
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,37758,-0.00814036551080421,0.00552149882156828,-0.018962503201078,0.00268177217946962,0.140423528073297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,40484,0.00408925558747611,0.00277450471194032,-0.00134877364792692,0.00952728482287915,0.140536587084216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37923,-0.00527769295185336,0.00358172971618778,-0.0122978831955814,0.00174249729187469,0.140638560094793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40395,-0.00676710455044854,0.00459288071973035,-0.01576915076112,0.00223494166022295,0.140665646041824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40037,-0.00970561970940786,0.00658736706668417,-0.0226168591601088,0.00320561974129311,0.140671871599088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,40531,0.00928292380870606,0.00630217597980438,-0.00306934111171053,0.0216351887291227,0.140778372053096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37810,-0.0040089044871954,0.00272367449069171,-0.00934730648895114,0.00132949751456035,0.141078580904686
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37896,0.00632853886884078,0.00431240656035903,-0.00212377798946292,0.0147808557271445,0.142258298232778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,37709,0.00680038767365152,0.00464438007055875,-0.00230259726464364,0.0159033726119467,0.143157941780025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,37557,0.00445643023368479,0.00305289158945641,-0.00152723728164977,0.0104400977490193,0.144385310019713
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,40437,-0.00940825055847437,0.00644612935676023,-0.0220426640977244,0.00322616298077568,0.144441868177787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,37666,-0.00871746080539513,0.00597583955103438,-0.0204301063254225,0.00299518471463225,0.144648258793434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,37993,-0.0115718505134043,0.00794247022867786,-0.0271390921616129,0.0039953911348043,0.145150989077044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40391,-0.00663427723765508,0.00456004265221573,-0.0155719608359979,0.00230340636068776,0.14572446220615
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,37536,0.00600855136744528,0.00413423756333182,-0.00209455425668509,0.0141116569915757,0.146146744983532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,37477,0.00613190054253326,0.00422556350050992,-0.00215020391846618,0.0144140050035327,0.146763887571453
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39920,0.00602567399652853,0.00415261232927921,-0.00211344616885871,0.0141647941619158,0.146784481875863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,37603,-0.00530142692725175,0.00365867011626436,-0.0124724203551299,0.00186956650062641,0.147360362669887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40354,0.00395186225042534,0.00273054304536074,-0.00140000211848171,0.00930372661933239,0.147838034766888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,37557,0.00802822416760746,0.00555024570843766,-0.00285025742093036,0.0189067057561453,0.148071343686008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37557,-0.00782138209530838,0.00541368949153319,-0.0184322134987134,0.00278944930809666,0.148554405696282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37985,-0.00508916935569226,0.00352454817307549,-0.0119972837749202,0.0018189450635357,0.148784329140442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,40391,-0.0109670899090968,0.00759817859050211,-0.025859519946481,0.00392534012828732,0.148931962881068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37567,0.00495914847519292,0.00343587529884875,-0.00177516711055063,0.0116934640609365,0.148947599773661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,37623,-0.00660042817783325,0.0045742425444489,-0.0155659435649531,0.00236508720928658,0.149056804233413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37896,-0.00593337359290569,0.00411630137914265,-0.0140013242960253,0.00213457711021391,0.149485619422231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40466,0.0100818714978274,0.00699501330119324,-0.00362835457251135,0.0237920975681662,0.149521162529961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,39946,0.0140647838819549,0.00976787187115708,-0.00508024498551303,0.0332098127494227,0.149915167735286
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,40511,-0.00968902406143648,0.0067420013568904,-0.0229033467209417,0.0035252985980687,0.150705106465721
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40484,0.00748055755650705,0.00520752693555638,-0.00272619523718345,0.0176873103501976,0.150882626299468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37982,0.0032716799400421,0.00228044084830873,-0.001197984122643,0.00774134400272721,0.151404286291766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40282,-0.0112229244352001,0.00782483639666671,-0.0265596037726669,0.00411375490226664,0.151515114671985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39752,-0.00822457721523976,0.00574017465188056,-0.0194753195329257,0.00302616510244614,0.151932695070392
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,40300,-0.00753343917738393,0.00526406884785341,-0.0178510141191766,0.00278413576440875,0.152419628682321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40300,0.00567296406065405,0.00396740530205822,-0.00210315033138007,0.0134490784526882,0.152767517464517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37914,-0.00752371209523478,0.00526213039837756,-0.0178374876760548,0.00279006348558523,0.15280210651109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40497,-0.00668784060315365,0.00467908068154172,-0.0158588387389754,0.00248315753266813,0.152935616744893
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40039,0.00583263479497972,0.00408521576408709,-0.00217438810263097,0.0138396576925904,0.153386119369875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,37593,0.00703821510389502,0.00493980816135386,-0.00264380889235854,0.0167202391001486,0.154240149663625
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,37666,0.00272335323345172,0.00191164791030772,-0.0010234766707514,0.00647018313765485,0.154293507380872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37567,0.012810899357653,0.00899531236092342,-0.00481991286975688,0.0304417115850629,0.15441959966773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37536,0.0135789751618928,0.00955733682030666,-0.00515340500590824,0.0323113553296939,0.155401448827857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,40223,-0.0101138389936658,0.00714949872343687,-0.0241268564916021,0.00389917850427047,0.157199063932182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37623,-0.0127726737459642,0.00903480177072749,-0.0304808852165901,0.00493553772466168,0.157467967077648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40374,-0.00370349615638074,0.00261977568760351,-0.00883825650408363,0.00143126419132214,0.157478608333237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37993,-0.0066886318901623,0.00473161831655441,-0.0159626037906089,0.00258534001028434,0.15750136109241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37557,-0.005138032605585,0.00363784943870707,-0.0122682175054509,0.00199215229428086,0.157861296675874
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37982,0.00588978024893029,0.00417258983270496,-0.00228849582317142,0.014068056321032,0.158108247724794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40417,0.0147234775105859,0.0104581474766613,-0.00577449154367028,0.0352214465648421,0.159195681570476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40485,-0.00561956651904182,0.00399364061889624,-0.0134471021320785,0.00220796909399481,0.15940859988913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40417,0.0032019603608917,0.00227725249637675,-0.00126145453200674,0.00766537525379013,0.1597248951875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,37593,0.00473174573145754,0.00337269396537928,-0.00187873444068585,0.0113422259036009,0.160653188256319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37593,0.00507413442419752,0.00361903716838513,-0.00201917842583735,0.0121674472742324,0.160918708980171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,37985,0.0031922432333041,0.00227840330513829,-0.00127342724476695,0.00765791371137515,0.161210728925611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37477,0.00514490366810443,0.00367903783500886,-0.00206601048851293,0.0123558178247218,0.162005602626891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37557,-0.00827100762270458,0.00591852825343731,-0.0198713229994417,0.00332930775403256,0.162293809173164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,37557,0.00807717977284324,0.00578191333042984,-0.00325537035479924,0.0194097299004857,0.162445190285086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,39975,-0.00750743893840343,0.00537632097455609,-0.0180450280485334,0.0030301501717265,0.162617157779584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,40352,0.00314508566098749,0.00225233046193098,-0.00126948204439723,0.0075596533663722,0.162622734111697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37955,0.012157620740404,0.00870741683650937,-0.00490891625915439,0.0292241577399623,0.162665980366241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,40345,0.0114378528699906,0.00819398421208181,-0.00462235618568971,0.027498061925671,0.162768876407959
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,37557,0.00530826971663569,0.0038040157606679,-0.0021476011742734,0.0127641406075448,0.162907318544447
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39975,-0.00777664630578442,0.00557598458204976,-0.0187055760866019,0.0031522834750331,0.163135987822628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37567,0.00510350319523686,0.00366070747638622,-0.00207148345848013,0.0122784898489539,0.163301879966671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,37593,0.00715598280385226,0.00513316537373638,-0.00290502132867104,0.0172169869363756,0.163320570289244
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,37557,0.0089279230660918,0.00640499620678989,-0.00362586949921639,0.0214817156314,0.163371492665262
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37916,0.00473658611153686,0.0033994038486321,-0.00192624543178205,0.0113994176548558,0.163534599220929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37955,-0.00605489855088727,0.00435273119277103,-0.0145862516887185,0.00247645458694396,0.16423096819505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,37557,0.00741352242725593,0.00533052768418367,-0.00303431183374406,0.0178613566882559,0.164319682543377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40333,0.0114984939926391,0.00827152648293156,-0.00471369791390674,0.027710685899185,0.164509002269816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40300,-0.00455736340646956,0.00328106041072418,-0.010988241811489,0.00187351499854984,0.164855001780418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,37536,-0.00671148347593896,0.00483188415025755,-0.0161819764104438,0.00275900945856585,0.164856617503705
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37557,0.0119153900222527,0.00858660862839459,-0.00491436288940073,0.0287451429339061,0.165260764768867
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39860,0.00462738482335541,0.00333537837453661,-0.00190995679073634,0.0111647264374472,0.16535077623493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,37567,0.0074815870107037,0.00539751161488491,-0.00309753575447072,0.0180607097758781,0.16573449641769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,40336,-0.00584705020153039,0.00421950530820109,-0.0141172806056045,0.00242318020254375,0.165852068869306
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,40039,0.0104789248576838,0.00759655181010322,-0.00441031669011854,0.0253681664054861,0.167781461246882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,40166,0.00709494310681292,0.00514844393768115,-0.00299600701104214,0.017185893224668,0.168199681523233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,37536,-0.00785626201219524,0.00572062243857499,-0.0190686819918022,0.00335615796741175,0.169675506913451
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37955,0.00723512097390441,0.00527040537385752,-0.00309487355885633,0.0175651155066652,0.169842728931956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37593,0.00587160482068839,0.00428006895151042,-0.00251733032427204,0.0142605399656488,0.170134122933308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37567,0.00641261778485165,0.00467453239599887,-0.00274946571130614,0.0155747012810094,0.170142894937354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,38008,0.00177709986608775,0.00129570880542153,-0.000762489392538451,0.00431668912471395,0.170233371439414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,37567,0.00724834301643089,0.00528604051164396,-0.00311229638639127,0.017608982419253,0.170328753210456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,39975,0.0112986217268536,0.00825879269781628,-0.00488861196086631,0.0274858554145735,0.171309392346446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,40325,0.00465348519026912,0.00340205585352353,-0.002014544282637,0.0113215146631752,0.171379953593858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,37709,0.0051824942967422,0.00379113941328541,-0.00224813895329721,0.0126131275467816,0.171647929202366
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37593,-0.0094766032930577,0.00694095565225822,-0.0230808763714838,0.00412766978536842,0.172176875218539
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37946,-0.00815139437519066,0.00597398326741794,-0.0198604015793298,0.0035576128289485,0.17243857777031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40336,0.00294129595415091,0.00215745823016304,-0.00128732217696866,0.00716991408527047,0.172802464550164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37557,0.00558223559184878,0.00409774562415554,-0.00244934583149607,0.0136138170151936,0.173136130153028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40131,-0.00354778698140363,0.00260733215138054,-0.00865815799810949,0.00156258403530224,0.173629271006354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37937,0.00774223393728878,0.00569841117552347,-0.00342665196673722,0.0189111198413148,0.174275375552226
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,37477,0.00449717672878724,0.0033153136023546,-0.00200083793182778,0.0109951913894023,0.174968074760107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39956,-0.00597361581831949,0.00440618332364422,-0.0146097351326622,0.00266250349602318,0.175203327614076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40281,-0.0214370004034285,0.0158435514060177,-0.0524903611592231,0.00961636035236619,0.176061336793969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,37520,-0.0113586884951979,0.0084220359869552,-0.0278658790296301,0.00514850203923426,0.177460968590721
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,37937,0.0109692555339001,0.00813972235163936,-0.00498460027531302,0.0269231113431132,0.177803159974372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37477,-0.00978331114797043,0.00726252577433371,-0.0240178616656645,0.00445123936972365,0.177973118296795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37593,0.00795957070168217,0.00591686576053939,-0.00363748618897503,0.0195566275923394,0.178572799564574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37567,-0.00580498519067281,0.00432265780555723,-0.014277394489565,0.00266742410821935,0.179321001772028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,40511,-0.00416257056538681,0.00310072894603618,-0.0102399992996177,0.00191485816884409,0.179469422651874
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,39975,0.0198862600718134,0.0148800816788186,-0.009278700018671,0.0490512201622977,0.181426762549658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40037,-0.00857984687843384,0.0064276518304827,-0.0211780444661799,0.00401835070931225,0.18195024913501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37593,-0.00933829986679888,0.00700830342682892,-0.0230745745833836,0.0043979748497858,0.182731437479951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,37955,0.00424992460444315,0.00319136062712465,-0.00200514222472116,0.0105049914336075,0.182982333261825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,39975,-0.00691328834360792,0.00520214507755007,-0.0171094926956061,0.00328291600839023,0.183890491154903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37593,0.00333308707745215,0.00251175289088652,-0.00158994858868543,0.00825612274358973,0.184532925314972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,40531,-0.00574592808632327,0.00433179788055787,-0.0142362519322167,0.00274439575957015,0.184708395752365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37955,-0.00734726757580851,0.00555551377373928,-0.0182360745723375,0.00354153942072048,0.186018081699631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37895,0.00497802761820928,0.00376420561262886,-0.00239981538254329,0.0123558706189618,0.186036081034595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,37567,0.00806517833448116,0.00610416133748391,-0.0038989778869873,0.0200293345559496,0.1864380570511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37896,-0.00457575780687478,0.00346649235193046,-0.0113700828166585,0.00221856720290893,0.186858657668441
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40335,-0.00656133136609928,0.00498640534671369,-0.0163346858456581,0.00321202311345955,0.188245412046904
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37993,0.00698199307376304,0.00531147635904961,-0.0034285005899742,0.0173924867375003,0.188696627762143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37709,0.00437616887766549,0.00333499483733678,-0.0021604210035146,0.0109127587588456,0.189476528899212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,37567,0.0054063584614506,0.00412963814430024,-0.00268773230137787,0.0135004492242791,0.190502980836075
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40386,-0.0026667920169574,0.00204040417109049,-0.00666598419229477,0.00133240015837996,0.191234274946278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,37843,-0.0106447270228766,0.00816095295855883,-0.0266401948216519,0.00535074077589874,0.192137192214088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,37477,0.00518949159305551,0.00397941977236703,-0.00261017116078387,0.0129891543468949,0.192228507840638
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37536,0.00475413422373181,0.00364667064522333,-0.00239334024090591,0.0119016086883695,0.192361660452853
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40352,-0.00322104964474336,0.00247164744794461,-0.0080654786427148,0.00162337935322807,0.192525541931648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37557,0.0102454674290476,0.00786592457036907,-0.00517174472887579,0.025662679586971,0.192764034411996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,40274,0.00822925274664463,0.00632069222451002,-0.004159304013395,0.0206178095066843,0.192950944641628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,37536,0.0132130138211033,0.0101603239027594,-0.00670122102830509,0.0331272486705117,0.193468993144697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,37666,0.0123570729067905,0.0095106437246784,-0.00628378879357913,0.0309979346071602,0.193867503617682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37567,0.00617863566971128,0.00475629718979748,-0.00314370682229178,0.0155009781617143,0.193951930370866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,40417,-0.0105482359982611,0.00812563234637028,-0.0264744753971469,0.00537800340062462,0.1942568162027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39956,0.00566165183162545,0.00437312614627068,-0.00290967541506509,0.014232979078316,0.195461533733591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,37955,0.00347308793253257,0.00268329206453169,-0.00178616451394955,0.00873234037901468,0.195570695987848
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,39975,0.00925737772581871,0.00716255937663507,-0.00478123865238604,0.0232959941040235,0.196214410718969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,40442,-0.00421398687269904,0.00326819185930977,-0.0106196429169462,0.00219166917154811,0.197279807565916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40531,0.00353480560331711,0.00274790240559689,-0.00185108311165279,0.00892069431828701,0.198334213011278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37477,0.00674841085569715,0.0052551766274408,-0.00355173533408681,0.0170485570454811,0.199113928582957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37666,-0.00410508554917215,0.0032114998402705,-0.0103996252361023,0.00218945413775804,0.201185293287123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,40465,0.00678536106762591,0.00531349126384767,-0.00362908180951553,0.0171998039447673,0.201618589550105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,40037,-0.0133035972359361,0.0104475445002267,-0.0337807844563803,0.00717358998450817,0.202905515114994
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,40336,-0.00757489782951759,0.00594881273146027,-0.0192345707831797,0.00408477512414455,0.202913868784521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37955,0.00774729363722806,0.00608537655112337,-0.00418004440297374,0.0196746316774299,0.203004432497391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37896,-0.0194179192015002,0.0152658432302351,-0.0493389719327609,0.0105031335297606,0.203400552813359
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40400,0.00571798817458605,0.00449578007568893,-0.00309374077376425,0.0145297171229363,0.203442571924488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37557,0.00792798667332227,0.00623533035990952,-0.00429326083210039,0.0201492341787449,0.203586842183309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,37709,-0.00496230565983883,0.00391321746988189,-0.0126322119008073,0.00270760058112969,0.204788654789438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39956,0.00756644803533924,0.00597075987326616,-0.00413624131626243,0.0192691373869409,0.205084791827916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,37895,0.012068769473671,0.00954571496117026,-0.00664083185022268,0.0307783707975648,0.206139702411882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37593,0.00475221857001995,0.00376249931215037,-0.00262228008179478,0.0121267172218347,0.206594211833748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37623,-0.0103445069953588,0.0081963674025739,-0.0264093871044037,0.00572037311368601,0.206940785161072
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37709,0.00971934618675713,0.00770388365169609,-0.00538026577056721,0.0248189581440815,0.207109038933675
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,39975,-0.00512407479969014,0.00406540113521598,-0.0130922610247135,0.00284411142533319,0.207540215266719
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40417,0.0122106626110457,0.00973150646328479,-0.00686309005699251,0.0312844152790839,0.209585848911747
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,40417,0.00845151431136874,0.00674771562889797,-0.00477400832127127,0.0216770369440088,0.210406048587504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40336,-0.00400390383361783,0.0031972631141172,-0.0102705395372875,0.00226273187005188,0.210482283926938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40484,0.00372723865301198,0.0029788455243729,-0.0021112985747589,0.00956577588078287,0.210866658220708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,40037,-0.0141567439861747,0.0113301921000432,-0.0363639205022594,0.00805043252990998,0.211511697595922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,40168,0.0114121295763056,0.00913611188338054,-0.00649464971512025,0.0293189088677315,0.211638609930064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,37896,-0.00737546552269012,0.00591622206490886,-0.0189712607699115,0.00422032972453125,0.212547127765684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39530,0.00418820749538515,0.00336184591148226,-0.00240101049112007,0.0107774254818904,0.212855017734861
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,40417,-0.00518923387174754,0.00416707781091774,-0.0133567063811463,0.00297823863765123,0.213042252691096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,37895,-0.0045028472610444,0.00362661381693421,-0.0116110103422354,0.00260531582014664,0.21440141219165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,37937,-0.00751459054547296,0.00605508761762142,-0.0193825622760109,0.00435338118506502,0.214613500171698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39956,0.00418916594332774,0.00338033496263901,-0.00243629058344473,0.0108146224701002,0.2152622871281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37593,0.00396365298357972,0.00320037631671565,-0.00230908459718295,0.0102363905643424,0.215554360219712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39975,-0.00620127076443155,0.00501366321411543,-0.0160280506640978,0.0036255091352347,0.216152494951974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,40223,-0.00132356971190787,0.00107491276324772,-0.0034303987278734,0.000783259304057651,0.218218738430609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,38008,0.00206257009149252,0.00167815540719222,-0.00122661450660423,0.00535175468958926,0.219066979603255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,37477,0.00499240404367643,0.00406224868342588,-0.0029696033758383,0.0129544114631912,0.219103200274355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39920,-0.00715916319008608,0.00582759348572897,-0.0185812464221149,0.0042629200419427,0.219280299606478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37982,0.00277362396994918,0.00225810000656263,-0.00165225204291357,0.00719949998281193,0.219355781187869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39975,0.00351001198636857,0.00285884495264545,-0.00209332412081651,0.00911334809355365,0.219550897313787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,37623,-0.0100440830100889,0.00818382831011819,-0.0260843864979205,0.00599622047774275,0.219728553545594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,37895,0.008428164829922,0.00686828728489322,-0.00503367824846871,0.0218900079083127,0.219801600123068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37536,0.00986440665506757,0.00804327426746221,-0.00590041090915835,0.0256292242192935,0.220063939033088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37709,-0.00644659211717312,0.00525906773325169,-0.0167543648743464,0.00386118064000019,0.220293797404808
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37955,-0.00317281599001565,0.00259428040814809,-0.00825760558998591,0.00191197360995461,0.221349431259036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37557,0.00522336084185908,0.00428300448777659,-0.00317132795418303,0.0136180496379012,0.222655446901015
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,40266,0.00582492595133512,0.00477783486731817,-0.00353963038860849,0.0151894822912787,0.222803180244268
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,39826,-0.00635915116346019,0.00522064326158503,-0.0165916119561669,0.00387330962924647,0.223212992666875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,37982,-0.00970666677225812,0.00796973439135917,-0.0253273461793221,0.00591401263480584,0.223267609355247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37985,0.00661869497188784,0.00543506306347676,-0.0040340286325266,0.0172714185763023,0.22332994640734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40220,0.00625344101079788,0.00513781879662173,-0.00381668383058071,0.0163235658521765,0.22356944817027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,40327,0.00436600556255651,0.00358793112788894,-0.00266633944810581,0.0113983505732188,0.223676034060809
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37536,0.00529930904999174,0.00436987014417454,-0.00326563643259036,0.0138642545325738,0.225269277147406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37452,0.00550856921558777,0.00454755973364769,-0.00340464786236169,0.0144217862935372,0.225793191068235
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40531,0.00313101097521515,0.00258731324000136,-0.00194012297518751,0.00820214492561781,0.226243006185794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37896,0.0103890798342324,0.00859595234086889,-0.00645898675387062,0.0272371464223354,0.226837283964618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37477,0.00602904379341727,0.00499373210291536,-0.00375867112829683,0.0158167587151314,0.22732999531626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,37567,0.0069823364887769,0.00578563399084969,-0.00435750613328849,0.0183221791108423,0.227515404325947
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37477,0.00683332368687973,0.00567683866462821,-0.00429328009579156,0.017959927469551,0.228719732666524
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40336,-0.0101747123537394,0.00847963503836544,-0.0267947970289357,0.00644537232145685,0.230196155547207
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39975,0.00349766860263572,0.00291732575826518,-0.00222028988356403,0.00921562708883546,0.230573569477908
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40330,0.00474747992260184,0.00396063510861834,-0.00301536489029009,0.0125103247354938,0.2306756074059
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37557,0.00518851288357645,0.00432998246654701,-0.00329825275085569,0.0136752785180086,0.230831362890314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40223,-0.00509063785123029,0.00425198254109084,-0.0134245236317683,0.00324324792930776,0.23123154281258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,39985,-0.00947148933926679,0.00792111500088269,-0.0249968747409968,0.00605389606246328,0.231821450374537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37709,-0.00453258354158384,0.00380285937748872,-0.0119861879214617,0.00292102083829405,0.233326387911737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,37593,0.00311083007873097,0.00261050180883815,-0.0020057534665918,0.00822741362405374,0.233416185286154
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37982,-0.0049086164061558,0.0041199314711316,-0.0129836820895737,0.00316644927726213,0.233505106039578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37985,-0.00676145800174004,0.00567696873445557,-0.0178883167212729,0.00436540071779287,0.233661457240726
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40004,0.00542308527510937,0.00455849335665787,-0.00351156170394005,0.0143577322541588,0.234195793530281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37536,0.012552867145621,0.0105569695801113,-0.00813879323139716,0.0332445275226391,0.234437751868083
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37955,-0.00602214687323798,0.00506628500007643,-0.0159520654733878,0.00390777172691181,0.234589997442931
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,40223,-0.00389837433190097,0.00328363304552724,-0.0103342951011343,0.00253754643733242,0.235161196353454
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,40262,-0.00360304666186784,0.00304180797379671,-0.00956499029050939,0.00235889696677371,0.236229735880337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37896,0.00923938140296807,0.00785265365658722,-0.00615181976394288,0.024630582569879,0.239378617617517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37567,0.00383729881363329,0.00326398929474601,-0.00256012020406889,0.0102347178313355,0.239757357085854
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,37896,-0.00608680731203096,0.00517835979087571,-0.0162363925021473,0.00406277787808543,0.239842935915125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,40327,0.00483735259523264,0.00411836043312485,-0.00323463385369206,0.0129093390441573,0.240179552077736
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37895,0.00980785985024014,0.00836558747011725,-0.00658869159118968,0.02620441129167,0.241055111730932
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37895,-0.00298880643276037,0.00255335722736079,-0.00799338659838753,0.00201577373286679,0.241804529538965
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40354,-0.00816762510125542,0.00697840543784435,-0.0218452997594304,0.00551004955691951,0.241851847271556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37557,-0.00396135611679091,0.00338592808976953,-0.0105977751727392,0.00267506293915736,0.242043609500824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,37557,0.00424734076459569,0.00363346046129297,-0.00287424173953853,0.0113689232687299,0.242444245214424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,37937,0.00551560700585619,0.0047281480507572,-0.00375156317362793,0.0147827771853403,0.243413979975463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,37054,0.00252403202048256,0.00216894531305464,-0.00172710079310453,0.00677516483406965,0.244561967233302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37536,0.00728062385358934,0.00626752082932298,-0.00500371697188369,0.0195649646790624,0.245401558668759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40259,0.00272930482155895,0.00235177094035925,-0.00188016622154517,0.00733877586466308,0.2458499055058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40039,0.00364778964142192,0.00314472371497203,-0.00251586883992325,0.0098114481227671,0.246078208612323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37536,0.00323815792010538,0.00279565762264481,-0.00224133102027845,0.0087176468604892,0.246770405091084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,37593,0.00437758447772166,0.00379397141074144,-0.00305859948733157,0.0118137684427749,0.248592321480253
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37593,-0.00572545876129937,0.00497007162968721,-0.0154667991554863,0.00401588163288755,0.249347301772742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,37557,0.00374558743521892,0.00325164241446336,-0.00262763169712928,0.0101188065675671,0.24938058589123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37567,0.008829533619776,0.00767617977410883,-0.0062157787374773,0.0238748459770293,0.250061470498785
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40037,0.00307759921605313,0.00267691918202467,-0.00216916238071523,0.00832436081282149,0.250293525740239
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,37937,-0.00719894990344412,0.00626458364736928,-0.0194775338522879,0.00507963404539967,0.250514278231666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,37937,0.00266922074147239,0.00232790283974775,-0.00189346882443319,0.00723191030737798,0.251558911707543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37562,-0.00600193031692965,0.00523665900951258,-0.0162657819755743,0.00426192134171501,0.25175925769109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37709,-0.00351794641505086,0.00306992847013183,-0.00953500621650924,0.00249911338640752,0.251841663028552
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37567,0.00365951048904313,0.00319393834889947,-0.00260060867479983,0.00991962965288609,0.251912306542204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40448,0.00280659373692,0.00245083640727128,-0.00199704562133172,0.00761023309517172,0.252161045734578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,39929,-0.0090068877841034,0.0078821295350596,-0.0244558616728202,0.00644208610461341,0.253181986062497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,40354,0.00767563558155593,0.006721948152375,-0.00549938279709906,0.0208506539602109,0.253522492730573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37557,0.00384881660546284,0.00337407336700046,-0.00276436719385806,0.0104620004047837,0.254014260498628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37896,0.00420927970217868,0.00370250858987534,-0.00304763713397699,0.0114661965383343,0.255611908516871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,37593,0.00583512264418731,0.00513468503318204,-0.0042288600208495,0.0158991053092241,0.255804495252327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,37709,0.00415562626312131,0.00365753758984835,-0.00301314741298145,0.0113243999392241,0.255901181972504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,37666,-0.00541377789773759,0.00477658110321497,-0.0147758768600389,0.00394832106456375,0.257066800024812
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37896,-0.00789122826800652,0.00697467873953063,-0.0215615985974865,0.00577914206147351,0.257902323756657
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37955,-0.00371023503902201,0.00329891193818926,-0.010176102437873,0.00275563235982894,0.260742754812192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,38008,0.00197248103835036,0.00175401246972334,-0.00146538340230738,0.00541034547900811,0.260798156609011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37477,-0.00546285848656299,0.00486252916878928,-0.01499341565739,0.00406769868426399,0.26126275785341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,40278,0.00408785883948014,0.00364963103853339,-0.00306541799604531,0.0112411356750056,0.262698992765211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,37477,-0.00511773815663254,0.00456929202915463,-0.0140735505337756,0.00383807422051054,0.262722189234256
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37567,0.00695264796029952,0.00621076986398288,-0.00522046097310693,0.019125756893706,0.262968599217671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,37567,0.00346534775193389,0.00309781643365892,-0.0026063724580376,0.00953706796190537,0.26331336156821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,40327,-0.00475984568798219,0.00425699661480762,-0.0131035590530051,0.00358386767704074,0.26353139805733
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,40037,0.00467392023060109,0.00418131223097866,-0.00352145174211708,0.0128692922033193,0.263664603017792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40177,0.00293256335271151,0.0026260161292386,-0.00221442826059615,0.00807955496601916,0.264124836273661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,39975,-0.00737984029627138,0.0066330440859765,-0.0203806067047853,0.00562092611224255,0.265902966944827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,37477,0.00352807503255221,0.00317173913547089,-0.00268853367297074,0.00974468373807516,0.266009442163269
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37756,0.00438291042158378,0.0039508791296193,-0.00336081267247005,0.0121266335156376,0.267298984876526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39975,-0.0118283701989567,0.0106779114560101,-0.0327570766527366,0.00910033625482314,0.267990451015299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,37567,0.00266064666407107,0.00240387430790652,-0.0020509469794257,0.00737224030756784,0.26839376819331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,40037,-0.00270149745731077,0.00244331894449978,-0.00749040258853034,0.00208740767390879,0.268887687457877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,40300,-0.00872674580276159,0.00789696732709523,-0.0242048017638682,0.00675131015834507,0.269143614423768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37557,-0.00460394478584579,0.00417000861576325,-0.0127771616727418,0.00356927210105018,0.269586854910029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,37593,0.00319687141088557,0.00290469075071716,-0.00249632246052007,0.00889006528229121,0.271095626659691
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39956,-0.00360426476630887,0.00328754796906907,-0.0100478587856843,0.00283932925306652,0.27294778104627
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37477,0.00922884465289433,0.00844100583978307,-0.00731552679308048,0.0257732160988691,0.274267089437713
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40466,0.00281734833925591,0.00258003243285171,-0.00223951522913344,0.00787421190764527,0.274857549375476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37623,-0.00406543459035691,0.00372349539127337,-0.0113634855572527,0.0032326163765389,0.274926547975417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,40187,-0.00330283532083123,0.0030257327404078,-0.00923327149203051,0.00262760085036805,0.275033596056599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,39873,0.00675024652375487,0.00620301459032983,-0.00540766207329159,0.0189081551208013,0.276514863015447
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37896,-0.0133030241205134,0.012254305344282,-0.0373214625953061,0.0107154143542792,0.277684486063907
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,40223,0.00463856166641158,0.00427465086000751,-0.00373975401920315,0.0130168773520263,0.277879655689596
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,40039,0.00760946452004435,0.00701807128230436,-0.0061459551932722,0.0213648842333609,0.27826311300231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,37557,0.00388712713255725,0.00358555792664142,-0.00314056640365994,0.0109148206687744,0.27833746607715
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40531,-0.00402962781458807,0.00373021786322559,-0.0113408548265102,0.0032815991973341,0.280039914511768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37536,0.00475417410658018,0.00440176424683579,-0.00387328381721797,0.0133816320303783,0.280134904202173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,40039,0.00447914230381605,0.00415165337643239,-0.00365809831399144,0.0126163829216235,0.280657221501639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40323,-0.00345144587876111,0.00320071542202783,-0.00972484810593566,0.00282195634841343,0.28090033506433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,40371,-0.00641730347657637,0.00595637472399871,-0.0180917979356138,0.0052571909824611,0.281325026267804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37955,0.00510220349281941,0.00473606962654616,-0.00418049297521106,0.0143848999608499,0.281362143084533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37557,0.00369567761600702,0.00344019269641679,-0.00304710006896989,0.0104384553009839,0.2827238350754
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40406,-0.00791973396949442,0.00737274200040316,-0.0223703082902846,0.00653084035129577,0.282753278509046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39956,0.00334093979539331,0.00311346932636059,-0.00276146008427345,0.00944333967506006,0.283260840123733
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37557,0.00492677693059655,0.00459787270375408,-0.00408505356876145,0.0139386074299545,0.283949124095866
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37709,-0.00423137488910393,0.00395475794850942,-0.0119827004681824,0.00351995068997454,0.284663386960433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40369,0.0053713787886302,0.00502429770670888,-0.0044762447165192,0.0152190022937796,0.285049602346316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37593,-0.00531629221253767,0.00498458383784034,-0.0150860765347047,0.00445349210962939,0.286196104175487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,37452,0.00774740879556686,0.00726509824109483,-0.00649218375697901,0.0219870013481127,0.286268385552236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37623,-0.00837078846584477,0.0078599384186652,-0.0237762677664286,0.00703469083473901,0.286898098291899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,37895,-0.00348325640565968,0.00327387313549941,-0.00990004775123853,0.00293353493991917,0.287367820644782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37985,0.00466202693463823,0.00439623533668534,-0.00395459432526502,0.0132786481945415,0.288954799191832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40037,-0.00586100301591544,0.00553020610924287,-0.0167002069900315,0.00497820095820058,0.289244568018068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37557,-0.00626194956870538,0.00590947236257585,-0.017844515399354,0.00532061626194328,0.289325144566027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37557,-0.00313644612635423,0.0029615005948768,-0.00894098729231276,0.00266809503960429,0.289585930779325
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,40406,0.00379291663501977,0.00358767604929225,-0.00323892842159304,0.0108247616916326,0.290433082164338
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37709,-0.00692062398349203,0.00655648538089849,-0.0197713353300531,0.00593008736306901,0.291198260139868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37477,0.00462175312556552,0.0043808673090173,-0.00396474680010839,0.0132082530512394,0.291451353860727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37567,0.004876219077381,0.00462426238814683,-0.00418733520338679,0.0139397733581488,0.291679978617737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37567,0.00474675488494145,0.00450618946183155,-0.00408537646024839,0.0135788862301313,0.292183728410191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37623,0.00571251826822388,0.00543142698931844,-0.00493307863084027,0.016358115167288,0.292932298347364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40327,-0.00539437581554826,0.00514664570786428,-0.0154818014029623,0.00469304977186573,0.294592699330336
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37985,0.00968021530273512,0.00924965099366134,-0.00844910064484111,0.0278095312503113,0.295326210696951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,37477,0.00481666713760852,0.00461011806790452,-0.00421916427548434,0.0138524985507014,0.296133222160642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,37593,0.00462211633795268,0.00442804800358027,-0.00405685774906465,0.01330109042497,0.296584609968151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37666,0.00298454556266858,0.00286183837667726,-0.00262465765561884,0.00859374878095601,0.297024318922253
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39975,-0.00544526718457416,0.00522419112290103,-0.0156846817854602,0.00479414741631185,0.297280613904671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40300,-0.00550877155253785,0.00528691303784687,-0.0158711211067177,0.00485357800164202,0.297444396238506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,38008,0.00171589962930383,0.00164755535384976,-0.0015133088642417,0.00494510812284936,0.297670368341239
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,37955,-0.00435340312202624,0.00418426257079425,-0.012554557760783,0.00384775151673048,0.29816203730032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,37296,-0.00212208847244332,0.00203967121028226,-0.00611984404459655,0.0018756670997099,0.298170373845161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37557,-0.0032641956125056,0.00313873437481753,-0.00941611498714795,0.00288772376213676,0.29837213303009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37896,0.00830393639830626,0.00798689675984429,-0.00735038125098854,0.0239582540476011,0.298500335181726
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40466,0.00660041982664397,0.00635926726072148,-0.00586374400437014,0.0190645836576581,0.299322302720259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40531,0.0019757537679996,0.0019070346474423,-0.00176203414098731,0.00571354167698651,0.30020160857693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37559,0.00348598936696829,0.00336747096933677,-0.00311425373293177,0.0100862324668684,0.300596916337958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37477,0.00812508211314129,0.00785935999637688,-0.00727926347975739,0.02352942770604,0.301244359041826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37973,-0.00220777510457164,0.00214015126938438,-0.00640247159256503,0.00198692138342174,0.302279074987567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40460,-0.00580607639859202,0.00563053421344126,-0.0168419234569369,0.00522977065975285,0.302473484857157
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,37557,0.00410974885383977,0.00398648993143072,-0.00370377141176445,0.011923269119444,0.302597755868168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39973,-0.00444951501975265,0.00431799372545058,-0.0129127827216358,0.0040137526821305,0.302810698016605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39920,-0.00397668158634122,0.0038633586293026,-0.0115488644997743,0.00359550132709188,0.303339430702561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40406,-0.00555635836721574,0.0054086995237113,-0.0161574094336899,0.00504469269925841,0.304294679924977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,40511,-0.00551079087478636,0.00536649913528445,-0.0160291291799439,0.00500754743037117,0.304488908317202
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37709,-0.00408343916478152,0.00397926219244906,-0.0118827930619817,0.00371591473241865,0.304825483338824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,40354,-0.0106936348306308,0.0104281365022241,-0.03113278237499,0.00974551271372846,0.305161880042217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37593,0.00283158709751333,0.00276341274008891,-0.00258470187306093,0.0082478760680876,0.305537619671558
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37593,0.00184774193524387,0.00180348659258442,-0.0016870917862216,0.00538257565670934,0.305599727552125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37914,-0.0034409613933846,0.00336065755827608,-0.0100278502076057,0.00314592742083651,0.305903140635605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,40327,0.0108929413819797,0.0106478596365526,-0.00997686350566336,0.0317627462696227,0.306315398507929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40300,-0.00502661062957426,0.00494652123696688,-0.0147217922540294,0.00466857099488082,0.309553928768272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37896,-0.0068701556137752,0.0067660140604535,-0.0201315431722641,0.00639123194471366,0.309937343775197
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,37452,-0.00314659465796514,0.00310705997020769,-0.00923643219957221,0.00294324288364194,0.311210788757072
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37955,0.00747474886682543,0.00739192960910803,-0.00701343316702631,0.0219629309006772,0.311936915721309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37567,-0.00470574670310116,0.00465422666760036,-0.0138280309715979,0.00441653756539556,0.312001812088667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37937,0.00362228982519527,0.00358335154748727,-0.00340107920787978,0.0106456588582703,0.312098495217926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37477,0.00808355538226158,0.00801503376273139,-0.00762591079269195,0.0237930215572151,0.313209646303419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40466,0.0056244993847908,0.00557692378815961,-0.00530627124000204,0.0165552700095836,0.313214949435652
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,40309,-0.00359045756016312,0.003562855710769,-0.0105736547532704,0.00339273963294413,0.313591257746111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,37993,-0.00220381885203879,0.00218728437809068,-0.00649089623309653,0.00208325852901894,0.313684050116108
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,39956,0.0092758736136575,0.00921093155476504,-0.00877755223368198,0.027329299460997,0.31392620307565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37557,-0.00898702080242947,0.00893255485634267,-0.0264948283208611,0.00852078671600215,0.314387263594982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,37593,0.00427600941318905,0.00425181526478548,-0.00405754850579048,0.0126095673321686,0.314583083249816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39956,-0.00547729311230896,0.00544713505512452,-0.016153677820353,0.0051990915957351,0.314654276514862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40531,0.00621731304284512,0.0061859797509896,-0.00590720726909449,0.0183418333547847,0.314880575100077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,40336,-0.00735661602718652,0.00734758271419905,-0.0217578781470167,0.00704464609264362,0.316731155242176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37666,0.0074667711778753,0.00747269293062474,-0.00717970696614918,0.0221132493218998,0.317712457164507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,40223,0.00305606597222464,0.00306005240013373,-0.00294163673203747,0.00905376867648676,0.317956687002653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,39975,0.0125983052985036,0.0126218088046932,-0.0121404399586951,0.0373370505557024,0.318228069576714
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,39975,0.00272806503963341,0.00273440757454359,-0.00263137380647202,0.00808750388573884,0.31844987688819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37985,-0.00938573041543804,0.00941350323122944,-0.0278361967486477,0.00906473591777167,0.318758221493882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39975,0.00673587858349802,0.00675881216578705,-0.0065113932614446,0.0199831504284406,0.318970908525997
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37896,-0.00668166596222318,0.00670709585766636,-0.0198275738432492,0.00646424191880289,0.319166775780302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,37896,-0.00248617788387883,0.00249726065965037,-0.00738080877679356,0.00240845300903589,0.319480910799815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37850,-0.00421105300711463,0.00423493879072333,-0.0125115330369324,0.00408942702270309,0.320065676072885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,37896,0.00295435257784709,0.00297269654961077,-0.00287213265939003,0.0087808378150842,0.320323923483353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,37929,-0.0022579637833555,0.00227316329128288,-0.00671336383426994,0.00219743626755894,0.320575034524665
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39956,0.00347458420238136,0.00349950619527044,-0.0033844479403487,0.0103336163451114,0.320784699862122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,37709,-0.0112540391914977,0.0113587531915857,-0.0335171954470056,0.0110091170640102,0.321810510946548
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,37993,0.00789776647817476,0.00797774613233111,-0.00773861594119422,0.0235341488975437,0.32220419626036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,40039,0.00418790695310395,0.00423704243951543,-0.00411669622834629,0.0124925101345542,0.322970488735176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,40178,0.00577560514639122,0.00584568413323008,-0.00568193575473974,0.0172331460475222,0.323162049664996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,40039,0.00469402299268238,0.00475829561756611,-0.0046322364177472,0.014020282403112,0.323906800894012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,40039,0.00450952286823934,0.00457779025875797,-0.00446294603892628,0.013481991775405,0.324596500556282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37557,0.0105795962028754,0.0107793823281098,-0.0105479931602198,0.0317071855659706,0.32638115957348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40417,-0.00330781106228177,0.00337419354929936,-0.00992123041890852,0.00330560829434499,0.326939875346586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39956,0.00443217672478883,0.00453471289879382,-0.00445586055684706,0.0133202140064247,0.328392050988955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37955,-0.00616279215498541,0.00631006719998245,-0.018530523866951,0.0062049395569802,0.328754849694879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40352,-0.0250543758889758,0.0258031856203338,-0.07562861970483,0.0255198679268784,0.33157303316537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37896,-0.00388279007267755,0.00400271676066362,-0.0117281149235782,0.00396253477822315,0.332044664602694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,40023,-0.00365301466742205,0.00376920086462597,-0.0110406483620889,0.00373461902724484,0.332473012628026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40304,-0.003326955599697,0.00343605858648823,-0.0100616304292139,0.00340771922981994,0.332935482242183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40336,-0.00613309444372297,0.00634260079570528,-0.0185645920033053,0.00629840311585938,0.333574561023139
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,37477,0.00461364842989743,0.00477122236350685,-0.00473794740257601,0.0139652442623709,0.333574937429076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37477,-0.00248961066038531,0.00258048155558924,-0.00754735450934023,0.0025681331885696,0.334670274337225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,37916,-0.00270248733078763,0.00280436532773087,-0.00819904337314013,0.00279406871156486,0.335227884975182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40039,-0.00578866424238244,0.00601716031795614,-0.0175822984655765,0.00600496998081159,0.336051503105693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,40406,-0.00540545765599454,0.00562122573987686,-0.0164230601061532,0.0056121447941641,0.336257369275511
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37567,-0.00251055670385577,0.00261219780341851,-0.00763046439855605,0.0026093509908445,0.33652472873018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,40466,-0.00349934701968534,0.00364298328812103,-0.0106395942644026,0.00364090022503188,0.336782015573686
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,40307,0.00568238857182913,0.00592387385178567,-0.00592840417767079,0.017293181321329,0.337454877056865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37536,-0.00660186289995339,0.0069020435949432,-0.0201298683460421,0.00692614254613529,0.338833098674272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37557,-0.00568553909748135,0.00595994228174544,-0.0173670259697024,0.00599594777473972,0.340122117501069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40336,-0.00314462796840831,0.0032971272927664,-0.00960699746223045,0.00331774152541383,0.340225821360175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,40037,0.00627945261205305,0.0065847468641479,-0.00662665124167685,0.0191855564657829,0.340282643377613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39975,0.00398029297323204,0.00418647003838351,-0.00422518830199963,0.0121857742484637,0.341745303549053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,37397,0.00661836444972904,0.00696596113048637,-0.00703491936602424,0.0202716482654823,0.342078832051206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,40304,-0.00226244009843214,0.0023924489786871,-0.00695164009665886,0.00242675989979458,0.344337127407743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,37593,0.00453739489317632,0.00480175185531583,-0.0048740387432427,0.0139488285295953,0.344703958795759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37896,0.00273325238396821,0.00289555924230837,-0.0029420437309562,0.00840854849889262,0.345214062170716
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,37536,0.00810257151830819,0.00858922968319463,-0.00873231866075329,0.0249374616973697,0.345523988491311
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40354,-0.00484198320476671,0.00513754438476118,-0.0149115701988986,0.0052276037893652,0.345966206814423
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37567,-0.00449062779496551,0.0047669237501377,-0.0138337983452354,0.00485254275530437,0.346190055672971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,40531,-0.0072960921777748,0.00775382211594796,-0.0224935835250328,0.0079013991694832,0.346735811410983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37687,-0.00463675795894446,0.0049282923491237,-0.0142962109632269,0.00502269504533798,0.346801598348254
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,37477,-0.00654691355718756,0.00697976811138296,-0.0202272590554982,0.00713343194112303,0.348269822812195
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37536,0.00540131707995558,0.00576135175757974,-0.00589093236490071,0.0166935665248119,0.348514283485131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37536,-0.00636676509436881,0.00679487730172955,-0.0196847246057587,0.0069511944170211,0.348778497289908
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37536,0.00247653163048101,0.00264946030859894,-0.00271641057437291,0.00766947383533493,0.349944401952523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37567,0.00349349454063306,0.00374443201850576,-0.00384559221563822,0.0108325812969043,0.350845490665079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,37536,-0.00373099714439429,0.00400871227963379,-0.0115880732124765,0.00412607892368795,0.352014502333589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40380,-0.00979344268349057,0.0105435271228742,-0.030458755844324,0.0108718704773429,0.352976601733541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,40273,-0.00487799294693156,0.00525399737802747,-0.0151758278078654,0.00541984191400228,0.353196342458642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40327,-0.0063223387437328,0.00681506968618664,-0.0196798753286586,0.00703519784119302,0.353577419432652
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37557,0.00334265422106614,0.00360672318704822,-0.00372652322554837,0.0104118316676807,0.354055634528872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40327,0.00256384817579347,0.00277148078210977,-0.00286825415714169,0.00799595050872862,0.354937093460681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37709,-0.00436977160188659,0.00472839090553382,-0.0136374177767329,0.00489787457295969,0.355421835492357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37477,-0.00364595674249681,0.00394856912512748,-0.0113851522277467,0.00409323874275306,0.355835948337098
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37557,0.00259308582773955,0.00281014221904791,-0.00291479292159436,0.00810096457707345,0.356149465089125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40327,-0.00307679179080081,0.00333678413884779,-0.00961688870294248,0.00346330512134086,0.35649931821635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,37623,-0.00239088571604837,0.00259582730669127,-0.00747870723716326,0.00269693580506652,0.357041398690369
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37593,0.00267801064138182,0.0029110329473396,-0.0030276139354038,0.00838363521816743,0.357614719109031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37709,-0.00688129735858994,0.00748241422589485,-0.0215468292413439,0.00778423452416397,0.357765777208019
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,37536,-0.00595800578187286,0.00648757632825636,-0.0186736553852553,0.00675764382150959,0.358441288398856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,37895,0.00223790905984348,0.00244128790045304,-0.00254701522504448,0.00702283334473144,0.359320509919467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39956,0.00402764275101411,0.00439558683835783,-0.00458770745216725,0.0126429929541955,0.359527812375847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,37666,-0.00622704361781245,0.00680049264607838,-0.0195560092041261,0.00710192196850117,0.359853896738839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,39956,0.00424633503691853,0.00464476596532875,-0.00485740625512582,0.0133500763289629,0.360615802704583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,40111,0.00544797261422905,0.00596284348193449,-0.00623920061036254,0.0171351458388206,0.360913029930923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,40511,-0.00508634112238351,0.00556885041585475,-0.0160012879374588,0.0058286056926918,0.361069222328769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37666,0.00898354750693024,0.00983666295196951,-0.01029631187893,0.0282634068927905,0.361116238799516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37557,0.00580245090744418,0.00635700895332797,-0.00665728664107863,0.018262188455967,0.361383302313806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37477,-0.00623838757869623,0.00683506766808857,-0.0196351202081498,0.00715834505075736,0.361415596001388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,40327,0.00351644526708019,0.00386579887067981,-0.00406052051945224,0.0110934110536126,0.363031667249823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,37985,-0.00294368317605522,0.00324659490892662,-0.00930700919755139,0.00341964284544095,0.364582328331055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37709,-0.00849163128389483,0.00937282070179546,-0.0268623598594139,0.00987909729162428,0.364960465254883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37623,-0.00248950067928641,0.00275038309394952,-0.00788025154342746,0.00290125018485465,0.365404134993703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,40142,-0.00369558491835442,0.00408307976363311,-0.0116984212550753,0.00430725141836647,0.365427681791914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40187,-0.00188486462264163,0.00209196703159231,-0.00598512000456256,0.00221539075927929,0.367601518157839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40272,-0.00824517742833578,0.00918180659098377,-0.026241518346664,0.0097511634899924,0.369204144639776
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37709,-0.00562948969229914,0.00627027192778875,-0.0179192226707651,0.0066602432861668,0.369305125416957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,36174,-0.00827334404232193,0.00922389287048494,-0.0263521740684724,0.00980548598382855,0.369765561182147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37895,-0.00223891657247389,0.00250560158933747,-0.00714989568757532,0.00267206254262754,0.371570956352513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37937,-0.00841055593472781,0.00943080939098527,-0.0268949423410589,0.0100738304716033,0.372506952265227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,37567,0.00296915937549744,0.00333125828481105,-0.00356010686273222,0.00949842561372711,0.372783172336343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37985,0.00233946936154981,0.00262903661981211,-0.00281344241328194,0.00749238113638155,0.373557937502183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37593,0.00733837531625876,0.00826130833841547,-0.00885378902703556,0.0235305396595531,0.374405089125524
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,40223,-0.00788941291994508,0.0088992911274415,-0.0253320235297304,0.00955319768984027,0.375350091533229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,37567,0.00182990944693065,0.00206869413033548,-0.00222473104852689,0.00588454994238819,0.376403588453105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,39919,-0.00530137088606319,0.00599446012820304,-0.0170505127373412,0.00644777096521477,0.376505741458395
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,37477,-0.00576875121256974,0.00652547720378381,-0.018558686531986,0.00702118410684652,0.376693556323264
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,37570,-0.00212631329049915,0.00240782179698816,-0.00684564401259594,0.00259301743159764,0.377206086566201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37593,0.00357127274139372,0.00404712082637094,-0.00436108407829332,0.0115036295610808,0.377564211313113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,39975,0.00835300460533788,0.0094708562715477,-0.0102098736868956,0.0269158828975714,0.377807058384569
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37955,-0.00351018625312314,0.00398380976973062,-0.0113184534017951,0.00429808089554887,0.378272388430264
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37896,-0.00496890568815413,0.005647509227565,-0.0160380237741815,0.00610021239787328,0.378961606472528
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,37567,-0.00242678689349845,0.00276723675830089,-0.00785057093976819,0.0029969971527713,0.380518353706102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37593,-0.00592204737090776,0.00675379525718292,-0.0191594860749863,0.00731539133317076,0.380585593869091
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,39956,-0.00520239989020768,0.0059373061978221,-0.016839520037939,0.00643472025752363,0.380922789598716
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,37477,0.00327449562874541,0.00374027034333094,-0.00405643424418322,0.010605425501674,0.381334202955161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,39956,0.00405133446124686,0.00462962180171834,-0.00502272427012109,0.0131253931926148,0.381538644320527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,37666,-0.00568662656247876,0.00650284921404054,-0.0184322110219982,0.00705895789704071,0.38187154622418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37955,-0.00238191897196956,0.00272824625347613,-0.00772928162878277,0.00296544368484364,0.382646639473556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37985,0.0054342894947628,0.00623290836516218,-0.00678221090095507,0.0176507898904807,0.383294446841484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37896,0.00199072693328196,0.00228953811064772,-0.00249676776358758,0.0064782216301515,0.384595547904655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,40069,-0.00409023490084319,0.00471877086048752,-0.0133390257873987,0.00515855598571236,0.386064417791712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,37955,-0.00485691211069948,0.00562015305892277,-0.0158724121061881,0.00615858788478914,0.387495744488953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37557,-0.00347889406278884,0.00402720751917895,-0.0113722208003796,0.00441443267480192,0.387687355432418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,37557,0.00281717733430167,0.00326298447545681,-0.00357827223759368,0.00921262690619703,0.387947438501439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,37709,0.00650124763230652,0.00754318133003931,-0.00828338777457052,0.0212858830391836,0.388774215049894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37557,0.00259062175316152,0.00300728432524843,-0.00330365552432539,0.00848489903064844,0.38900661877091
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,40437,-0.00528909333967274,0.00615609328215202,-0.0173550361726907,0.00677684949334522,0.390262960334331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,37955,-0.00330811090589624,0.00385967712172747,-0.0108730780644821,0.0042568562526896,0.391407460102933
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,37557,0.00561756354857072,0.00656015634689926,-0.00724034289135184,0.0184754699884933,0.391838948143177
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,40223,0.00457941502998674,0.00536499244846019,-0.00593597016899522,0.0150948002289687,0.393354347048335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,40037,0.00410639007920988,0.00481133011374087,-0.00532381694372223,0.013536597102142,0.393404441552163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,40300,0.00549105828837654,0.00643693325498115,-0.0071253308913865,0.0181074474681396,0.393641680377012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,37638,-0.0106158612770304,0.0124481127549208,-0.0350141622766752,0.0137824397226143,0.393780780518478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37557,0.00392816581368121,0.00461232891837821,-0.00511199886634008,0.0129683304937025,0.394414806924593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,40354,0.00261445721783508,0.00307119153213061,-0.00340507818514092,0.00863399262081107,0.394624247507959
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37955,-0.00354236962810949,0.00416396446999957,-0.0117037399893087,0.00461900073308967,0.394939758673915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,37557,-0.00445435222984567,0.00524921140583549,-0.0147428065852832,0.0058341021255919,0.396133039990416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37536,0.00423913944275984,0.00500946166013551,-0.00557940541110576,0.0140576842966254,0.397441851292806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37895,0.00327956122038777,0.00388083062976251,-0.00432686681394674,0.0108859892547223,0.39808856914509
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,40414,-0.00248241546309527,0.00295104383637549,-0.00826646138239124,0.0033016304562007,0.4002489977134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37937,0.00439617208541775,0.00522605320378107,-0.00584689219399315,0.0146392363648287,0.400249087833527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,37985,0.0038634722428508,0.00460347871353,-0.00515934603566801,0.0128862905213696,0.401343526214052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39818,0.00639809189983742,0.00764518408580829,-0.00858646890834683,0.0213826527080217,0.402673755647882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,40406,0.00585322994406913,0.00700061657021997,-0.00786797853356202,0.0195744384217003,0.403110010917704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37536,-0.00338698105492699,0.00405634748591265,-0.0113374221273158,0.0045634600174618,0.403742544992755
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,37937,-0.00490464909823495,0.00588708107445364,-0.0164433280041641,0.00663402980769418,0.404791416245494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,40039,-0.00302733483963283,0.0036354727166216,-0.0101528613642112,0.0040981916849455,0.405014800228422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37536,-0.00319140239553462,0.00383872204917742,-0.0107152976119224,0.00433249282085312,0.405779217593593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37557,-0.0049421292220358,0.00595474528237562,-0.016613429975492,0.0067291715314204,0.40658327551694
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,37557,0.00386265903424862,0.00465492439902962,-0.00526099278784944,0.0129863108563467,0.406666649563496
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,39956,-0.00409725392201904,0.00495914322692543,-0.0138171746467929,0.0056226668027548,0.408702242551394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,40484,0.00800932413211866,0.00970035409577529,-0.0110033698956009,0.0270220181598382,0.409001684166021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37985,0.00199453846861634,0.00241647837568064,-0.00274175914771771,0.0067308360849504,0.409164435025936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37955,-0.00444289268052603,0.00538466527434051,-0.0149968366182334,0.00611105125718136,0.409328830139646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,40039,0.00219662503325439,0.0026629818758308,-0.00302281944337398,0.00741606950988276,0.409455640699846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,37666,-0.00246160502681216,0.00298469088943389,-0.00831159917010259,0.00338838911647828,0.40953199967537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37896,0.00315530104167839,0.00382670308506032,-0.00434503700503984,0.0106556390883966,0.409642783681706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39754,-0.00224130276761038,0.00271897162150485,-0.00757048714575988,0.00308788161053913,0.409770589088464
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37567,0.00530718799662315,0.00644318645122465,-0.00732145744777715,0.0179358334410235,0.410130723067271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37557,-0.00293057681206648,0.00356107008281203,-0.00991027417437805,0.0040491205502451,0.410552329920909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37709,0.00507216444611578,0.006172548171774,-0.00702602997056127,0.0171703588627928,0.411245687375913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40223,-0.00686163187320787,0.00835331201276056,-0.0232341234182186,0.00951085967180284,0.411415789469033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,40327,0.00548229888448358,0.00667978262684399,-0.00761007506413064,0.0185746728330978,0.411812326543427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',37557,0.00311639676400912,0.00381041368662578,-0.00435201406177741,0.0105848075897957,0.413450229975245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39831,0.0086885379395626,0.010636944584099,-0.0121598734452715,0.0295369493243967,0.414040253368797
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39956,-0.00398836651978479,0.00488300543733807,-0.0135590571769674,0.00558232413739782,0.4140637476508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40466,-0.00411173505180579,0.00503974546742315,-0.0139896361679552,0.00576616606434357,0.41459140303831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,40039,-0.00596297619968923,0.00735663014826779,-0.0203819712902941,0.00845601889091565,0.417631858842488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37937,-0.00267809091012353,0.00330486213789406,-0.0091556207003959,0.00379943888014884,0.417754062897992
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,40417,0.00253300380481293,0.00312730079633131,-0.00359650575599644,0.00866251336562231,0.417972434718462
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37477,0.00455308322109981,0.00563462558728171,-0.00649078292997234,0.015596949372172,0.419074103232026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40417,-0.00187126748133253,0.00231675742145903,-0.00641211202739223,0.00266957706472716,0.419269742454046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,39892,0.00334513692113464,0.00414860025270987,-0.00478611957417671,0.011476393416446,0.42006556067406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,37819,0.00207493346343648,0.00257541782413049,-0.00297288547185928,0.00712275239873224,0.42044824814598
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,40429,0.00438523699494526,0.0054474298567605,-0.00629172552430533,0.0150621995141958,0.420825730981485
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39975,-0.00524346259085362,0.00651482372010891,-0.0180125170822671,0.00752559190055984,0.420917975962564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37955,0.00806447930260929,0.010022687496189,-0.0115799881899211,0.0277089467951397,0.421051753052252
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37536,0.00231035105923587,0.00287487877816597,-0.00332441134596943,0.00794511346444116,0.42162283443308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40354,-0.00452250849773698,0.00563094334278578,-0.0155591574495971,0.00651414045412315,0.421898366874249
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,37895,0.00372180596398772,0.0046493808152599,-0.00539098043392169,0.0128345923618971,0.42343822203194
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,40336,-0.00698948467015251,0.00875736116680846,-0.0241539125570971,0.0101749432167921,0.424808840846474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,40511,0.00622177051910901,0.00781639608304845,-0.00909836580366596,0.021541906841884,0.426049806934153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,40305,-0.00326742315716222,0.00410792426468928,-0.0113189547159532,0.00478410840162877,0.426395571842829
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37937,-0.00222545364975989,0.00280051200892588,-0.00771445718725461,0.00326354988773482,0.426825545316899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,40255,-0.00207953155918341,0.00262182739368078,-0.00721831325079775,0.00305925013243093,0.427695862998313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39956,-0.0027003120559485,0.00340695242745361,-0.00937793881375757,0.00397731470186056,0.428029611709074
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,37666,-0.00629916816251128,0.00795188173540473,-0.0218848563639045,0.00928652003888199,0.428281203896832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,40354,0.00472651194785365,0.00597118347718015,-0.00697700766741944,0.0164300315631267,0.428632800875204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,37593,-0.00636183888089982,0.00804332294083629,-0.0221267518449389,0.0094030740831393,0.428989431677802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,40336,0.00438259106009409,0.0055431215776228,-0.0064819272320466,0.0152471093522348,0.429168280271214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37593,-0.00341145410503713,0.00431526852942953,-0.011869380422719,0.00504647221264474,0.429218388310841
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37593,0.00279597081134173,0.00354485404822095,-0.00415194312317134,0.0097438847458548,0.430277779256037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40319,0.00169264910056043,0.00214638530212688,-0.00251426609160826,0.00589956429272912,0.430354984032803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39956,0.00210761134946865,0.00267542253991533,-0.0031362168287654,0.00735143952770269,0.43084466506494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37985,-0.00174340472098353,0.00221347784446375,-0.00608182129613248,0.00259501185416541,0.430926118955666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,37982,-0.00473007130015538,0.00601027219349468,-0.016510204799405,0.00705006219909418,0.431296908972274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40392,-0.00762521450390357,0.00968913320163918,-0.0266159155791164,0.0113654865713092,0.431301621859168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37593,0.0019472855148525,0.00247655891825204,-0.00290676996492151,0.0068013409946265,0.431713679125625
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,40466,-0.00245280152790265,0.00312194084861784,-0.00857180559119362,0.00366620253538833,0.432075045957263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,37593,0.008151337367038,0.0103891265030613,-0.0122113505789621,0.0285140253130381,0.432700652512296
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40511,0.00241002251819146,0.00307550493292201,-0.00361796715033568,0.00843801218671859,0.433275562454971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37477,-0.00442714281382429,0.00567173947109496,-0.0155437521771704,0.00668946654952182,0.435074488562584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,40037,0.00580411533022956,0.00745345157219501,-0.00880464975127265,0.0204128804117318,0.436159378516254
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,37536,0.00250544515178128,0.00321922462254684,-0.00380423510841052,0.00881512541197309,0.436420414850191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40465,0.00418361752772207,0.00538241177921917,-0.0063659095595475,0.0147331446149916,0.437007649890696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40223,0.00413698435931473,0.00534593085114452,-0.00634104010892852,0.014615008827558,0.439027142844014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,37709,0.0039302669557721,0.00508567361810025,-0.00603765333570438,0.0138981872472486,0.439647736198355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37709,0.00371225137055553,0.00480623892934144,-0.00570797693095368,0.0131324796720648,0.439902112034827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37895,0.00391544962580339,0.00507198785915987,-0.00602564657814995,0.0138565458297567,0.440142594883311
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37557,0.00277528168166128,0.00359581067623467,-0.00427250724375867,0.00982307060708123,0.440241042551339
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37895,-0.00274096843487319,0.00355567815410857,-0.00971009761692599,0.00422816074717961,0.440797069183351
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,39956,-0.00562018503550557,0.00729275696702338,-0.0199139886908714,0.00867361861986025,0.440924380498274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37557,-0.00241682252277854,0.00315265302014992,-0.00859602244227238,0.0037623773967153,0.443333426169239
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,39898,-0.007710435815598,0.0100668632281569,-0.0274414877427855,0.0120206161115896,0.443734194194264
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37709,0.00373959563796233,0.00489298056495101,-0.00585064626934165,0.0133298375452663,0.444715410213472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,40327,-0.00359908313728929,0.00471021660549808,-0.0128311076840655,0.00563294140948696,0.444818170183965
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37593,0.0019989709255776,0.00261961281508142,-0.00313547019198199,0.00713341204313719,0.445430118196605
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,37567,-0.00276248012937176,0.00362032903557048,-0.0098583250390899,0.00433336478034638,0.445449268912851
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,37593,0.00512902368842749,0.00672345706475622,-0.0080489521584947,0.0183069995353497,0.445563493906361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40354,0.00658172959754766,0.00864213677839591,-0.0103568584881083,0.0235203176832036,0.446318481381076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37557,-0.00304939418442346,0.00401105548274283,-0.0109110629305994,0.00481227456175248,0.447120440870961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37709,-0.00614489491417682,0.00810927698424516,-0.0220390778032973,0.0097492879749437,0.448607463161902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,39929,0.00240239729228605,0.00317086891651779,-0.00381250578408881,0.00861730036866091,0.448674253787532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,40336,-0.00324764920801919,0.00429974014244813,-0.0116751398872175,0.00517984147117915,0.450072458121809
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40466,-0.00635030492189763,0.00840780235749613,-0.02282959754259,0.0101289876987948,0.450087826554333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40223,-0.00527877755184467,0.00699096474128127,-0.018981068444756,0.00842351334106661,0.45020883454995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37623,-0.00677388439025591,0.00900406550637104,-0.0244218527827431,0.0108740840022313,0.451875704755215
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39956,0.00322702228008546,0.00429503586783187,-0.005191248020865,0.0116452925810359,0.452460862703235
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37709,-0.00516611658575421,0.00687732580836746,-0.0186456751701544,0.00831344199864602,0.452557057634199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,39956,0.0040717509680917,0.00542485572371799,-0.00656096625039557,0.014704468186579,0.452920984784407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37477,-0.00175761928236662,0.00234328035411449,-0.00635044877643103,0.00283521021169778,0.453227383025445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37623,-0.00504242732562611,0.00672494089920821,-0.0182233114880742,0.00813845683682198,0.453382592319963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,40484,-0.00371926986739242,0.00496533294861945,-0.0134513224466865,0.0060127827119017,0.453839610319992
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37666,0.00781612466336604,0.0104400065277789,-0.0126462881310805,0.0282785374578126,0.45406916785956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,40367,0.00166223470799578,0.00222375282562361,-0.00269632083022649,0.00602079024621805,0.454778417110302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,37896,-0.00383899251805115,0.00514004831746181,-0.0139134872202763,0.006235502184174,0.455149855793656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37593,0.00449611187447959,0.00601988161598252,-0.00730285609284614,0.0162950798418053,0.455151097444774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40039,-0.00359548512350942,0.00481911397353199,-0.0130409485116321,0.00584997826461328,0.455625256636101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37477,0.0030886597138101,0.00415637589364952,-0.00505783703774295,0.0112351564653632,0.45742627116907
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,40039,-0.00324910670366098,0.00437231549672685,-0.0118188450772456,0.00532063166992365,0.45742693138407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37937,-0.00142206481177656,0.00193120649705191,-0.0052072295459983,0.00236309992244518,0.461523947161386
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40039,0.00372773300917069,0.00506500364704243,-0.00619967413903246,0.0136551401573738,0.461754950673749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,40428,-0.00385202096301417,0.00525496153542911,-0.0141517455724552,0.00644770364642688,0.46355361366387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,40037,0.00394742230607514,0.0053953998891474,-0.00662756147665376,0.014522406088804,0.46440702987435
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,40495,-0.00393352051419806,0.00538065076190189,-0.0144795960075258,0.00661255497912964,0.464759769310053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,40484,0.00188609521430716,0.00258713227607536,-0.00318468404680055,0.00695687447541486,0.465994393698577
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,37477,0.00204691345523099,0.0028091734544366,-0.00345906651546474,0.00755289342592672,0.466226877777774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37895,-0.0032482627396618,0.00446152019962536,-0.0119928423309275,0.0054963168516039,0.466588394639375
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40039,0.00424241022167162,0.00583938072221765,-0.00720277599387497,0.0156875964372182,0.46753270949999
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,40039,0.0031645951145013,0.00435722132867772,-0.00537555868970702,0.0117047489187096,0.467673484621968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,37937,0.00292580707034172,0.00403132412950634,-0.0049755882234907,0.0108272023641741,0.467993447360482
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37570,-0.00227208011054708,0.00314006701622185,-0.00842661146234191,0.00388245124124774,0.469338399502263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40039,0.00767205281100914,0.0106085993090474,-0.0131208018347237,0.028464907456742,0.469572862431968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37567,0.00319440836251411,0.00442500880345566,-0.00547860889225898,0.0118674256172872,0.470369594728819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,37405,-0.00279313218680976,0.00387200919381533,-0.0103822702066878,0.00479600583306828,0.470697951078316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,37937,-0.00444283527592692,0.00616322494405791,-0.0165227561662804,0.00763708561442659,0.471006859372635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37567,0.00382154648450429,0.00533050936071282,-0.00662625186249283,0.0142693448315014,0.473436492158317
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,40179,-0.00296086820083631,0.00413063694339077,-0.0110569166098822,0.0051351802082096,0.473504026948145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39956,0.00308364643610479,0.00431083366248575,-0.00536558754236728,0.0115328804145769,0.47441910950348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,40039,0.00244327627783686,0.00341583126912413,-0.00425175300964642,0.00913830556532015,0.474446669688498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39975,-0.00275497699301668,0.00385588432447359,-0.0103125102689849,0.00480255628295155,0.474937193351191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,37896,0.00220703879980456,0.00309049501766834,-0.00385033143482538,0.0082644090344345,0.475154474891408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38008,-0.00123053405009737,0.00172494516748144,-0.00461142657836099,0.00215035847816625,0.475625556172822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37895,-0.00325108887134129,0.00455911994428971,-0.0121869639621491,0.00568478621946654,0.475798912319879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37593,0.00582381139809492,0.00816957377217905,-0.010188553195376,0.0218361759915659,0.47594133619706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,37937,-0.00601054968238468,0.00844007133506965,-0.0225530894991212,0.0105319901343518,0.476387672074451
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39975,0.00223675882776151,0.00314288822809327,-0.0039233020993013,0.00839681975482432,0.476668105642847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37593,-0.00587937546036942,0.00827191774417684,-0.022092334238956,0.0103335833182172,0.477243547613346
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,37567,0.0030396742948329,0.00428743612672802,-0.00536370051355403,0.0114430491032198,0.478354146632043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37455,0.00158307892032462,0.00223399593274157,-0.00279555310784886,0.0059617109484981,0.478566155936156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37536,0.00379695501276341,0.0053592290606544,-0.00670713394611922,0.014301043971646,0.478654242461377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37557,0.00379907704163628,0.00537169367081399,-0.00672944255315915,0.0143275966364317,0.479429873198478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40336,-0.00343452196048075,0.00485754788235346,-0.0129553158098935,0.00608627188893203,0.479546708658586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39956,-0.00203252478311706,0.00287888810173247,-0.00767514546251269,0.00361009589627857,0.480192312212421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37858,0.00269474182476309,0.00381889964166344,-0.00479030147289724,0.0101797851224234,0.480428622690614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,37593,0.00165387388217551,0.00234709135106861,-0.00294642516591896,0.00625417293026998,0.481041633106943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37623,0.00292985959561558,0.00416247150587962,-0.00522858455590847,0.0110883037471396,0.481523070263373
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,40039,-0.00558442513980896,0.00793590554845589,-0.0211388000147825,0.00996994973516459,0.481635751226609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37985,-0.00182985394858647,0.00260090996774006,-0.006927637485357,0.00326792958818405,0.481729056647088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,40065,-0.00340981763453226,0.00485703419413469,-0.0129296046550363,0.00610996938597174,0.482666564717921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,40039,0.00330527986584629,0.00471800058704874,-0.00594200128476924,0.0125525610164618,0.483583160351274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37557,0.00300960603364168,0.0042972729725541,-0.00541304899256436,0.0114322610598477,0.48371960169041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37666,0.00536628962052354,0.00767922440533892,-0.00968499021394075,0.0204175694549878,0.484685452381499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,37593,0.00257189022877199,0.00369109589315189,-0.00466265772180572,0.00980643817934969,0.485951379501016
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37955,-0.00724426947898927,0.0104057236483608,-0.0276394878297765,0.013150948871798,0.486327324083352
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,37666,0.00346605926457128,0.00497932445967676,-0.00629341667639517,0.0132255352055377,0.486384547783868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40223,0.00638528162128459,0.00920828829717983,-0.0116629634411879,0.024433526683757,0.488051433580861
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40336,0.00560349818683664,0.00808795063617895,-0.0102488850600741,0.0214558814337474,0.488432320345357
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40037,0.00266851900633513,0.00385534139623757,-0.00488795013029052,0.0102249881429608,0.488846205397185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,40265,0.00244179411901099,0.00353896992735633,-0.00449458693860743,0.0093781751766294,0.490221217574471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37557,0.00310711415146179,0.00450782006389516,-0.00572821317377272,0.0119424414766963,0.490664318182471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37937,0.00161972276121813,0.00235288785429534,-0.00299193743320074,0.006231382955637,0.491214167240059
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37593,-0.00178471983345464,0.00259473652850251,-0.00687040342931957,0.00330096376241028,0.491576300688646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37985,0.00543117787762843,0.00789929172938466,-0.0100514339119655,0.0209137896672224,0.491746404119678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37896,-0.00528827448539902,0.00770332930850924,-0.0203867999300771,0.00981025095927908,0.492414702683667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39975,0.00540604467815801,0.00787735627929011,-0.0100335736292506,0.0208456629855666,0.49254900073509
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37477,0.00209247548654636,0.00305401595629474,-0.00389339578779133,0.00807834676088405,0.493258064774523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,37567,0.00398726351698292,0.00585949206404189,-0.00749734092853918,0.015471867962505,0.496212987240153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,37937,-0.00131586881575667,0.00193777926675752,-0.00511391617860141,0.00248217854708807,0.497111360488671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,40304,-0.00233283789400069,0.00343639621959779,-0.00906817448441235,0.00440249869641097,0.497235384807407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,37709,0.00439901702819008,0.00648609671188203,-0.00831373252709871,0.0171117665834789,0.497642436777585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,40222,-0.00314616410680149,0.00464949424339814,-0.0122591728238618,0.00596684461025886,0.498626530090814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37895,0.00211831184836918,0.00314121012336606,-0.0040384599934283,0.00827508369016665,0.500092972316498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37709,0.00426883154587808,0.00634460374319318,-0.00816659179078056,0.0167042548825367,0.50106799856712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,37355,0.00278831307816399,0.00414836550320688,-0.00534248330812149,0.0109191094644495,0.501501899659771
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37896,0.0031372813578594,0.00466849404315716,-0.00601296696672864,0.0122875296824474,0.501587967758558
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37557,0.00192573895442552,0.00286937754897072,-0.00369824104155709,0.00754971895040813,0.502146526480972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,37536,0.0038342784414195,0.00574430970391819,-0.00742456857826015,0.0150931254610992,0.504469949506809
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37937,-0.00279516089108493,0.00421030967627808,-0.01104736785659,0.0054570460744201,0.506775350789151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37955,0.00732451460179223,0.0110426787316414,-0.014319135712225,0.0289681649158094,0.507155222009578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39975,0.0027771320407777,0.00419363192256509,-0.00544238652744988,0.0109966506090053,0.507836232806237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,37479,0.00318190086219396,0.00481084131690101,-0.00624734811893203,0.0126111498433199,0.508366135518813
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37557,0.00365890808954157,0.00553349528427246,-0.00718674266763245,0.0145045588467156,0.508477028379754
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37593,-0.00254709104445456,0.00385257915766563,-0.0100981461934792,0.00500396410457008,0.508534648522006
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,37993,0.00258876853972896,0.0039238539586555,-0.00510198521923582,0.0102795222986937,0.509424531657803
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39975,-0.00446353731041015,0.00676603021851884,-0.0177249565387071,0.00879788191788678,0.509457370407954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37495,0.00200320670226679,0.00304070895072676,-0.00395658284115766,0.00796299624569125,0.510038446095881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40037,0.00539659048315049,0.00820318468070878,-0.0106816514910387,0.0214748324573397,0.510634411477763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37895,-0.00494514526620498,0.00751702473206743,-0.0196785137410571,0.00978822320864718,0.510639755504762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37895,0.00223810784479489,0.00340574727285189,-0.00443715680999483,0.0089133724995846,0.511091753202765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37985,-0.00153068275854024,0.00233281331076584,-0.00610299684764129,0.00304163133056081,0.511736757259668
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40327,0.00243293614522147,0.00370838030361578,-0.00483548924986545,0.0097013615403084,0.511792223965518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,37567,-0.00353971069845388,0.00539689047003851,-0.0141176160197294,0.0070381946228216,0.511913060450243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,40037,0.00615971456841172,0.00948555876181704,-0.0124319806047497,0.0247514097415731,0.516103555469531
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40336,0.00268040407404953,0.00414394311727024,-0.00544172443580015,0.0108025325838992,0.517754858646347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,38008,0.00370839693216477,0.00574077256225014,-0.0075435172898455,0.014960311154175,0.518306325425385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,40336,0.00317876867519305,0.00492382335261332,-0.00647192509592906,0.0128294624463152,0.518554562163701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40039,0.00204976488637169,0.00318956621071198,-0.00420178488662379,0.00830131465936717,0.52046268604884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40300,-0.00475069629379651,0.00739332448770036,-0.0192416122896892,0.00974021970209618,0.520515278698312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,37557,-0.00268995599687601,0.00419280849334672,-0.0109078606438356,0.00552794865008355,0.52116737799506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37709,0.00357887550979524,0.00558461379281757,-0.0073669675241272,0.0145247185437177,0.521634041420571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40466,0.00267362265548423,0.00417750627534538,-0.00551428964419272,0.0108615349551612,0.522178854770846
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37709,0.00299726768056728,0.00469386072930799,-0.00620269934887639,0.0121972347100109,0.523126344296984
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40300,-0.00252770475360763,0.00396179300043495,-0.0102928190344601,0.00523740952724488,0.523469619307969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40037,-0.00192432118532478,0.00303052438399162,-0.00786414897794836,0.0040155066072988,0.525451036433509
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37567,0.00279172060942118,0.00439727430052836,-0.00582693701961442,0.0114103782384568,0.525520856985223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,37593,0.0024317831594703,0.00383183403933743,-0.00507861155763106,0.00994217787657167,0.525683133938091
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,40484,-0.00113964220738909,0.00179715682116278,-0.00466206957686814,0.00238278516208997,0.526000983952964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40511,0.00254462212418494,0.00401841033923336,-0.00533146214071244,0.0104207063890823,0.526585302192448
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,37896,0.00426662044182212,0.00674396914287082,-0.00895155907820469,0.0174847999618489,0.526968303704193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37623,-0.0014834781876075,0.0023484792690424,-0.00608649755493061,0.00311954117971561,0.527609521875761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,40406,-0.00398840246183457,0.00631751831064461,-0.016370738350698,0.00839393342702886,0.527837583719572
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37993,0.00344045868775294,0.00545599281762324,-0.00725328723478862,0.0141342046102945,0.528323575073464
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37477,-0.00242636244839509,0.00385658521158511,-0.00998526946310191,0.00513254456631173,0.529263274284575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37557,0.00201083942216321,0.00319742146076266,-0.0042561066409316,0.00827778548525803,0.529429364531481
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37589,0.00213907225543577,0.00340173957770241,-0.00452833731686095,0.00880648182773249,0.529479690722197
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,37985,-0.00194330000116409,0.00309167186565432,-0.00800297685784656,0.00411637685551839,0.529648030734104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,40470,0.00120603197340539,0.00191932146072467,-0.00255583808961497,0.00496790203642574,0.529774656972222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,40406,-0.00205096713593064,0.00326724664409578,-0.00845477055835837,0.0043528362864971,0.530186123799672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37830,-0.00323906776429722,0.00516187466103772,-0.0133563420999311,0.0068782065713367,0.530343335844881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,37993,-0.00454877231176579,0.00727911814503365,-0.0188158438760317,0.00971829925250016,0.532042588794128
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40037,-0.00224628735890834,0.00359582479452989,-0.00929410395618693,0.00480152923837024,0.532181570805974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37895,-0.00357695104195677,0.00572977360372149,-0.0148073073052509,0.00765340522133735,0.532457979855059
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,37593,0.00260939229611088,0.00417988769776056,-0.00558318759149982,0.0108019721837216,0.532458951357792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37985,0.00402610196399651,0.00646085095177286,-0.00863716590147829,0.0166893698294713,0.533194148542832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37709,-0.00454562616696862,0.00729772180216256,-0.0188491608992072,0.00975790856527,0.533372186106865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37874,0.00385371809668221,0.00618915958428262,-0.00827703468851172,0.0159844708818761,0.533521101697289
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,37623,-0.00163471477107908,0.00263751654055702,-0.00680424719057084,0.00353481764841268,0.535404679349669
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37557,0.00528736392028693,0.00853812552757393,-0.011447362113758,0.0220220899543318,0.535752438018661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,40354,-0.00211356230741059,0.00342713553261977,-0.00883074795134533,0.00460362333652416,0.537432244048576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37557,0.00263391420312936,0.0042714535952665,-0.00573813484359298,0.0110059632498517,0.537488313075466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37666,0.00473543148580578,0.00769595909976576,-0.0103486483497351,0.0198195113213467,0.538357960919928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40309,0.00592131158278189,0.00963340266059713,-0.0129601576319885,0.0248027807975523,0.538785062848691
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,37955,0.00115130666045428,0.00187869841137088,-0.00253094222583265,0.00483355554674121,0.540004735252595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37709,-0.0026650024189342,0.00435323407901068,-0.0111973412137951,0.00586733637592674,0.540423156970234
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39956,0.00302017131521411,0.00494350436424683,-0.00666909723870968,0.0127094398691379,0.541250032101662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37666,-0.00451949648465302,0.00740428337691405,-0.0190318919034046,0.00999289893409852,0.541614350070759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40511,-0.0030037187607533,0.00492513880989926,-0.0126569908281558,0.00664955330664925,0.541953279982134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,37536,0.00341405007799832,0.00560394214306625,-0.00756967652241153,0.0143977766784082,0.542387258375616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37937,-0.00243936289367802,0.00403487689669225,-0.0103477216111948,0.00546899582383878,0.545475350233828
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,37557,-0.00250598105876911,0.00414799251068605,-0.0106360463797138,0.00562408426217556,0.545758964071108
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37895,-0.00412518201814947,0.00685974504919874,-0.017570282314579,0.00931991827828007,0.547609817993193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,37477,0.00380803531692742,0.00633853866671246,-0.008615500469829,0.0162315711036838,0.548000337501305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40511,-0.00285035806209816,0.00478192570347718,-0.0122229324409134,0.00652221631671712,0.551137479173795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,37477,0.00243753473551913,0.0040984782314248,-0.00559548259807348,0.0104705520691117,0.55202666587901
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,37955,-0.00841025027670828,0.0141720244206346,-0.0361874181411521,0.0193669175877356,0.552896472133513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37666,0.00493532680296514,0.00832502181492741,-0.0113817159542926,0.0212523695602229,0.553304742191956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,37709,0.00154808275846001,0.0026132047835322,-0.00357379861726311,0.00666996413418313,0.553587683591439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37895,-0.00429598637334941,0.00725386970968182,-0.0185135710043258,0.00992159825762695,0.553704040693729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,40300,-0.00168650528727812,0.00284904171833589,-0.00727062705521646,0.00389761648066021,0.553888979364655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37536,0.0038153638451815,0.00645190592211773,-0.00883037176216924,0.0164610994525322,0.554293110634964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,37896,-0.00532357003407486,0.00901964591845927,-0.023002076034255,0.0123549359661053,0.555053485296083
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,40300,0.00428374681074038,0.00725816713959149,-0.00994226078285895,0.0185097544043397,0.555067151570378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39975,0.00237837704336914,0.00403826783347518,-0.00553662791024221,0.0102933819969805,0.555896872959021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,37955,0.00198266803149773,0.00336651726253566,-0.00461570580307216,0.00858104186606762,0.555913098118952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37709,0.00240646602035549,0.00410276793795357,-0.0056349591380335,0.0104478911787445,0.557518007640122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39975,-0.0024033156162283,0.00410492874930271,-0.0104489759648616,0.00564234473240501,0.558239755521017
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37623,-0.0031654279392457,0.00545417411659062,-0.0138556092077633,0.00752475332927192,0.561676431370211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40493,0.00269592565378949,0.0046462362475297,-0.00641069739136872,0.0118025486989477,0.561761871319255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39975,-0.00247750861294564,0.004279869154441,-0.01086605215565,0.00591103492975873,0.562682020668155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37896,0.00134180114684024,0.00232338771124756,-0.00321203876720497,0.00589564106088545,0.56359840455009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,40354,-0.00642838164645148,0.0111663228262089,-0.0283143743858209,0.0154576110929179,0.564830384198152
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,37637,-0.00518335333672917,0.0090293029941231,-0.0228807872052104,0.0125140805317521,0.565937617595777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37955,-0.00186593696153422,0.00325226915415959,-0.00824038450368702,0.00450851058061857,0.566157461766
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37709,-0.00340396980156607,0.00593407215881209,-0.0150347512328378,0.00822681162970563,0.566227025956023
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37557,-0.00240040539209393,0.00418683417039608,-0.0106066003660702,0.00580578958188238,0.566436327292886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,40336,-0.00268194698205874,0.00467963347279128,-0.0118540285887297,0.00649013462461217,0.566578005275423
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37593,-0.00312190891114147,0.00544974826360308,-0.0138034155078035,0.00755959768552058,0.566753500730068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,40271,-0.00168661802973177,0.00294975718046906,-0.00746814210345112,0.00409490604398759,0.567477804548284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37593,-0.00458413786879251,0.00801790976667771,-0.0202992410114808,0.0111309652738958,0.567509757545787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37567,-0.00178790474769291,0.00313256192275943,-0.00792772611630138,0.00435191662091557,0.568179974564419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39956,0.00217295144241059,0.00380844766964226,-0.00529160599008823,0.00963750887490941,0.568305577935916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40417,0.00136076293621874,0.00238499364772362,-0.00331382461331955,0.00603535048575703,0.568311382019599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37937,-0.00188690836460666,0.00330913169670978,-0.00837280649015782,0.0045989897609445,0.56854305696753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37623,-0.00245114925340014,0.00430210639356063,-0.010883277784779,0.0059809792779787,0.568853183984109
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,37933,0.00116903278176272,0.00205373860756182,-0.00285629488905845,0.00519436045258389,0.569215113389979
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,40327,-0.00132703369708727,0.00233662115900887,-0.00590681116874465,0.00325274377457012,0.570091566308971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,39956,-0.00263232067379808,0.00464956968761877,-0.0117454772615309,0.00648083591393471,0.571304864583413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37985,0.00485985753043518,0.00861367157193447,-0.0120229387505564,0.0217426538114267,0.572625479559609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37985,0.00446419897762362,0.00791672470124559,-0.0110525814368177,0.019980979392065,0.572835151915265
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,40037,-0.00222831244446397,0.00395328415700184,-0.00997674939218757,0.00552012450325963,0.57299291485034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37536,0.00316221205938277,0.00562459451775309,-0.00786199319541329,0.0141864173141788,0.573981517259897
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,40336,0.00236293573912089,0.0042070243515051,-0.00588283198982912,0.0106087034680709,0.574352629556388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40039,0.00298032991857106,0.00531790709330779,-0.0074427679843122,0.0134034278214543,0.575192273424937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37477,0.00243834151916173,0.00436097757768917,-0.00610917453310903,0.0109858575714325,0.576084473022657
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,37593,0.00312075126826771,0.00559346784920853,-0.00784244571618101,0.0140839482527164,0.576903184770367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,40202,0.00220645372691326,0.00395955925233355,-0.00555428240766049,0.00996718986148701,0.577366391302138
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,37536,-0.00426127245662933,0.00769149366143691,-0.0193366000330457,0.010814055119787,0.579571855917314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40037,0.00257102777060479,0.00464283142333885,-0.00652892181913935,0.0116709773603489,0.579749069473662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37630,0.00237121761024149,0.0042863323643582,-0.00602999382390058,0.0107724290443836,0.580132888978534
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37477,0.00200092520272534,0.00362378233572881,-0.00510168817530313,0.0091035385807538,0.580844893473084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40391,0.00412096091304964,0.00747167854154073,-0.0105235290283702,0.0187654508544695,0.581268412342872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,40467,-0.0011309103823561,0.00205406169673247,-0.00515687130795174,0.00289505054323954,0.581934277583882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,37666,-0.00276128150439878,0.00502170760970325,-0.0126038284194172,0.0070812654106196,0.582418499250237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37477,-0.00245474802020441,0.00447508009065015,-0.0112259049978787,0.00631640895746989,0.583332477152693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,37567,0.0029096804588274,0.00531506852575957,-0.00750785385166136,0.0133272147693162,0.584085881034347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,38008,-0.00120804638418516,0.00220941655737995,-0.00553850283664987,0.00312241006827955,0.584544607191087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39975,-0.00372112143401204,0.00687641650860149,-0.017198897790871,0.00975665492284689,0.588417110516333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,40037,-0.00181376429801042,0.00336549889540678,-0.0084101421330077,0.00478261353698686,0.589943678476364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40037,-0.00302233270912474,0.00560936965294298,-0.014016697228893,0.0079720318106435,0.590032025433258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,37477,0.00555285999458282,0.0103329229920283,-0.0146996690697927,0.0258053890589584,0.591004054088918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37709,0.00170701742420883,0.00319413790206622,-0.00455349286384097,0.00796752771225862,0.593058594029259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37567,-0.00197561347886174,0.00370013524742851,-0.00922787856382162,0.00527665160609815,0.593398964847432
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37623,-0.00153092120879222,0.00288414846307965,-0.00718385219642833,0.00412200977884388,0.595562676325065
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40039,0.00175852166837021,0.00331460671208484,-0.00473810748731607,0.00825515082405649,0.595747185869081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,37593,0.00486939584849909,0.00925215619090987,-0.0132648302856843,0.0230036219826824,0.598689712969586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,40223,-0.00160746222635208,0.0030582518676606,-0.00760163588696686,0.0043867114342627,0.599163310800361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37955,0.00394117104917839,0.00751406849232303,-0.0107864031957748,0.0186687452941315,0.599935531580369
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40336,-0.00461592679001765,0.00885295023059111,-0.0219677092419762,0.0127358556619409,0.602095535644298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37536,0.00393873745544882,0.00756062213540761,-0.0108800819299501,0.0187575568408477,0.602407530164254
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37593,-0.00100724533930034,0.00193581579257663,-0.00480144429275053,0.00278695361414985,0.602848724298606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37593,0.00251762113924771,0.00484198281483927,-0.00697266517783725,0.0120079074563327,0.603102551806277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37985,0.0011418770776479,0.00219936398667868,-0.0031688763362423,0.00545263049153811,0.60364013773546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39956,-0.00343863403114466,0.00664398045907244,-0.0164608357309266,0.00958356766863733,0.604775253215944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,37557,-0.00182068605414156,0.00353951077783643,-0.00875812717870097,0.00511675507041784,0.606988595151259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37682,0.00229579147106985,0.00447860911371417,-0.00648228239180993,0.0110738653339496,0.608230894154737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37557,0.00172697180735528,0.00338054659134446,-0.00489889951167986,0.00835284312639042,0.60946064392593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37982,0.00236834581862392,0.00464305282002948,-0.00673203770863386,0.0114687293458817,0.610001106026701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,37567,0.00261411351405173,0.00513066112450143,-0.00744198228997108,0.0126702093180745,0.610404679482667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37557,-0.00379335577112945,0.00745701095989439,-0.0184090972525225,0.0108223857102636,0.610973502422607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37709,-0.00328022613260903,0.00646418550096524,-0.0159500297145009,0.00938957744928285,0.61185024324881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37985,-0.00446615104077137,0.0088296218200875,-0.0217722098081429,0.0128399077266001,0.61299509356555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,37937,-0.00369638355113583,0.00736102032396404,-0.0181239833861054,0.0107312162838337,0.615565700560177
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,37477,0.00137610651389199,0.00274154914422031,-0.00399732980877982,0.00674954283656379,0.615714789753696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,37477,0.00359565808870014,0.00716959921363527,-0.010456756370025,0.0176480725474253,0.61601753969406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40223,0.00182314163932128,0.00363778672966148,-0.00530692035081523,0.00895320362945779,0.616260015687769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,37593,-0.00227632110983657,0.00455170194145647,-0.0111976569150912,0.00664501469541811,0.617010724823672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40327,-0.00116551565164783,0.00233157466549153,-0.00573540199601123,0.00340437069271558,0.61716405545807
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39975,-0.00231200602746855,0.00464061029228091,-0.0114076022003391,0.00678359014540203,0.618341942998403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39975,-0.00342607438749012,0.00689325712349948,-0.0169368583495491,0.0100847095745689,0.619183241659327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37709,0.00291868103984488,0.00588123846383557,-0.00860854634927283,0.0144459084289626,0.619712297808389
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,40324,0.00423258354887641,0.00855674123275891,-0.0125386292673311,0.0210037963650839,0.620854749391886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,40300,-0.00816886961729048,0.0165294515411109,-0.0405665946378678,0.0242288554032868,0.621171162934394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37332,-0.00215012254289304,0.00435098259197348,-0.0106780484231611,0.00637780333737498,0.621194962065284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37557,-0.00223642865247172,0.00452584823543599,-0.0111070911939263,0.00663423388898282,0.621211534842822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,39956,-0.00314319931017515,0.00639402274271248,-0.0156754838858916,0.0093890852655413,0.623020411952947
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37623,0.00123511130048386,0.00251429053760407,-0.00369289815322012,0.00616312075418785,0.62326736652382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40352,-0.00165464727377336,0.00338440976152681,-0.00828809040636591,0.00497879585881918,0.62491728491207
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37557,-0.00165612863488255,0.00339098293309749,-0.00830245518375364,0.00499019791398854,0.625280442115984
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,40347,0.00217920321868661,0.00446440491274549,-0.00657103041029454,0.0109294368476678,0.625465567117445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40466,0.00286672111645904,0.00589762185143179,-0.00869261771234727,0.0144260599452654,0.626916486029372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40039,0.00255278444445217,0.00525327409540797,-0.00774363278254744,0.0128492016714518,0.627015400201348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37557,0.00207758225669543,0.00427579763207944,-0.00630298110218027,0.0104581456155711,0.627050804379987
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40187,0.00407080636923582,0.00838358268859718,-0.0123610157004147,0.0205026284388863,0.627279667288092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,37477,-0.00267056699547451,0.00551003687929224,-0.0134702392788873,0.00812910528793828,0.627916357425266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37567,0.00443837134154497,0.00918678736090166,-0.0135677318858223,0.0224444745689122,0.629014685730651
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37477,-0.00366125565769684,0.00761484029956332,-0.0185863426448409,0.0112638313294473,0.630662951141784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37593,0.00373688198379995,0.00779723568964412,-0.0115456999679025,0.0190194639355024,0.631763583007504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37593,-0.00164819243878274,0.00344741966433904,-0.00840513498088726,0.00510875010332177,0.632590887454463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,40300,0.00178299994587253,0.00374166555589187,-0.00555066454367554,0.0091166644354206,0.633706444134124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,37617,-0.00277356584357597,0.00582477439334825,-0.0141901236545386,0.0086429919673866,0.63396324882649
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37955,-0.00284571649075623,0.00600632542418136,-0.0146181143221517,0.00892668134063922,0.635659752432024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,37692,0.00411976501977344,0.00871546685431353,-0.0129625500146811,0.021202080054228,0.636437978932319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40406,-0.00302598647129002,0.00640936138376358,-0.0155883347834666,0.00953636184088659,0.636847731340018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37906,0.00237274956364982,0.00503567532178395,-0.00749717406704673,0.0122426731943464,0.637514158336695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40300,-0.00479078273008588,0.0102141664400999,-0.0248105489526816,0.0152289834925099,0.63905238809429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,40039,-0.00134167654956209,0.00286969970914476,-0.00696628797948582,0.00428293488036164,0.64012581287782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,37709,0.00094622244826157,0.00203387433251667,-0.00304017124347111,0.00493261613999425,0.641773310144214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37536,-0.00225676430673308,0.00486559108464543,-0.0117933228326381,0.00727979421917196,0.642783567534439
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37567,-0.00175741025494921,0.00380270766889213,-0.00921071728597779,0.00569589677607937,0.643983514478138
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37937,0.00220137678571384,0.00477228706568465,-0.00715230586302808,0.0115550594344558,0.644602735634231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40300,0.00382549038463665,0.00832533892818815,-0.0124921739146121,0.0201431546838854,0.645881700858888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,39956,-0.00194836601453035,0.0042709495909114,-0.0103194272127167,0.00642269518365599,0.648259489642592
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37623,0.00171482831436555,0.00375968522095714,-0.00565415471871044,0.00908381134744154,0.64831872716806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,37709,-0.0024323460919799,0.00537972010947895,-0.0129765975065587,0.00811190532259885,0.651180957466568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,37477,0.0016721116141539,0.0037034710676605,-0.00558669167846068,0.00893091490676848,0.651637826617234
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37623,0.00154788827051611,0.00344238440235329,-0.00519918515809634,0.00829496169912855,0.652966012960194
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37895,-0.00208818283087843,0.00466680306192768,-0.0112351168322567,0.00705875117049981,0.654554018807442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,40039,-0.00116072902227498,0.00261683434039424,-0.00628972432944768,0.00396826628489773,0.657365234315057
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,40300,-0.000741201698567579,0.0016864515726103,-0.00404664678088377,0.00256424338374862,0.660302597501173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,37765,0.00126482275293144,0.00288929957185251,-0.00439820440789948,0.00692784991376236,0.661566625948452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37955,-0.00181610381584387,0.00417498153197278,-0.00999906761851053,0.00636685998682279,0.663571665702482
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39975,-0.00201339225387885,0.00463167375131619,-0.0110914728064586,0.00706468829870088,0.663785665156661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37896,-0.00177874083963691,0.00410845008579402,-0.00983130300779319,0.00627382132851937,0.665060272331087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,37875,-0.00195230441890536,0.00451557663242868,-0.0108028346184656,0.00689822578065485,0.665494824464176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,40354,-0.00249033331442771,0.00581203465877331,-0.0138819212456234,0.00890125461676797,0.668308408796193
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,40311,-0.00481437759122528,0.0112615982871752,-0.0268871102340886,0.0172583550516381,0.66901812336504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,39956,0.00259526063568176,0.00607662017491395,-0.00931491490714958,0.0145054361785131,0.669320075572786
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,40198,-0.00170800554534249,0.00400313051448252,-0.00955414135372823,0.00613813026304325,0.669627384744599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37567,0.00146619770260488,0.00343730303749107,-0.00527091625087762,0.00820331165608739,0.669710713123655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37955,-0.00260000117346657,0.00612422496535678,-0.0146034821055659,0.00940347975863272,0.671176100590242
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37557,-0.00437757530233631,0.0103204711320579,-0.0246056987211699,0.0158505481164973,0.671452964765937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,37593,0.00233950491491865,0.00551724147423137,-0.00847428837457484,0.0131532982044121,0.671547040558429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,37623,-0.00314535809677458,0.00742551409279909,-0.0176993657186608,0.0114086495251116,0.671873280884347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37536,0.00275495817595199,0.00652323334602566,-0.0100305791822583,0.0155404955341623,0.672790987355827
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37905,-0.0015250708546781,0.00361292122072808,-0.00860639644730514,0.00555625473794895,0.672947297196508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37567,0.00262033724789806,0.00620822249691494,-0.00954777884605522,0.0147884533418513,0.67297698925815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37536,0.00279821052051996,0.00667571508572105,-0.0102861910474933,0.0158826120885332,0.67510413739464
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37955,-0.00178977401755084,0.0042759887099602,-0.0101707118890728,0.00659116385397116,0.675541618483185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,37593,-0.00190016481346148,0.00454708711346237,-0.0108124555558477,0.00701212592892476,0.676037173301406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,40306,-0.00322598388049798,0.00773830334524182,-0.0183930584371719,0.011941090676176,0.676768047962842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,37567,0.00283263704195409,0.00681003705679699,-0.010515035589368,0.0161803096732762,0.677453168153832
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,37567,-0.00178734921860641,0.00432239518706747,-0.0102592437852587,0.00668454534804584,0.679240506665369
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37896,0.00196553492121407,0.00475581286001647,-0.00735585828441822,0.0112869281268464,0.679399973343963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37895,-0.00169467507057172,0.00411463064437602,-0.00975935113354872,0.00637000099240529,0.680444457795029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,37557,0.00153760652557688,0.00373399644905079,-0.00578102651456267,0.00885623956571643,0.680503202123969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,37623,0.00245282655038846,0.00599887709580783,-0.0093049725573949,0.0142106256581718,0.68263367962393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,40294,0.0010200604112293,0.00250254833162264,-0.00388493431875107,0.00592505514120968,0.683566501802482
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,38008,0.000938736759133794,0.00230700717195758,-0.00358299729790307,0.00546047081617066,0.684082912445158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40352,-0.00180082709312964,0.00443252923208374,-0.0104885843880138,0.00688693020175449,0.684545807946487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37937,-0.00323342301170039,0.0080005794583255,-0.0189145587500184,0.0124477127266176,0.686109855364939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39956,-0.00400047926002152,0.00990399394045144,-0.0234123073833063,0.0154113488632633,0.686272811207049
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37955,0.00120139553915049,0.00298086863260302,-0.00464110698075144,0.00704389805905241,0.686928573982875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37557,0.00238978144436434,0.00593719953733654,-0.00924712964881528,0.014026692537544,0.68731538740332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,38008,-0.000916238319582701,0.00228915735770815,-0.00540298674069067,0.00357051010152527,0.688977704717749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37593,-0.00102436850484512,0.00255934490962454,-0.00604068452770922,0.00399194751801897,0.688981571762981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,37593,-0.00218501846823406,0.00549596863941368,-0.0129571170014849,0.00858708006501675,0.690955484566387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40223,0.00125166660536909,0.00317813069197463,-0.00497746955090119,0.00748080276163936,0.693706443222188
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37955,0.00258997200131598,0.00658392383046751,-0.0103145187064003,0.0154944627090323,0.694046390754696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,37709,-0.00192151407438083,0.00488922527606139,-0.0115043956154611,0.00766136746669949,0.694318467942084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37477,-0.00103878352918964,0.00266837561013027,-0.00626879972504497,0.00419123266666569,0.697064785069202
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,37567,0.00299438817125475,0.00769742103692697,-0.0120925570611221,0.0180813334036316,0.697273679294021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37895,0.00153906597086187,0.00398819205014004,-0.0062777904474126,0.00935592238913634,0.699572629555469
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37709,-0.00185610686563298,0.00481419553566422,-0.0112919301155349,0.00757971638426889,0.699837113125005
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37623,0.00323607127027822,0.00840535964649656,-0.013238433636855,0.0197105761774115,0.700242944124192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,37955,0.00258162445177729,0.00670980138254101,-0.0105695862580031,0.0157328351615577,0.700425573461777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40037,-0.0016867155055734,0.00439810229153069,-0.0103069959969735,0.00693356498582674,0.701347007005039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37477,-0.00301680274227934,0.00786670373748297,-0.018435542067746,0.0124019365831873,0.701362692864526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37709,-0.002848989146282,0.00751389453510213,-0.0175762224350822,0.0118782441425182,0.704573060881394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37477,0.00187010410051305,0.00493756367545228,-0.00780752070337341,0.0115477289043995,0.704879413803257
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,38008,0.00249854190065202,0.00660691601109503,-0.0104510134810942,0.0154480972823983,0.705309728601514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,40300,-0.000998268532785643,0.00265301798719887,-0.00619818378769543,0.00420164672212415,0.706716326169642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,37536,-0.00168203774214975,0.00447574352031641,-0.0104544950419699,0.00709041955767041,0.70706282211481
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37666,0.00202001809977977,0.00538492985313209,-0.00853444441235912,0.0125744806119187,0.707574038190626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,37709,0.00204022545618461,0.00545048408022417,-0.00864272334105476,0.012723174253424,0.708172206011331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37536,0.00181249158970383,0.00484660715507109,-0.0076868584342355,0.0113118416136432,0.708431788169918
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37955,0.00127856070079055,0.00345636958431392,-0.00549592368446474,0.00805304508604584,0.711452111895633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,40037,-0.00197007777215236,0.00538043073053416,-0.0125157220039993,0.00857556645969461,0.714253534833519
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,37982,-0.000821048882054428,0.00225092237443324,-0.00523285673594358,0.00359075897183472,0.715295458917446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37623,0.0016060830320259,0.00441664452325205,-0.00705054023354811,0.0102627062975999,0.716130251656237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40037,0.00188372673382258,0.00518398499012683,-0.008276883846826,0.0120443373144712,0.716330252123434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37955,0.00139374239614134,0.00384135545722159,-0.00613531430001298,0.00892279909229566,0.716740788171593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37955,0.00254361088582306,0.00704188797476254,-0.0112584895447115,0.0163457113163576,0.717947000495559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,37567,-0.00133545382939376,0.00371856493656785,-0.00862384110506676,0.00595293344627923,0.719502494015871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37557,-0.00181665602293142,0.00512416803010442,-0.0118600253619361,0.00822671331607324,0.722949662519729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37937,-0.00165076637186197,0.00467250224623536,-0.0108088707744833,0.00750733803075935,0.723873667884489
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37666,-0.00220995126841618,0.00627717477439781,-0.0145132138262359,0.0100933112894035,0.724797790691562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40360,0.00152713816618708,0.00435612780049614,-0.00701087232278536,0.0100651486551595,0.72591380940119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,39956,-0.000966031613683303,0.00277905511707556,-0.0064129796431514,0.0044809164157848,0.728136661408221
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37895,0.00188835156135,0.00547482031194269,-0.00884229625005766,0.0126189993727577,0.730163132115064
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37477,0.00171189070361428,0.00496464474653622,-0.00801881299959671,0.0114425944068253,0.730238004540273
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40406,0.000764847281510809,0.00222508150605973,-0.00359631247036627,0.00512600703338789,0.731047111900076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37709,-0.00161505343465644,0.00471531338289369,-0.0108570676651281,0.00762696079581519,0.731970723027692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37878,0.00126372446694354,0.0037117343905663,-0.0060112749385664,0.00853872387245349,0.733509914117087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,37557,0.00114845227655924,0.00337386241610747,-0.0054643180590114,0.00776122261212988,0.733563115832904
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37557,-0.00359021703489872,0.0105574506763177,-0.0242828203604813,0.0171023862906839,0.733813202141446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37973,0.0014388920472518,0.00425282182850102,-0.0068966387366102,0.0097744228311138,0.735113599369231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,37931,-0.00224793838058271,0.00664836653196667,-0.0152787367832374,0.010782860022072,0.735278854000436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,40265,-0.00233606327603849,0.00694157540913229,-0.0159415510779378,0.0112694245258608,0.736474079648298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40198,-0.00117482133865863,0.00349458726719576,-0.00802421238236232,0.00567456970504507,0.736737241816228
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37709,0.00224208766114755,0.00669986904172349,-0.0108896556606305,0.0153738309829256,0.737897064789773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37477,0.000990754166892186,0.00297116844883099,-0.00483273599281655,0.00681424432660093,0.738795409136184
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40484,-0.000914404467598447,0.00274832281541518,-0.00630111718581219,0.0044723082506153,0.739354808220844
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37895,-0.00130394271822247,0.00392025465109438,-0.00898764183436744,0.00637975639792251,0.739428715686166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,37477,0.00169048656297589,0.00509529108347683,-0.0082962839606387,0.0116772570865905,0.74006504020602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,40466,-0.000903074341202052,0.00272499857746547,-0.00624407155303437,0.00443792287063026,0.740343981772313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38008,0.000553030719269943,0.00167504963143982,-0.00273006655835211,0.003836127996892,0.741285825047328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37955,-0.00197839856686264,0.00601134090273063,-0.0137606267362147,0.0098038296024894,0.742076875420973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,40336,0.00175487959909727,0.00535367063991948,-0.00873831485514491,0.0122480740533395,0.74307478312997
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,37477,-0.00197593329057742,0.00603556786382678,-0.0138056463036779,0.00985377972252307,0.743384614661619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37623,-0.00748587037527992,0.023132595551109,-0.0528257576554535,0.0378540169048936,0.746240708369816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,40006,-0.000873381131511879,0.00271280167523111,-0.00619047241496486,0.0044437101519411,0.747496399159421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37937,0.00670592074011426,0.0210063076851316,-0.0344664423227436,0.0478782838029721,0.749554269861911
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40511,-0.00116210796172361,0.00364466679948801,-0.00830565488872012,0.00598143896527289,0.749843169294245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,37477,-0.00227606807816188,0.00715604489477419,-0.0163019160719193,0.0117497799155955,0.750442781261576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37985,0.00206871030867314,0.00653740287227099,-0.010744599320978,0.0148820199383243,0.751671752240841
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37709,0.00103145470844108,0.00326466090967467,-0.00536728067452128,0.00743019009140343,0.75204889919383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,40466,-0.00072556554830451,0.00229900267680142,-0.0052316107948353,0.00378047969822628,0.752310150110728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37895,-0.00189721293819097,0.0060265081384101,-0.0137091688894748,0.00991474301309283,0.752909807796233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,40391,0.00159308802122775,0.00506135289108999,-0.00832716364530863,0.0115133396877641,0.752951517265631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37477,0.00101184130257808,0.00322111507321578,-0.00530154424092485,0.007325226846081,0.753429122254996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,40328,-0.00249969821006798,0.00796571139114495,-0.0181124925367121,0.0131130961165761,0.753671539189763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37985,0.00244309515018003,0.00779028931204886,-0.0128258719014357,0.0177120622017958,0.753823801449484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40037,0.00074937297502718,0.00239191052204602,-0.00393877164818302,0.00543751759823738,0.754060941697611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37666,0.00147336325227435,0.00472218401305682,-0.00778211741331702,0.0107288439178657,0.755038712477096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37692,0.00277612255938482,0.0089173504008447,-0.0147018842262708,0.0202541293450404,0.755564564590498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37709,0.00204585768485771,0.00661096315139035,-0.0109116300918674,0.0150033454615828,0.756973159218308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37557,-0.00188977423307297,0.00612941619855852,-0.0139034299822477,0.0101238815161017,0.757849629343683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,38008,-0.000859605952237339,0.00279562092447911,-0.00633902296421639,0.00461981105974171,0.758480472447573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,37593,0.000806805368982363,0.00262876275654966,-0.00434556963385496,0.00595918037181969,0.758913326017966
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37709,-0.00122054954707841,0.00403020030749544,-0.00911974214976946,0.00667864305561265,0.762008288932068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37982,0.00068660989626819,0.00227416663412001,-0.00377075670660704,0.00514397649914342,0.76271986629666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37593,-0.000866087609663039,0.00287506882958582,-0.00650122251565124,0.00476904729632517,0.763235758881381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,40039,0.00130081736643586,0.0043315114880904,-0.00718894515022131,0.00979057988309305,0.763940986824123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37593,0.000734765668270927,0.00245338011984249,-0.00407385936662035,0.00554339070316221,0.764570049311233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37985,-0.000851761542473066,0.00284896004595212,-0.00643572323253922,0.00473220014759309,0.764965395351102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,37982,0.00171058088890038,0.00572846268871055,-0.00951720598097231,0.0129383677587731,0.765241601489495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,40187,-0.00200829972862176,0.00673471661164623,-0.0152083442874484,0.0111917448302048,0.76555363928445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37709,0.00107379121100044,0.00361763214397399,-0.00601676779118858,0.00816435021318947,0.766607395650684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36969,-0.00131131763173449,0.00441944560244299,-0.00997343101252275,0.00735079574905377,0.766688711176059
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,40465,-0.000872137063760424,0.00294183603000217,-0.00663813568256469,0.00489386155504384,0.766882562839422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40298,0.000576644055053181,0.00196667873710999,-0.0032780462696824,0.00443133437978876,0.769367741346696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,37638,0.00215013251651051,0.00733463373398067,-0.0122257496020916,0.0165260146351126,0.769413714154565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37623,0.0016151146287866,0.00553532427973744,-0.00923412095949878,0.012464350217072,0.77045698669814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40417,0.00223578133163235,0.00766682099200318,-0.0127911878126939,0.0172627504759586,0.770582666948774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37593,-0.00163487476750901,0.00560801119466583,-0.012626576709054,0.00935682717403602,0.770654522890312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37993,0.000639162267521886,0.00219823293575391,-0.00366937428655578,0.00494769882159955,0.771237920216314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,37623,0.00057230131927501,0.0019795333039204,-0.00330758395640898,0.004452186594959,0.772502352346634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37895,-0.000939378155146467,0.00325418874215601,-0.00731758808977224,0.00543883177947931,0.772840374326821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,37477,-0.00182078366170201,0.00631085415914681,-0.0141900578136298,0.0105484904902257,0.772956222684415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37567,0.00171283202202943,0.00594932586147552,-0.00994784666646259,0.0133735107105214,0.773425120406438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37666,-0.000711932750551257,0.00248785727979046,-0.00558813301894055,0.00416426751783804,0.774757752227482
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37557,-0.000992739874340346,0.00347127073344744,-0.00779643051189732,0.00581095076321663,0.774892252069958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,40037,0.0012272413671251,0.00430911322477299,-0.00721862055342997,0.00967310328768017,0.775800103659607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37955,0.00092545798224832,0.00324955041034943,-0.00544366082203656,0.0072945767865332,0.775805034665286
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37937,-0.00241204803632589,0.00849764191716671,-0.0190674261939726,0.0142433301213209,0.776530380460157
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37567,0.00158073433168974,0.00564304395490198,-0.00947963181991813,0.0126411004832976,0.779389198276911
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37937,0.00112668948952605,0.00405742536456261,-0.00682586422501667,0.00907924320406876,0.781257803564141
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37557,-0.0011154474305222,0.00403572678621345,-0.00902547193150055,0.00679457707045616,0.782250439561271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,40209,-0.000559146329193039,0.00202506017374285,-0.00452826426972903,0.00340997161134295,0.782464559898235
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,37985,0.000732756283279087,0.0026614545357749,-0.00448369460683971,0.00594920717339789,0.783073269889916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40037,-0.00081253504431786,0.00297911552799611,-0.00665160147919023,0.00502653139055451,0.785053840002395
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37896,-0.00114146520906447,0.00422104209090587,-0.00941470770723998,0.00713177728911103,0.786839300515987
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40037,-0.00259923458283058,0.00974544254812512,-0.0217003019771558,0.0165018328114947,0.789693801739309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37477,-0.00141351180571986,0.00536398932642028,-0.0119269308855036,0.00909990727406389,0.792154936041039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37593,0.000499745600875194,0.00189884965390029,-0.00322199972076938,0.00422149092251977,0.792413394487048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,40008,0.00166667423364923,0.00638707269559399,-0.010851988249715,0.0141853367170135,0.794138430342825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37477,-0.000608356132657323,0.0023334419809904,-0.0051819024153985,0.00396519015008386,0.794318796705948
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37567,-0.0018013515903374,0.00691778208850824,-0.0153602044838136,0.0117575013031388,0.794563664167724
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,40367,0.000642179111202312,0.00247452291163387,-0.00420788579560007,0.00549224401800469,0.79524023864014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,40466,0.00149939608983818,0.00578848439247583,-0.00984603331941444,0.0128448254990908,0.795614759461781
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,37593,-0.000883161288665632,0.00342411817969124,-0.00759443292086046,0.00582811034352919,0.796469819297423
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37895,-0.00156247327102697,0.00616552275689432,-0.0136468978745398,0.0105219513324859,0.799946735701597
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40446,0.000952753248692093,0.00376958248609175,-0.00643562842404775,0.00834113492143193,0.800466444282455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,37937,0.000512953526590159,0.0020452235811173,-0.00349568469239975,0.00452159174558007,0.80196823324076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40531,-0.000543747959572087,0.00217162915053047,-0.0048001410946118,0.00371264517546763,0.802291191529218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37623,-0.00181418451007357,0.00727466139892364,-0.0160725208519639,0.0124441518318168,0.803067611881217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,39987,-0.00105012108083575,0.00421327447924576,-0.00930813906015745,0.00720789689848594,0.803177599828001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40300,-0.000451026726053174,0.00182031623708652,-0.00401884655074274,0.0031167930986364,0.804312614191771
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,39975,-0.000827612252997493,0.00334614858125079,-0.00738606347224904,0.00573083896625406,0.804653957827577
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37536,0.00118465005140011,0.00479424189149363,-0.00821206405592741,0.0105813641587276,0.80483585996303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37709,0.00138698380771869,0.00564636658833467,-0.00967989470541725,0.0124538623208546,0.80596330991372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,37477,0.000989428690258052,0.00404218839677999,-0.00693326056743072,0.00891211794794683,0.80663412017849
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,37937,0.00128598254076595,0.00525596212029393,-0.00901570321501015,0.0115876682965421,0.806714754829944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37709,0.00120599308448859,0.00497144208114421,-0.00853803339455407,0.0109500195635313,0.808331308574917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37536,0.00108193288935982,0.00446178322676735,-0.00766316223510418,0.00982702801382383,0.808405160559442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37895,0.00104803555913669,0.00432465528055839,-0.00742828879075776,0.00952435990903113,0.80852066977443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,37623,-0.00241721748755972,0.010297121282399,-0.0225995752010618,0.0177651402259423,0.81440881870001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37782,-0.00126951719386923,0.00541955235133826,-0.0118918398024922,0.00935280541475375,0.814796351927543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37623,0.000536873549822953,0.00229493836499103,-0.00396120564555947,0.00503495274520537,0.815036660309535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37567,-0.00127047207793937,0.00545895269945561,-0.0119700193688724,0.00942907521299363,0.81597327897753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37623,-0.000823271501816144,0.00358321606668431,-0.00784637499251739,0.0061998319888851,0.818283619473996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,40336,0.00127997306580103,0.00567064908245609,-0.0098344991358129,0.012394445267415,0.821422907528229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40417,0.00262150400096253,0.0116155108219735,-0.0201448972101056,0.0253879052120307,0.821445467821871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37536,-0.0011364031125688,0.00505551249522156,-0.0110452076032031,0.00877240137806546,0.822150086571741
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,37477,-0.00123008366175573,0.00551029526528581,-0.0120302623817159,0.00957009505820446,0.823357116848771
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37557,0.000802122713953933,0.0036003144882404,-0.00625449368299725,0.00785873911090512,0.823700553632794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,37567,-0.000680886898056534,0.00308608116101131,-0.00672960597363871,0.00536783217752564,0.825382760301527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,37593,-0.00084473457067131,0.00383218917234195,-0.00835582534846154,0.00666635620711892,0.82553866896523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,40211,0.000940472024795897,0.00426805024864106,-0.00742490646254059,0.00930585051213238,0.825600131907472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,37896,-0.00116792028208972,0.00530279950016017,-0.0115614073024036,0.00922556673822422,0.825682931642344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37937,0.000762588912503437,0.00351106326341254,-0.00611909508378513,0.00764427290879201,0.828058884165925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,37536,-0.0010108534632391,0.00471753451478035,-0.0102572211122086,0.0082355141857304,0.830335330839292
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40512,-0.000446030844277754,0.00209318330271621,-0.00454867011760152,0.00365660842904601,0.831261550415356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,37567,-0.000976825466321897,0.00460342260933012,-0.00999953378060893,0.00804588284796513,0.831957831118723
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,40354,0.00159546920912154,0.00757045998106312,-0.0132426323537622,0.0164335707720053,0.833085596016501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,39956,0.000613044860578402,0.00291262084220412,-0.00509569199014167,0.00632178171129848,0.833296783386163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37536,-0.000745159596950919,0.00355029600431186,-0.00770373976540216,0.00621342057150032,0.833759440195863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37557,-0.0006951158129667,0.00331719308056533,-0.00719681425087474,0.00580658262494134,0.834022634499457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,40336,0.000567866662723658,0.0027120035011898,-0.00474766019960834,0.00588339352505566,0.834146412016635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37477,0.00122218591687983,0.00588148717698141,-0.0103055289500037,0.0127499007837634,0.835386671292705
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37557,-0.000870365119151784,0.00419308174116011,-0.00908880533182561,0.00734807509352204,0.835566625909129
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,37477,0.000620470416132783,0.00303405631820279,-0.00532627996754468,0.00656722079981025,0.837964468051012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37666,-0.00147752011975472,0.00725001015533033,-0.0156875400242022,0.0127324997846927,0.83851637502491
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37593,-0.00056207901407333,0.00276742240278222,-0.00598622692352648,0.00486206889537982,0.839055631918365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,40037,0.00129035038686014,0.00640354852055074,-0.0112606047134193,0.0138413054871396,0.840305941925265
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,39956,-0.000687064083194776,0.00345389373261823,-0.00745669579912651,0.00608256763273696,0.842324412854247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37593,0.000777050752518994,0.00393586469480434,-0.00693724404929751,0.0084913455543355,0.843495502991872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40037,-0.00139649909180111,0.00707613103971439,-0.0152657159296413,0.0124727177460391,0.843553504175512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40300,-0.000751142994135697,0.00389663828372663,-0.00838855403023988,0.00688626804196849,0.847143974846422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37557,-0.000891464451532701,0.00463708580902277,-0.00998015263721734,0.00819722373415193,0.84755194431326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,37567,-0.00155679400540789,0.00819756308140248,-0.0176240176449568,0.014510429634141,0.849383092297725
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37593,0.000790958120853382,0.00417872355005805,-0.00739934003726039,0.00898125627896715,0.849874543583222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37945,0.000327693822388412,0.0017469435583095,-0.00309631555189821,0.00375170319667504,0.85120776144851
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,40300,0.000680282805243822,0.0036415390043171,-0.0064571336432177,0.00781769925370534,0.851810510824947
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,40039,0.00105000774362463,0.00564027118901829,-0.0100049237868512,0.0121049392741005,0.85231964765356
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37567,-0.00109094228144591,0.00590527203159895,-0.0126652754633799,0.010483390900488,0.853435518166932
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,37895,-0.000748096687215683,0.00404991119942401,-0.00868592263808675,0.00718972926365538,0.853452008385801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37557,0.000846916678163879,0.00461544878495911,-0.00819936294035597,0.00989319629668373,0.854411646897192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,37567,-0.000782223606768071,0.00430043775873474,-0.00921108161388816,0.00764663440035202,0.855668764318095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,37452,0.000652339275302928,0.0035929473779786,-0.00638983758553513,0.00769451613614099,0.855930054016468
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,37477,0.000412590868203052,0.00228718364034288,-0.004070289066869,0.0048954708032751,0.856847216286227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37955,0.000752107370338489,0.00418860611781457,-0.00745756062057807,0.00896177536125505,0.857500468415935
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37557,-0.000672562268916759,0.00374838890494328,-0.00801940452260558,0.00667427998477206,0.857605186940393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37955,-0.00123683744974324,0.00691100279417728,-0.0147824029263307,0.0123087280268442,0.857966751587777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,40484,-0.000704871418771831,0.00396641668926935,-0.00847904812973975,0.00706930529219608,0.858953073786585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,37623,0.000276150301333938,0.00157387857075348,-0.00280865169734288,0.00336095230001076,0.860722110171382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37895,0.000770703603764385,0.00443875046200003,-0.00792924730175568,0.00947065450928445,0.862158272728313
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,37593,0.000485125351052978,0.0028137291107017,-0.00502978370592235,0.00600003440802831,0.863114984290596
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37567,0.000652348088351396,0.00379984474672342,-0.00679534761522651,0.0081000437919293,0.863693674245963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,37477,-0.000821987213205095,0.00480829536503867,-0.0102462461286809,0.0086022717022707,0.864264244895745
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37567,-0.000922151818010039,0.0054056397378943,-0.0115172057042829,0.00967290206826278,0.864548249649582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,40039,0.000471816614645901,0.0027674182355186,-0.00495232312697056,0.00589595635626236,0.864627158744039
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,37557,0.000985715663617203,0.00579963818842088,-0.0103815751856877,0.0123530065129221,0.865042976074802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37536,0.000893475331269731,0.00532780542784461,-0.0095490233073057,0.0113359739698452,0.866821539382053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37455,0.000721049662895299,0.00430808545567153,-0.00772279783022089,0.00916489715601149,0.867080545217961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37593,0.000595152943205269,0.00357409502330021,-0.00641007330246314,0.00760037918887368,0.867751487214104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37536,0.000962491945295098,0.00588755653040209,-0.010577118854293,0.0125021027448832,0.870143819008004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37895,-0.000589655734179949,0.00361076179683782,-0.00766674885598208,0.00648743738762218,0.870280691311988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,40300,0.00130344535255055,0.00798388720138379,-0.0143449735621617,0.0169518642672628,0.87031620991388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37709,0.000442887205845493,0.0027425700833938,-0.00493255015760635,0.00581832456929733,0.871712944708027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39975,-0.000963690492011217,0.00597275514441202,-0.0126702905750588,0.0107429095910363,0.871821631350072
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37955,-0.000534916718931399,0.00333166642641869,-0.00706498291471204,0.00599514947684924,0.87244606134728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40336,0.00113676697969789,0.00712892620988082,-0.0128359283916685,0.0151094623510643,0.873309779043027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39975,0.0010564715411309,0.00673449737066495,-0.0121431433053724,0.0142560863876342,0.875345723111167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40336,-0.00153594012205002,0.00983171165147109,-0.0208060949589334,0.0177342147148333,0.875859182546963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37937,-0.00110964131965158,0.00717071177025089,-0.0151642363893433,0.0129449537500402,0.87702362087986
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,37814,0.000604953771000273,0.00392553982485127,-0.00708910428570821,0.00829901182770875,0.877527574815209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,39956,0.000722058351107992,0.0046954171923157,-0.00848095934583077,0.00992507604804676,0.877785693179957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37895,0.000738428600642659,0.00481886167312931,-0.00870654027869079,0.0101833974799761,0.878213566787197
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40037,-0.00114172580859143,0.00747976734275899,-0.0158020698003991,0.0135186181832162,0.878682666244666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,40286,-0.000550845557528489,0.00361624858000819,-0.00763869277434453,0.00653700165928756,0.878932441218802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37955,-0.000988995566258697,0.00649490798873305,-0.0137190152241755,0.0117410240916581,0.878974326516241
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37552,-0.00112274138939659,0.00744629182535768,-0.0157174733670976,0.0134719905883045,0.88015269660763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40417,-0.000350051175557603,0.00241542546512759,-0.00508428508720769,0.00438418273609248,0.884773342260516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,37562,-0.000546299558936395,0.00377879178359921,-0.00795273145479085,0.00686013233691806,0.885052684294318
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37593,0.000820372354026712,0.0056971937561105,-0.0103461274079499,0.0119868721160033,0.885505941374495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37536,-0.000483661186254707,0.00339200787889919,-0.00713199662889711,0.0061646742563877,0.886617405985494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37477,0.000523461011495897,0.00367242224938566,-0.0066744865973,0.00772140862029179,0.886656993635319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40039,-0.000426043152746869,0.00309254324412875,-0.00648742791123923,0.00563534160574549,0.890428198751876
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,37937,0.000440369746121222,0.00340794039492796,-0.00623919342793758,0.00711993292018003,0.8971864994149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,40417,0.000376801146492803,0.00292184325353634,-0.00535001163043843,0.00610361392342403,0.897390859189506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,40039,-0.000501884310679095,0.00391881570485716,-0.00818276309219913,0.00717899447084094,0.898094909511442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40154,0.000660448401326203,0.00521322962875605,-0.00955748167103565,0.0108783784736881,0.899189760682418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40300,-0.000290538784858254,0.00232078168974708,-0.00483927089676254,0.00425819332704603,0.900374679023162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37557,0.000692032085602254,0.00556108925154314,-0.0102077028474223,0.0115917670186268,0.900967369143265
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37567,-0.000755767981236948,0.00608834224640695,-0.0126889187841946,0.0111773828217207,0.901211379071271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37896,0.00055023911643821,0.00448789345432357,-0.00824603205403598,0.0093465102869124,0.902421561736466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37593,0.00093934838924509,0.0077368602829237,-0.0142248977652854,0.0161035945437756,0.903366496397986
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37683,0.000563656363626237,0.00464494865637916,-0.00854044300287691,0.00966775573012939,0.903417051772428
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37709,-0.000723865905302255,0.00606525642734603,-0.0126117685029005,0.011164036692296,0.905002812904454
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37623,-0.000585612877567563,0.0049174208884769,-0.0102237578189823,0.00905253206384715,0.905206316667009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37477,0.000333557980437525,0.00287877777503694,-0.00530884645863487,0.00597596241950992,0.907759010215471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,37593,0.000310213977167148,0.00268764927626456,-0.00495757860431138,0.00557800655864568,0.908112369484173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,37593,0.000479248639149293,0.00425471015836352,-0.0078599832712432,0.00881848054954179,0.910318048432108
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37982,0.000346464276293912,0.00308067510841882,-0.00569165893620697,0.0063845874887948,0.910457378799928
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,39920,-0.000336435744453884,0.00301345268701477,-0.00624280301100284,0.00556993152209507,0.911106649518076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39956,-0.000798738993202418,0.00716196176286287,-0.0148361840484136,0.0132387060620088,0.911201352111249
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37895,0.000925231008013885,0.00830247905578033,-0.0153476279413156,0.0171980899573433,0.91126884402826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,40037,-0.000496688271234013,0.00451134957881507,-0.00933893344571154,0.00834555690324352,0.912333475256416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37666,0.000649102436925014,0.00594345739900624,-0.0110000740651272,0.0122982789389772,0.913035257999564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39956,-0.00137239515773614,0.0125724862829374,-0.0260144682722935,0.0232696779568212,0.913078099256516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37557,0.000395965847268289,0.00363672385316243,-0.00673201290493007,0.00752394459946665,0.913299477853752
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,40466,0.00124387111011337,0.0115336271294945,-0.0213620380636958,0.0238497802839225,0.914118133922639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,37929,-0.000299291692589514,0.00277737154943068,-0.00574293992947366,0.00514435654429463,0.914187067926587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,37557,-0.000451150761621377,0.00421484440294249,-0.00871224579138865,0.00780994426814589,0.914760048917303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37955,-0.000222702214523686,0.00208195337672037,-0.00430333083289562,0.00385792640384825,0.914816021888118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,40354,-0.00064089878864427,0.00604719963877429,-0.0124934100806419,0.0112116125033533,0.915597383142854
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37536,-0.000920791100393239,0.00877863435366145,-0.0181269144335697,0.0162853322327832,0.916464688912287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37896,-0.000542037892679037,0.00517227634277674,-0.0106796995245214,0.00959562373916337,0.916538630554502
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,37879,0.000807125805921298,0.00778991815135269,-0.01446111377073,0.0160753653825726,0.917479137084335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37567,-0.000522275475842391,0.00505397094858624,-0.0104280585350714,0.00938350758338665,0.917695005707453
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37895,0.000782435594009362,0.00762646419085001,-0.0141654342200567,0.0157303054080754,0.918286097658624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,37557,-0.000494540504087866,0.00482662055358714,-0.00995471678911866,0.00896563578094293,0.91839231275051
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37955,-0.000247415914712017,0.00243898752125055,-0.00502783145636309,0.00453299962693905,0.9192010570036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40300,-0.000792713389880361,0.00788340940433661,-0.0162441958223801,0.0146587690426194,0.919905278608418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39975,-0.000716665959935921,0.00744022816505972,-0.015299513163453,0.0138661812435811,0.923265196052384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,39956,0.000511617820634456,0.00533720669047642,-0.00994930729269933,0.0109725429339682,0.923634016313659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37593,0.000188377767741112,0.00197290971301651,-0.00367852526977125,0.00405528080525347,0.923933280705061
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,40037,0.000252538249042061,0.00269432160027678,-0.00502833208750043,0.00553340858558455,0.925324995197393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39956,0.000540995884831773,0.00579779008742137,-0.0108226726865141,0.0119046644561777,0.925657932933661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39525,-0.000232153060600318,0.00252761567045495,-0.00518627977469201,0.00472197365349138,0.926821090840201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37477,0.000200456899572231,0.00225939970184364,-0.0042279665160413,0.00462888031518576,0.929304761041607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37477,0.000440476765433956,0.00499440334474927,-0.00934855379027462,0.0102295073211425,0.929723785111103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39975,-0.000443518730502534,0.00503704118081835,-0.0103161194449065,0.00942908198390144,0.929836927294029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40466,0.000995478939326226,0.0113264381499923,-0.0212043398346587,0.0231952977133111,0.929965323618633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,40039,0.00085807617034782,0.0100311026226625,-0.0188028849700707,0.0205190373107663,0.931831954829208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40286,-0.000217803123884906,0.00255825963244081,-0.0052319920034689,0.00479638575569909,0.93215337347981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39956,-0.000227675146773557,0.0027146174398665,-0.0055483253289119,0.00509297503536479,0.933160821517614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39956,-0.000435573474989392,0.00523938612779794,-0.0107047702854734,0.00983362333549458,0.933745708144576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37557,-0.000395920343171019,0.00490348049151642,-0.0100067421065432,0.00921490142020117,0.935647796507144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37955,-0.000471077645339402,0.00587299055381682,-0.0119821391308204,0.0110399838401416,0.936070738636265
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,40039,0.000206225071109585,0.00262184554957756,-0.00493259220606243,0.0053450423482816,0.937306893305273
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37937,0.000316221162492477,0.0040283358430945,-0.00757931708997275,0.00821175941495771,0.937432127043581
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,37477,0.000286392778917568,0.00370261638438478,-0.0069707353344766,0.00754352089231174,0.938347291804065
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,37895,0.00029125284231293,0.00393698899081558,-0.00742524557968561,0.00800775126431147,0.941028532496983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37593,0.000240521150775715,0.00325568021134329,-0.00614061206345713,0.00662165436500856,0.941109072731104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40223,0.000163582387384723,0.00225329705026457,-0.00425287983113383,0.00458004460590328,0.942127811874498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37896,-0.000490354527306119,0.00676209482377951,-0.013744060381914,0.0127633513273017,0.942193003639607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,40388,0.00017659508307389,0.00247432192648684,-0.00467307589284032,0.0050262660589881,0.943103303664335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37536,0.000406848861567703,0.00570550228232173,-0.0107759356117829,0.0115896333349183,0.943153592013749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37896,-0.000804268114435074,0.0113332628649994,-0.0230174633298339,0.0214089271009638,0.943426447977991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,40039,0.000415783624139462,0.005874706409968,-0.0110986409393978,0.0119302081876767,0.943577563873045
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37895,-0.000233129983102628,0.0033057260265138,-0.00671235299506968,0.00624609302886443,0.943778379622904
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37593,0.000382057595109546,0.00551090759191653,-0.0104193212850469,0.0111834364752659,0.94472996988683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37896,0.000162174888489424,0.00240198951417077,-0.00454572455928529,0.00487007433626413,0.946171211614893
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,40180,-0.000336427642133986,0.00511041469783662,-0.0103528404498938,0.00967998516562579,0.94751259944471
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,40497,0.00011649973225236,0.00177991927137657,-0.00337214203964571,0.00360514150415043,0.947814734202278
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,39956,-0.000280790493203326,0.00435354956212689,-0.00881374763497203,0.00825216664856538,0.94857539916945
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37593,-0.000210253522327588,0.0033276074603434,-0.00673236414460066,0.00631185709994548,0.949620474437654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37567,-0.000164999088514098,0.00262707049314229,-0.00531405725507299,0.0049840590780448,0.949920945101294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,40261,0.000211693983206183,0.00340379475972822,-0.00645974374586112,0.00688313171227349,0.950409507687656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40485,0.000168854152006995,0.00282223790760163,-0.00536273214689221,0.0057004404509062,0.952291874023878
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37557,-0.000252711027610722,0.0043125240205702,-0.00870525810792831,0.00819983605270687,0.953272136073777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,40039,0.000474531026179089,0.00811582234475643,-0.0154324807695435,0.0163815428219017,0.953375116234334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,37993,-0.000288992761321216,0.00503402237605095,-0.0101556766183811,0.00957769109573865,0.954221100030488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37709,0.000336670853543566,0.00601585691785224,-0.0114544087054468,0.012127750412534,0.955371403954316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,37424,-0.00017049967360524,0.00308845731909871,-0.00622387601903872,0.00588287667182824,0.955975637911771
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,40336,0.000179306884103519,0.00329336981862532,-0.00627569796040211,0.00663431172860915,0.956581465682589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37593,-0.000249455293716294,0.00460898018644787,-0.00928305645915413,0.00878414587172154,0.956837392561014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,37567,0.000330407571494889,0.00617064222360886,-0.0117640511867785,0.0124248663297683,0.957298423880077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40300,-0.000250143093815123,0.00474359226281473,-0.00954758392893199,0.00904729774130175,0.957945437185194
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,37567,-0.000198677230932036,0.00381303572632465,-0.00767222725452834,0.00727487279266427,0.958446030549507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,37985,-0.000321245167153476,0.00630892911334491,-0.0126867462293095,0.0120442558950026,0.959390715074248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40336,0.000382090001296365,0.00750605635022486,-0.0143297804451444,0.0150939604477371,0.959402476768746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37593,0.000123518740696578,0.00248451830910575,-0.00474613714515068,0.00499317462654384,0.960349965709383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37567,-0.000143840398712307,0.00294857978049425,-0.00592305676848105,0.00563537597105643,0.961093018511996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37937,-0.000109703709630714,0.00229636301328298,-0.00461057521566534,0.00439116779640392,0.961898015230798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,39975,-0.00027403083516611,0.00606337442335558,-0.012158244704943,0.0116101830346108,0.963952904197645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37567,-0.000156017946371886,0.0034732825303924,-0.006963651705941,0.00665161581319723,0.96417219627046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,39948,-0.00033105419450188,0.00783366857421364,-0.0156850445999606,0.0150229362109569,0.966291634653952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37557,0.000140569202109125,0.00353834199880139,-0.0067945811155416,0.00707571951975985,0.968311045320948
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,40517,-0.000113313551048089,0.00297590497633018,-0.00594608730465525,0.00571946020255907,0.969626757846301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,37985,9.68129480518786e-05,0.00257185785489896,-0.00494402844755009,0.00513765434365385,0.969972722509576
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,37477,0.000190664922993385,0.00507150800117108,-0.00974949075930193,0.0101308206052887,0.970010922329044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,37896,-0.000844133887250956,0.0228868391236548,-0.0457023385696143,0.0440140707951124,0.970578890943903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37567,-0.000232251425235285,0.00642003568829391,-0.0128155213742914,0.0123510185238208,0.971142546655164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37623,0.000131470711355168,0.00365172970403895,-0.00702591950856118,0.00728886093127152,0.971281061206666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37874,-0.000126239784764659,0.00366129076943875,-0.00730236969286461,0.00704989012333529,0.972495234528936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40229,8.94081023930367e-05,0.00260483065031355,-0.00501605997222153,0.0051948761770076,0.972619253222894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,37709,0.000100991243919254,0.00310987527438238,-0.00599436429387022,0.00619634678170872,0.974094242976745
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40354,-0.000232086313324252,0.00739070089322271,-0.0147178600640408,0.0142536874373923,0.974948960023887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,39956,-0.000195334696958524,0.00624374727043542,-0.012433079347012,0.0120424099530949,0.975042775120084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,37557,-9.7956308790872e-05,0.00321751932257308,-0.0064042941810341,0.00620838156345236,0.975712884741316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,37593,-0.000129025265730968,0.00433016279941184,-0.00861614435257817,0.00835809382111623,0.976229513475548
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37593,9.17167500097129e-05,0.00339389403190638,-0.00656031555252679,0.00674374905254622,0.978440965080814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37896,-0.000317354197492029,0.0129497267692257,-0.0256988186651744,0.0250641102701903,0.980448856891168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,39891,-6.59239048478648e-05,0.00270263454781198,-0.00536308761855934,0.00523123980886361,0.98053987790185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,40039,-0.000139816496057627,0.00587167107137529,-0.0116482917959532,0.0113686588038379,0.981002837028796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40327,5.33833482673044e-05,0.0024074718432206,-0.00466526146444506,0.00477202816097967,0.982309413766416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37666,0.000134708774853766,0.00609028581554407,-0.0118022514236126,0.0120716689733201,0.982353659973019
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,37896,6.10476458900752e-05,0.00306576081460956,-0.00594784355074465,0.0060699388425248,0.984113291175114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37567,6.36116299268221e-05,0.00323551139324938,-0.00627799070084197,0.00640521396069561,0.984314535162776
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40437,-3.72197367173483e-05,0.00200127388880344,-0.00395971655877209,0.00388527708533739,0.985162012534956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39920,-7.49894827098893e-05,0.00420632918822183,-0.00831939469162467,0.0081694157262049,0.985776478417462
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40354,-8.84112070829255e-05,0.00506365443792317,-0.0100131739054123,0.00983635149124649,0.986069893814754
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,40300,0.000100825605733015,0.00691064806741606,-0.0134440446064025,0.0136456958178685,0.988359547437298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,37477,7.74588080627282e-05,0.00539382213026679,-0.0104944325672602,0.0106493501833856,0.988542470439234
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37603,6.55024310182354e-05,0.00497724752859976,-0.0096899027250373,0.00982090758707377,0.989500044771221
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40039,4.47538471093399e-05,0.00371055782544871,-0.00722793949077013,0.00731744718498881,0.990376927995384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37985,2.64762162307553e-05,0.00243163905977539,-0.00473953634092902,0.00479248877339053,0.9913127910957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37709,3.976429070414e-05,0.00398851044325877,-0.00777771617808304,0.00785724475949132,0.992045604453902
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,40336,-5.84410182524079e-05,0.00595050264361866,-0.011721426199745,0.0116045441632402,0.992164073281852
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,37557,-2.67495673180466e-05,0.00283123307380201,-0.00557596639196998,0.00552246725733389,0.992461820868304
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,37477,-6.1098228264133e-05,0.00649063573649602,-0.0127827442717963,0.0126605478152681,0.992489537335589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,37878,-3.77530728467399e-05,0.00405385750848898,-0.00798331378948514,0.00790780764379166,0.992569645689324
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,37709,-0.000128254102022827,0.0151195376043786,-0.0297625478066049,0.0295060396025592,0.99323201452968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37937,7.25456294407435e-05,0.00877131771352839,-0.0171192370890749,0.0172643283479564,0.993401070793231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37709,4.37388539023372e-05,0.00655107883807162,-0.012796375668718,0.0128838533765227,0.994672993609404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39975,2.77344162298107e-05,0.00450596361801483,-0.00880395427507926,0.00885942310753888,0.995089093416347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,40327,1.01124485604602e-05,0.00171119015293256,-0.00334382025118735,0.00336404514830827,0.995284923457583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,40369,-9.62586004610294e-06,0.00260433472061661,-0.00511412191245466,0.00509487019236245,0.9970509985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37709,-4.06612895715358e-06,0.00594887385785475,-0.0116638588903525,0.0116557266324382,0.999454646347914
